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Cholesterol ester hydrolase (CEH) in adrenocortical cytosol was known
to be phosphorylated and activated, in response to ACTH in a cAMP-
dependent protein kinase mediated process. The purification of CEH from
bovine adrenocortical cytosol was attempted. The use of detergents to
solubilise the enzyme from lipid-rich aggregates was investigated and
sodium cholate was found to be effective. A purification procedure using
cholate solubilised enzyme was developed. The detergent interfered in
the operation of the ion-exchange columns, and pure enzyme was not
obtained. Hydrophobic chromatography was studied but it was found to
be unsuitable for the purification of CEH under the conditions investigated.
An affinity chromatography technique was developed using columns of glass
beads coated non-covalently with cholesterol oleate. Some positive
results were obtained but the low capacity of the columns combined with
the low concentration of the enzyme in the tissue cytosol prevented further
study of the purified activity. A further purification procedure
utilising a non-ionic detergent and gradient sievorptive chromatography
resulted in a 150-fold purification of CEH from bovine adrenocortical
cytosol with a recovery of about 25%. The specific activity of the
partially purified enzyme (CEH^ preparation) was approximately
60 nmol oleic acid produced.min 3.mg protein Labelling studies using
the CEH^ preparation, ATP and [i,3-3h] DFP suggested that the
enzyme activity was associated with a protein with Mr approximately 84 000.
A phosphoprotein phosphatase with Mr 35 000 wTas purified from bovine
adrenocortical cytosol to a state approaching homogeneity. The purified
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phosphatase was active when measured towards P-phosphoprotexn and
p-nitrophenyl phosphate. The role of this phosphoprotein phosphatase
in the modulation of cytosolic CEH activity was investigated, but the
enzyme did not deactivate partially-purified CEH from bovine adrenocortical
cytosol.
ii.
Cytosolic CEH in rat adrenal was found to exhibit a diurnal variation
in activity. The enzyme activity was significantly higher during the
dark phase. Serum corticosterone concentration reflected this variation
in CEH activity. In vivo experiments including acute ACTH administration
and dexamethasone suppression of pituitary ACTH secretion suggested that
ACTH was involved in the production and maintenance of the diurnal rhythm
of rat adrenal cytosolic CEH activity.
The protein components of bovine adrenocortical and rat adrenal
lipid droplets were investigated. The lipid droplets from both species
contained a major protein subunit with Mr 40 000 and several other minor
proteins. The protein profile was similar in both species. The Mr 40 000
apoprotein was able to be phosphorylated in rat lipid droplets but not
in bovine lipid droplets. The delipidated apoprotein was phosphorylated
in both cases. Bovine adrenocortical lipid droplets contained about 4%




The following abbreviations were used throughout the text:
ACTH - Adrenocorticotropic hormone, Corticotropin
Cholesterol - 5-Cholesten-3B~ol
CEH - Cholesterol ester hydrolase
DFP - Di-isopropyl phosphorofluoridate
DTT - Dithiothreitol
h - Hour(s)
(h)HDL - (human) High density lipoprotein
HSL - Hormone-sensitive lipase
LDL - Low density lipoprotein
LH - Luteinising hormone, lutropin
min - minute(s)
Mr - Molecular weight (relative molecular mass)
MSH - Melanocyte stimulating hormone
NCS - Nuclear Chicago Solubiliser - Tissue solubiliser
PAGE - Polyacrylamide gel electrophoresis
s - Second(s)
S.D. - Standard deviation
SDS - Sodium dodecyl sulphate
S.E.M. - Standard error of the mean
TCA - Trichloroacetic acid
TES - N-tris (hydroxymethyl) methyl-2 aminoethane sulphonic acid
TEMED - N,N,N',N'-tetramethylethylenediamine
VLDL - Very low density lipoprotein




Adenylate cyclase or ATP pyrophosphate-lyase (cyclising) (EC 4.6.1.1)
Alkaline phosphatase or orthophosphoric-monoester phosphohydrolase
(alkaline optimum) (EC 3.1.3.1)
Cholesterol acyltrar.sferase or acyl-CoA:cholesterol O-acyltransferase
(ACAT) (EC 2.3.1.26)
Cholesterol ester hydrolase (CEH), cholesterol esterase or sterol-
ester acylhydrolase (EC 3.1.1.13)
Cholesterol 7a-monooxygenase, cholesterol 7a-hydroxylase or
cholesterol, NADPH:oxygen oxidoreductase (7ot*-hydroxylating)
(EC 1.14.13.17)
Cholesterol 20-hydroxylase or cytochrome P-450 (EC 1.14.1.9)
Glyceraldehyde-phosphate dehydrogenase or D-glyceraldehyde-3-phosphate:
NAD+ oxidoreductase (phosphorylating) (EC 1.2.1.12)
Hydroxymethylglutaryl-CoA reductase (NADPH), HMGCoA-reductase or
mevalonate:NADP+ oxidoreductase (CoA-acylating) (EC 1.1.1.34)
Lecithin-cholesterol acyltransferase (LCAT) or lecithin:cholesterol
acyl transferase (EC 2.3.1.43)
Phosphoglycerate kinase or ATP:3-phospho-D-glycerate 1-phosphotransferase
(EC 2.7.2.3)
Phosphoprotein phosphatase or phosphoprotein phosphohydrolase
(EC 3.1.3.16)
Protein kinase or ATP:protein phosphotransferase (EC 2.7.1.37)
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1.
1.1 GENERAL INTRODUCTION
Cholesterol has been shown to play an important role as the sole
precursor for the steroid hormones produced in the adrenal cortex,
gonads and placenta (Sandor, Fazekas and Robinson (1976), Dufau and
Catt (1978), Simpson and Mason (1979)). The adrenal steroids fall into
two main groups. The mineralocorticoids, such as aldosterone, have a
primary effect on the excretion of Na+ and K+ and so regulate
electrolyte and water balance. The glucocorticoids, such as Cortisol
and corticosterone, exert major effects on carbohydrate, fat and
protein metabolism and play a vital but poorly-understood role in the
response to stress. After adrenalectomy an animal is in a very
unstable metabolic condition and soon dies in response to the slightest
stress. There are also several diseases resulting from adrenal
hypofunction (Addison's disease) and hyperfunction (Cushing's disease
or Cushing's syndrome) (see James (1975), Baxter and Rousseau (1979)).
The first and rate limiting step in the process of steroidogenesis
is the cholesterol side chain cleavage reaction which occurs in the
inner cristae of the mitochondria (Stone and Hechter (1954)).
The reaction is catalysed by a cytochrome P-45Crdependent mixed function
oxygenase (cytochrome P-450scc)and involves sequential hydroxylations
in the sterol side chain at C^2 a^d C^q followed by cleavage of the
cholesterol side chain between C^q and C^ to yield the key intermediate
pregnenolone and isocaproic aldehyde (McKerns (1968), Burstein,
Kimball and Gut (1970), Gower (1975)). In the adrenal cortex the
pregnenolone is further metabolised in the endoplasmic reticulum by
17a-hydroxylation and or 21-hydroxylation and by oxidation of the
38~hydroxysteroid A-5 structure to the 3-keto A-4 structure to form
deoxycortisol and deoxycorticosterone. The differential production of
these steroids is partly dependent upon the species (Sandor, Fazekas
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and Robinson (1976)). Deoxycortisol and deoxycorticosterone may then
be transported back into the mitochondria for llg-hydroxylation to
form Cortisol and corticosterone and in the zona glomerulosa,
18-hydroxylation may also occur to form aldosterone.
The process of steroidogenesis in the adrenal cortex is stimulated
by ACTH (reviewed Schulster (1974), Halkerston (1975), Haynes (1975),
Gill (1979), Tait, Tait and Bell (1980)). The mechanisms involved in
the ACTH-induced stimulation of steroidogenesis have been vigorously
investigated during the past twenty-five years. It was found that
incubation of bovine adrenocortical slices with ACTH resulted in a
marked increase in cAMP concentration in this tissue (Haynes (1958)).
Subsequently, it was shown that the addition of cAMP in vitro to rat
adrenal slices resulted in an increased corticoid production that was
similar to the effect of ACTH on this tissue (Haynes, Koritz and
Peron (1959)). These initial observations were confirmed by several
other studies (see Halkerston (1975)) and the role of cAMP as the
intracellular secondary messenger for the ACTH stimulus was established.
Investigation of the mechanism of action of cAMP led to the discovery
of a specific cAMP-binding protein in the cytosol and microsomes of
adrenal cortex (Gill and Garren (1969)). Following the discovery of
rabbit skeletal muscle cAMP-dependent protein kinase (Walsh, Perkins
and Krebs (1968)), a protein kinase from bovine adrenal cortex cytosol
was identified and it was shown that its activity was enhanced by cAMP
(Gill and Garren (1970)). The relationship between the cAMP-activatable
protein kinase and the previously discovered cAMP-binding protein was
subsequently elucidated (Gill and Garren (1970), Gill and Garren (1971))
and the mechanisms by which the nucleotide activates the cAMP-dependent
protein kinase are now well understood (see Flockhart and Corbin (1982)).
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The free catalytic-subunit of cAMP-dependent protein kinase
catalyses the transfer of the terminal phosphate group of ATP to various
protein acceptors and in this way can alter the activity or function of
the protein. The diverse manifestations of cAMP in different tissues
results from the phosphorylation of tissue-specific proteins by the
activated protein kinase (see Lincoln and Corbin (1978)). The specific
protein phosphorylated in adrenal cortex was not known. It is now
accepted that certain criteria should be satisfied to establish that a
given enzyme undergoes physiologically significant phosphorylation-
dephosphorylation. The criteria, as formulated by Krebs (1972) and
later modified (Krebs and Beavo (1979)) can be summarised as follows.
The enzyme in question should be phosphorylated in vitro at a
significant rate in a protein kinase mediated reaction; the enzyme
should be dephosphorylated by a phosphoprotein phosphatase; the enzyme
should also show significant changes in its functional properties and
these should correlate with the degree of phosphorylation. Furthermore,
the most difficult criterion which has been met by only very few
enzymes, so far, demands that the phosphorylation-dephosphorylation of
the enzyme occurs in vivo and correlates with functional changes.
Cholesterol is stored in the adrenal cortex as large cholesterol
ester rich lipid droplets in the cytoplasm (Garren, Gill et al. (1971)).
It was known that administration of ACTH to animals resulted in a
reduction of the cholesterol content of the adrenal cortex (Sayers,
Sayers g£ al. (1944)) and this was due, almost entirely, to a decrease
in the esterified cholesterol (Davis and Garren (1966)). The mobilization
of cholesterol esters in response to ACTH was not affected by prior
injection of cycloheximide, an inhibitor of protein synthesis in the
cytosol which blocks ACTH stimulation of adrenal steroidogenesis.
It was discovered that administration of ACTH to rats, 15 min before the
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adrenals were removed, led to an activation of cholesterol ester
hydrolase (CEH) in the adrenal homogenate (Shima, Mitsunaga and Nakao
(1972)). Approximately 70% of the neutral CEH activity was associated
with the cytosol, and thus was present in the same subcellular
compartment as the lipid droplets (Trzeciak and Boyd (1973)). Ether
anaesthesia stress, which is known to increase the ACTH concentration
in the blood (Matsuyuna, Ruhmann-Wennhold and Nelson (1971)), has been
shown to activate cytosolic CEH and produce cholesterol ester depletion
in rat adrenal lipid droplets (Trzeciak and Boyd (1973)). Administration
of cycloheximide did not affect these observations, but there was an
increase in free cholesterol in the lipid droplets (Boyd and Trzeciak
(1973)). This was consistent with previous findings that cycloheximide
did not affect the ACTH-induced increase in intracellular cAMP
(Grahame-Smith, Butcher et. al. (1967)). Incubation of rat adrenal
cytosol in vitro with cAMP and ATP resulted in the activation of CEH
(Trzeciak and Boyd (1973)). The cAMP-dependent activation of
adrenocortical cytosolic CEH has been confirmed by several other studies
(Trzeciak and Boyd (1974), Naghshineh, Treadwell et al. (1974),
Beckett and Boyd (1975), Wallat and Kunau (1976), Beckett and Boyd
(1977), Pittman and Steinberg (1977), Naghshineh, Treadwell et al.
(1978)). The activation was dependent upon the presence of cAMP-
dependent protein kinase (Beckett and Boyd (1977), Naghshineh,
Treadwell e_t al. (1978)) and inhibited by the heat-stable inhibitor of
cAMP-dependent protein kinase (Beckett and Boyd (1977)). Incubation
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of impure preparations of the enzyme in vitro with cAMP and y- P
ATP led to the activation of the enzyme with concomitant phosphorylation
of the protein fraction (Trzeciak and Boyd (1974), Beckett and Boyd
(1977), Wallat and Kunau (1976), Naghshineh, Treadwell et al. (1978)).
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Furthermore, incubation of the P-labelled enzyme fraction with Mg
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(Trzeciak and Boyd (1974), Wallat and Kunau (1976)) or exogenous
alkaline phosphatase (Beckett and Boyd (1977)) led to a decrease in the
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enzyme activity with a concomitant loss of P from the protein
fraction. These studies led to the conclusion that ACTH stimulated
steroidogenesis in the adrenal cortex via cAMP by the cAMP-dependent
protein kinase-mediated phosphorylation and activation of cytosolic
CEH. This results in the hydrolysis of cholesterol esters in the
lipid droplets and an increase in the free cholesterol available to
the rate limiting side chain cleavage reaction.
The situation with CEH in other steroidogenic tissues is less
clearly defined. Beckett (1975) found that LH administration in vivo
caused a depletion of esterified cholesterol in the lipid droplets
from rat corpora lutea, associated with a two-fold stimulation of
cytosolic CEH. Dibutyryl cAMP, when added to bovine corpus luteum
cytosol, gave an activation of CEH (Bisgaier, Treadwell and Vahouny
(1979)). However, it had also been shown that LH addition to bovine
corpora lutea did not produce any evidence for the activation of CEH
(Goldstein and Marsh (1973)). Furthermore LH administration in vivo
to pregnant mare serum gonadotropin-primed immature female rats did
not stimulate CEH, but incubation of the ovarian cytosol with cAMP
in vitro did activate CEH (Gorban (1980)). Cholesterol ester depletion
upon LH administration in vivo has been demonstrated in rat and rabbit
(Behrman and Armstrong (1969), Flint and Armstrong (1978)), and cAMP
accumulation and the stimulation of cAMP-dependent protein kinase have
been observed in rat ovarian tissue in response to LH (Mason, Schaffer
and Toomey (1973), Lamprecht, Zor et_ a\_. (1973)). However
in ovarian tissues, the different cell types and the physiological
state of the organ complicate the interpretation of some of the
published work.
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Although little work has been carried out, there is no evidence
to suggest CEH in the Leydig cell cytoplasm is activated by LH or
cAMP. It has been shown recently that cytosolic, neutral CEH activity
in certain macrophages can be activated by cAMP in a cAMP-dependent
protein kinase mediated reaction (Khoo, Mahoney and Steinberg (1981)).
The physiological significance of this activity in macrophages is not
clear, although it may be involved in atherosclerotic lesions derived
from macrophages. Finally the enzyme has been shown to be not
activatable in liver tissue (Gorban (1980)). It could be argued that
liver does not require a rapid activation of CEH as a rapid increase
in cholesterol ester hydrolysis is not required as it is in the adrenal
cortex.
1.2 ADRENAL STEROIDOGENESIS
1.2.1 Role of lipoproteins
Cholesterol has been established as the sole precursor for
steroidogenesis. It was known that the bulk of adrenal cholesterol
in man was derived from plasma cholesterol (Borkowski, Delcroix and
from plasma into rat adrenal cortex (Dexter, Fishman and Ney (1970)).
Goldstein and Brown (1974) showed that cultured human fibroblasts
possess a specific uptake mechanism for cholesterol in plasma
lipoproteins. These cells had a specific receptor for the apolipoprotein
B found in LDL and after binding to the cell the LDL was internalised
by endocytosis and degraded by lysosomal action (Brown and Goldstein
(1976)). The so-called LDL receptor pathway has subsequently been
found in mouse Y-l adrenal tumour cells (Faust, Goldstein and Brown
(1977)), 4-APP treated-rat adrenal cortex (Balasubramaniam, Goldstein
et al. (1977)), cultured bovine adrenocortical cells and fresh bovine
adrenal membranes (Kovanen, Faust et al. (1979)) and human fetal
adrenal membranes (Brown, Kovanen and Goldstein (1979)).
Levin (1972)) and that ACTH
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It has been shown that ACTH increases the number of LDL receptors
in cultured mouse and bovine adrenal cells and human fetal adrenal
membranes in vitro (Faust, Goldstein and Brown (1977), Kovanen, Faust
et al. (1979), Ohashi, Carr and Simpson (1981a)). The number of
receptors are also increased some 5-fold in mice and rats in vivo
when the animals are rendered lipoprotein deficient. The receptor
has been partially purified from bovine adrenal cortex, which has one
of the highest LDL receptor densities of all tissues, and antibodies
have been prepared against it (Schneider, Goldstein and Brown (1980)).
The LDL receptor can also bind apolipoprotein E and so lipoproteins
with this apoprotein can also be taken up via this pathway (Mahley
and Innerarity (1977)). However in rats the LDL concentration is low
and 70-80% of plasma cholesterol is carried in HDL. It was found that
rat adrenal cells can take up HDL, including human HDL which has no
apolipoprotein E, by a receptor-mediated mechanism that was stimulated
by ACTH (Gwynne and Hess (1980)). Human fetal adrenal membranes have
also been shown to contain specific, saturable binding sites for HDL
(Ohashi, Carr and Simpson (1981b)). Further kinetic studies on the
uptake of lipoproteins have shown that rat adrenal can take up both
LDL and HDL cholesterol, by separate mechanisms, and that HDL was the
major source of adrenal cholesterol in this species (Anderson and
Dietschy (1981)). The mechanism of HDL uptake is not known, but it
is not via endocytosis and total degradation (Gwynne and Hess (1980)).
With the evidence obtained from these and several other studies a
working model for cholesterol homeostasis in adrenal cortex has been
formulated (see Brown, Kovanen and Goldstein (1979)). In this model,
shown schematically in Fig. 1.1, adrenal cholesterol is considered to
be in three pools. There is a fixed pool of free cholesterol in cell
membranes, a metabolically active, rapidly turning over pool of free
B ACUTE STIMULATION
FC= Free Cholesterol
EC= Ester if ied Cholesterol
LP= Lipoprotein
Fig. 1.1. Model for cholesterol homeostasis in the adrenal gland.
The model shows sequential changes in cholesterol input and output
during acute and prolonged stimulation of steroid secretion.
(Taken from Brown, Kovanen and Goldstein (1979)).
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cholesterol (FC) and stored cholesterol, esterified to fatty acids in
the lipid droplets (EC). Net output from FC is via steroidogenesis
and secretion of steroids and net input to FC can come from de novo
synthesis, plasma lipoprotein uptake or hydrolysis of cholesterol
ester. Upon acute stimulation by ACTH, the rapid increase in cholesterol
utilization for steroidogenesis is met by a large and rapid increase
in cholesterol ester hydrolysis via activation of CEH. There may also
be a slight stimulation of de novo synthesis via activation of HMGCoA-
reductase (and HMGCoA synthase in the rat). If the stimulation is
prolonged the EC stores will be depleted and the cholesterol will now
be supplied by plasma lipoproteins via increased uptake due to
induction of receptors. As the stimulus ceases there will be a
transient phase where uptake from lipoproteins will exceed steroid
hormone output, leading to stimulation of microsomal ACAT activity by
membrane cholesterol, increased esterification and build up of EC
stores. Normal turnover of receptors leads to a return to the basal
state where a dynamic equilibrium probably exists with the low level
of steroid hormone output balanced by input from lipoprotein uptake.
1.2.2 The role of ACTH and pituitary peptides
The stimulation of steroidogenesis by ACTH does not require the
entrance of the ACTH polypeptide into the adrenal cell (Schimmer, Ueda
and Sato (1968), Richardson and Schulster (1972)). These studies
indicated the existence of a specific receptor or receptors on the
external surface of the adrenal cell plasma membrane that bound the
ACTH molecule. ACTH is a single polypeptide chain of 39 amino-acids,
although only the N-terminal 24 are required for full steroidogenesis
(Schwyzer (1977), Seelig and Sayers (1973)). Durand and Locatelli
(1980) have shown that the number of ACTH receptors in rabbit adrenals
decreases after hypophysectomy and receptor numbers are restored by
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administration of ACTH. However, studies with I-labelled ACTH
indicated that there are 'spare receptors' as it was possible to get
further ACTH binding to rat adrenocortical cells after maximal
steroidogenesis was attained (Mcllhinney and Schulster (1975)).
Scatchard analysis in the same study also suggested two types of
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receptor, but a recent study using I-labelled ACTH Q, that wasl~JO
biologically active with a high specific activity, found only one
class of binding site (Buckley and Ramachandran (1981)).
The interaction of ACTH with its receptor may involve the activation
of membrane phospholipase and alteration of the membrane phospholipids,
or changes in the sequestration of membrane calcium (see Rubin and
Laychock (1978)). The hormone-receptor complex on the external surface
of the cell membrane interacts with and activates the catalytic subunit
of adenylate cyclase, located on the inner surface of the cell membrane,
leading to the production of cAMP from ATP (see Rodbell (1978)).
The activation of the catalytic subunit of adenylate cyclase by the
hormone-receptor complex is mediated by the guanine nucleotide-binding
regulatory protein. Bound GTP is required for full activity of adenylate
cyclase,and the subsequent hydrolysis of GTP to GDP is required to
'switch-off' the activity (Rodbell (1978), Ross and Gilman (1980)).
Cholera toxin stimulates cAMP accumulation and steroidogenesis in
isolated rat adrenocortical cells (Palfreyman and Schulster (1975))
by ADP-ribosylating a 41 000-45 000 Mr polypeptide in the GTP binding
protein, preventing hydrolysis of GTP and so activating the adenylate
cyclase (Ross and Gilman (1980)). Recently, a 68 000 Mr protein has been
implicated in the coupling of the ACTH hormone receptor to the adenylate
cyclase complex (Watt and Schimmer (1981)).
The release of ACTH from the pituitary is stimulated by
corticotropin-releasing factor (CRF) (Turkelson, Arimura et al. (1981),
possibly via a cAMP-dependent process (Labrie, Vielleux et al. (1982)).
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It now appears that CRF has been identified as a 41 amino-acid peptide
(Vale, Spiess et al. (1981)), and has been purified, sequenced and
synthesised by solid-phase techniques.
In the anterior pituitary, ACTH is initially synthesised as part
of a larger molecule with Mr 30 000-34 000 called pro-opiomelanocortin
(POMC) (see Herbert (1981)). This molecule is a polyprotein containing
the sequences of MSH, ACTH and g-endorphin, and is first cleaved into
an ACTH containing fragment and g-lipotropin (g-LPH). In the
anterior lobe of the pituitary the ACTH sequence is cleaved from the
former fragment but in the intermediate lobe the ACTH, so produced,
can be cleaved further to form a-MSH. Similarly in the intermediate
lobe, g-lipotropin is cleaved to form y-lipotropin (y-LPH) and
g-endorphin (see Fig. 1.2a).
Pederson and Brownie (1979) found that in stressed rats, CEH
activity in adrenal cytosol was increased along with increased
steroidogenesis, but in hypophysectomised rats, injections of
purified ACTH or ACTH gave increased steroidogenesis withouti jy l z4
activation of CEH. This was in contrast to previous studies where
hypophysectomy in rats reduced CEH activity in the adrenal and ACTH
administration restored the enzyme activity to the control level
(Behrman and Greep (1972)) or above (Trzeciak, Mason and Boyd (1979)).
Further work investigating various peptides derived from the 31 COO
precursor showed that the N-terminal end prior to the ACTH sequence
(16K fragment), in similar amounts to ACTH, had a slight effect in
potentiating ACTH^_2^ action, and that trypsin treatment of the 16K
fragment increased this effect (Pederson and Brownie (1980)).
Administration of the trypsin digest alone to hypophysectomised rats
resulted in an apparent increase in adrenal CEH activity but no
activation of side chain cleavage, whereas when added with ACTH^^
a
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Fig. 1.2. a) The processing of the Mr 30 000-34 000 pro-opiomelanocortin
(POMC) molecule in the pituitary gland.
(Taken from Herbert (1981)).
b) Relationship of the POMC molecule to some of the peptides derived
from it. The 16K fragment has an apparent Mr approximately 16 000 on
SDS/PAGE. Amino acid analysis has shown this molecule is identical to
N-P0C^_^g with Mr approximately 12 000.
(Taken from Estivariz, Iturriza et al. (1982)).
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there was an increase in both adrenal CEH activity and serum corticosterone.
It was subsequently discovered that a synthetic peptide of 27 amino-acids
(a portion of the 16K fragment, also termed y -MSH or N-POCri
o 51—/o
see Fig. 1.2b) containing the y-MSH sequence plus a carboxyl terminal
extension was responsible for the stimulation of CEH activity
(Pederson, Brownie and Ling (1980)). These workers postulated that in
stress, ACTH^_^g and another peptide, derived from the POMC molecule,
were necessary for the full stimulation of steroidogenesis in the
adrenal cortex.
Another study has found that circulating human pituitary y-MSH precursor
(pro-y-MSH or N-P0C^_^^, see Fig. 1.2b) at nanomolar concentrations,
potentiated and enhanced ACTH action in perfused rat and human adrenal
cells (Al-Dujaili, Hope e£ al. (1981)), but this effect was blocked by
transcription inhibitors such as actinomycin D (Al-Eujaili, Williams
et al. (1982)). It has also been found that a-MSH and g-MSH stimulate
corticoid production in rat capsular cells (Vinson, Whitehouse et al.
(1980), Matsuoka, Mulrow et al. (1981)) and decapsular cells (Li, Ng
and Cheng (1982)), although at concentrations about 1000 x greater
than ACTH. The physiological significance and the possible role of
these peptides in stimulating adrenal steroidogenesis are not known.
1.2.3 The role of cAMP
The role of cAMP as the secondary, intracellular mediator of the
action of ACTH in the adrenal cortex was established by Grahame-Smith,
Butcher et al. (1967). However further studies produced some
conflicting evidence that may be summarised briefly as follows:
In isolated adrenal cells or perfusion systems, the correlation was poor
between the rise in cAMP and increasing steroidogenesis at low or high
ACTH concentrations (Mackie, Richardson and Schulster (1972), Charchman,
Jaanus and Rubin (1971), Hudson and McMartin (1975)). Analogues of ACTH
such as NPS-ACTH (o-nitropnenylsulphonyl derivative) could give maximal
steroidogenesis with little effect on cAMP (Moyle, Kong and
Ramachandran (1973)). Low levels of ACTH that did not appear to
activate protein kinase could give increased steroidogenesis
(Richardson and Schulster (1973)).
These observations suggested that the cAMP secondary messenger
concept in its simplest form may not be a full explanation of acute
stimulation of steroidogenesis by ACTH in the adrenal cortex
(Ramachandran and Moyle (1977)). However there are several possible
reasons for the discrepancies observed in some experiments.
There are deficiencies in certain cAMP assays, and furthermore,
stimulated adrenal cells generally produce more cAMP than is needed
for complete protein kinase activation and maximal steroidogenesis
(Podesta, Milani at al. (1979a)). It is also possible that there may
be two populations of ACTH receptors with differing affinities,
as suggested by Scatchard analysis (Mcllhinney and Schulster (1975)).
Furthermore, it has been suggested that there may be spare receptors
so that there could be more ACTH receptors than are required for
maximal steroidogenesis (Mcllhinney and Schulster (1975)). It has
been shown in isolated adrenal cells that bound cAMP correlates well
with steroidogenesis at low concentrations of ACTH (Podesta, Milani
et al. (1979a)). Recently a mathematical model was produced that
suggested there may be an obligatory separation of hormone binding
and biological response curves in systems dependent upon secondary
mediators (Strickland and Loeb (1981)).
Some investigators have found that ACTH stimulated cGMP production
in isolated rat adrenal cells with no increase in cAMP (Sharma, Ahmed
and Shanker (1976), Perchellet, Shanker and Sharma (1978)), but this
was contrary to all previous evidence. Subsequent studies have again
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shown that ACTH caused a rise in intracellular cAMP while cGMP levels
remained virtually unchanged (Laychock and Hardman (1978), Saez, Evain
and Gallet (1978), Podesta, Milani et al. (1979a)).
Recently, further work using ACTH analogues that were either
agonists or antagonists to ACTH has suggested that, of the two possible
classes of ACTH receptor (Mcllhinney and Schulster (1975)), only one
operates via the cAMP-dependent mechanism while the other operates
through some other unknown mechanism (Bristow, Gleed et al. (1980)).
However Rae, Gutmann et al. (1979) have shown the obligatory need for
cAMP-dependent protein kinase in ACTH-stimulated steroidogenesis in
adrenal cells. Therefore, although most of the evidence is in agreement
with cAMP as the major intracellular mediator of ACTH action in adrenal
cells, there may be other factors involved at the secondary messenger
level in response to ACTH, such as calcium (Rubin, Jaanus and
Charchman (1972), Mahaffee and Ontjes (1980), Podesta, Milani et al.
(1980), Garcia, Laychock and Rubin (1982)) or cGMP (Guillemant and
Guillemant (1981)).
1.2.4 The role of cAMP-dependent protein kinase and other protein
kinase activities
Since the discovery by Gill and Garren (1970) of a cAMP-dependent
protein kinase in adrenal cortex, and subsequently, the importance of
CEH as a major substrate for the kinase in this tissue (Trzeciak and
Boyd (1974)), several other protein kinase activities have been found
in adrenal cortex. Both type I and type II cAMP-dependent protein
kinase activities have been isolated from and characterised in bovine
adrenal cortex, but the possible differential roles of each activity
in ACTH-stimulated steroidogenesis are not known (Ebert and Finn (1981)).
The heat-stable inhibitor protein (HSIP) of cAMP-dependent protein
kinase was also found in adrenal cortex (Cochet, Job and Chambaz (1977b)).
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A cGMP-dependent protein kinase has also been purified from bovine
adrenal cortex (Ahrens, Paul et al. (1982)). This enzyme had the same
structure as other cGMP-dependent protein kinases(see Flockhart and
Corbin (1982)) and was activated by cGMP, its analogues and possibly
also by calmodulin. Several cyclic nucleotide-independent protein
kinase activities have been isolated from bovine adrenal cortex since
the initial discovery of a cAMP-independent protein kinase that
preferentially phosphorylated casein (Cochet, Job and Chambaz (1977a&b)).
These investigators have now isolated four cyclic nucleotide-
independent protein kinase activities that phosphorylated casein,
including one that utilised ATP as a phosphate donor (CKA) and three
that could use either ATP or GTP (CKG) (Cochet, Job et al. (1980)).
A specific heat-stable inhibitor protein (CKG I) of the CKG type
was also found (Job, Cochet et al. (1979)) and the effect of the
inhibitor could be reversed by polyamines (Job, Pirollet et al. (1979)).
Further studies have shown that naturally occurring glycosaminoglycans
can inhibit the CKG type (Pirollet, Feige et al. (1980), Feige,
Pirollet et_al. (1980)).
A protein kinase (PK380), whose activity was independent of
2+ . .
cyclic nucleotides, Ca or calmodulin, and that specifically
phosphorylated an endogenous 120 000 Mr protein and eukaryotic
initiation factor 2cx (eIF-2a), was found in bovine adrenal cortex
(Kuroda and Sharma (1980)). The PK380-catalysed phosphorylation of
eIF-2ot was found to be inhibited by polyamines such as spermine,
spermidine and putrescine (Kuroda, Merrick and Sharma (1982)).
A further study showed that incubation of intact adrenocortical cells
proteins with Mr 39 000 and 76 000, and after addition of ACTH,
a further protein with Mr 87 000 was phosphorylated (McPherson and
phosphorylation of two endogenous
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Ramachandran (1980)). This protein kinase activity was found to be
cyclic nucleotide-independent and was associated with the outer surface
of the plasma membrane. A cAMP-dependent protein kinase, that is an
integral protein in the plasma membrane of bovine adrenocortical
cells has also been described (Reitherman, Chen et al. (1981)).
Takai, Kishimoto _et a_l. (1977) described a protein kinase activity
in rat brain tissue that was independent of cyclic nucleotides,
phosphorylated histone and protamine, and was activated by limited
2+
proteolysis with Ca -dependent protease. The activated kinase
(protein kinase C) could phosphylate phosphorylase kinase and glycogen
synthase. Subsequently, it was found that the protein kinase could be
2+
activated without proteolysis by Ca and phospholipids (Takai,
Kishimoto et al. (1979a)). Unsaturated diacylglycerol sharply
2+
decreased the Ca and phospholipid concentrations required for full
activation (Takai, Kishimoto et al. (1979b)). Phosphatidyl serine was
established as the sole phospholipid effective for the activation,
although other phospholipids could modulate this effect (Kaibuchi,
2+ . .
Takai and Nishizuka (1981)). This Ca -activated, phospholipid-
dependent protein kinase has been demonstrated in heart (Limas (1980)),
platelets (Takai, Kaibuchi et al. (1981)), pancreas, liver, vas deferens
and adrenals (Wrenn, Katoh and Kuo (1981)). It was shown that in
2+
adrenal 30 000 x g supernatant, phosphatidyl serine/Ca stimulated the
phosphorylation of proteins with Mr 49 000, 18 000 and 13 000, whereas
2+
there was no calmodulin/Ca —dependent phosphorylation (Wrenn, Katoh
2+
and Kuo (1981)). However, there was Ca /calmodulin-dependent protein
kinase activity found in adrenal membranes in a previous study
(Schulman and Greengard (1978)).
2+
The role of the Ca -activated, phospholipid-dependent protein
kinase in an integrated cellular control system in platelets has been
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discussed (Michell (1981)), but the role of this kinase in basal or
ACTH-stimulated steroidogenesis in the adrenal cortex is not known at
present. Similarly, the roles, if any, of cyclic nucleotide-
independent protein kinases in adrenal steroidogenesis are unknown.
However, possible roles for cGMP-dependent protein kinase (Ahrens,
Paul e£ a_l. (1982)) and membrane bound protein kinase (Bristow, Salmon
and Schulster (1981)) have been postulated.
1.2.5 The role of protein synthesis and polyphosphoinositides
It had been known for some time that inhibitors of cytosolic
protein synthesis such as puromycin or cycloheximide, inhibit ACTH-
stimulated steroidogenesis (Ferguson (1963), Garren, Ney and Davis
(1965)). This led to the belief that some rapidly turning over,
labile protein was involved in ACTH-stimulated steroidogenesis, and
that ACTH, in some way stimulated its synthesis. The role of this
protein and the mechanism by which ACTH stimulates its formation are
still unclear. A major site of stimulation by ACTH in adrenal
steroidogenesis is the mitochondrial, side chain cleavage reaction.
This is probably due to increased association of substrate cholesterol
with cytochrome P-450 rather than an intrinsic effect on the activity
see
of the components of the enzyme system (see Tait, Tait and Bell (1980)).
It was thought that the labile protein may be a "cholesterol translocase"
involved in the transport of free cholesterol to the inner mitochondrial
membrane (Simpson and Mason (1979)) but the overall evidence now
suggests that the labile protein may be involved in the binding of
cholesterol to cytochrome P-450^^ (Koritz and Hall (1964)).
It was known that cAMP-dependent protein kinase phosphorylated
adrenocortical ribosomal proteins in vitro (Walton and Gill (1973)).
Furthermore, it has been shown that an Mr 150 000 polypeptide in
adrenocortical polyadenylated messenger ribonucleoprotein complex was
phosphorylated by endogenous cAMP-dependent protein kinase (Moore and
Sharma (1980)). In both cases the phosphorylation of these proteins
may lead to some translational control, resulting in the increased
synthesis of the labile protein in response to the ACTH stimulus.
However, evidence from experiments with perfused rat adrenocortical
cells prompted the authors to suggest that the labile protein may exist
as a stable, inactive precursor, with cAMP converting it, possibly via
phosphorylation, into an active but unstable form (Lowry and McMartin
(1974)). Some recent work on LH- and cAMP-stimulated steroidogenesis
in isolated rat Leydig cells has provided evidence that this may be
the mechanism operating in gonadotropin-stimulated steroidogenesis
(Cooke, Lindh and Van Der Molen (1979)).
There is no evidence for the identity, in molecular terms, of the
labile protein. In general, in vivo labelling studies with ACTH and
labelled amino-acids have only given information about the long-term
trophic effect of the hormone. Incubation of adrenal slices with
labelled leucine and ACTH showed a general trophic effect on most
proteins, with marked stimulation of a cytosolic protein with Mr 30 000
(Dazord, Gallet and Saez (1978)) and a mitochondrial protein with
Mr 134 000 (Dazord, Gallet de Santerre and Saez (1981)). A similar
experiment with mouse Y-l adrenocortical cell cultures showed amino-acid
incorporation into eight mitochondrial proteins, six of which were
translated in the cytoplasm including possibly, adrenodoxin and its
reductase (Ray, Horst and Kowal (1980)). Using cultured bovine
adrenocortical cells it has also been shown that long-term ACTH
stimulation induced the synthesis of mitochondrial cytochrome P —450^
first as a 54 500Mr precursor, possibly by an increase in the
transcription of messenger RNA (DuBois, Simpson et al. (1981)).
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Recently, however, a series of experiments have suggested that
the cycloheximide-sensitive factor may be involved in phospholipid
metabolism. It was known that polyphosphoinositides were implicated
in the regulation of membrane permeability and synaptic transmission
in neurons, and possibly many other membrane events (Michell (1975)).
Furthermore ACTH was known to affect polyphosphoinositide metabolism
in rat brain membranes (Jolles, Wirtz et al. (1979)). It was also
reported that ACTH increased adrenal polyphosphoinositides and it was
suggested that they could stimulate cholesterol side-chain cleavage
2+
via the polyphosphorylated head group m a Ca -dependent process
(Farese, Sabir and Vandor (1979), Farese and Sabir (1979)). To be an
intermediary in the ACTH stimulatory pathway, the polyphosphoinositides
must fulfil certain criteria such as rapid synthesis and degradation
preceding rapid changes in steroidogenesis in response to ACTH;
a sustained increase during prolonged ACTH; graded increases paralleling
graded steroidogenesis in response to doses of ACTH; an increase in
response to stress; an increase in response to cAMP; dependence
2+
upon Ca ; dependence on protein synthesis. A subsequent study
claimed that polyphosphoinositides fulfilled these criteria and it
was postulated that the ACTH-induced rise in cAMP caused an increase
in polyphosphoinositides (along with activation of protein kinase)
and these stimulated the cholesterol side-chain cleavage reaction
(Farese, Sabir et al. (1980)).
The cAMP-induced rise in polyphosphoinositides was inhibited by
cycloheximide. Further labelling studies (Farese, Sabir and Larson
(1980a), Farese, Sabir and Larson (1981a)) and kinetic studies
(Farese, Sabir and Larson (1980b), Farese, Sabir and Larson (1981b))
showed that ACTH stimulated a rapid rise in phosphatidic acid and
2+
phosphatidyl inositol that required Ca and was blocked by cycloheximide.
However the conversion of phosphatidic acid to polyphosphoinositide was
rapid and not inhibited by cycloheximide, and so the cycloheximide-
sensitive factor was postulated to be a rapidly turning over protein
involved in the de novo synthesis of phosphatidic acid. Similar work
has been performed with bovine luteal cells and LH, producing similar
results (Davis, Farese and Marsh (1981)). However, cAMP has not
always mimicked the effects of the hormones in these experiments
(Farese, Sabir and Larson (1980a), Davis, Farese and Marsh (1981)).
Furthermore, whereas the ACTH stimulation of phosphatidic acid
concentration appeared to be due to an increase in the diacylglycerol
precursor, the cycloheximide inhibition appeared to be due to
decreased diglyceride kinase (Farese, Sabir and Larson (1981c)).
Therefore the identity of the cycloheximide-sensitive factor,
or labile protein, is still unclear, as are the main mechanisms
involved in ACTH or cAMP induction of the protein. However, the
possibility that ACTH may stimulate the formation of diacylglycerols
2+ . .
may lead to the discovery of a role for the Ca -sensitive, phospholipid-
dependent protein kinase discussed in Section 1.2.4.
1.2.6 The role of protein phosphorylation
The classical pathway for cAMP-mediated regulation is via protein
and enzyme phosphorylation through the action of cAMP-dependent protein
kinase (see Krebs and Beavo (1979), Cohen, (1980), Flockhart and
Corbin (1982)). Hardie (1981) reviewed the enzymes involved in lipid
biosynthesis that can be phosphorylated, although not all were regulated
by cAMP. In the adrenal cortex it was discovered that CEH was
phosphorylated and activated by cAMP-dependent protein kinase in
response to ACTH or cAMP (Trzeciak and Boyd (1973)). The cAMP-
dependent phosphorylations of ribosomal protein (Walton and Gill (1973))
and a protein in polyadenylated messenger ribonucleoprotein complex
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(Moore and Sharma (1980)) have also been demonstrated and the possible
role of these phosphorylations in ACTH-stimulated steroidogenesis was
discussed in Section 1.2.5. However, many other proteins are known to
be phosphorylated in adrenal cortex in response to ACTH or cAMP.
Podesta, Milani et al. (1979b) have shown that incubation of
32
intact, isolated adrenocortical cells with and ACTH or cAMP
resulted in increased phosphorylation of a cytosolic protein with
Mr 150 000. Receptor bound cAMP, corticosterone production and
appearance of the phosphorylated protein all increased in parallel.
32
Koroscil and Gallant (1980) incubated rat adrenal quarters with P^
and ACTH, and found consistent and distinctive phosphorylation and
dephosphorylation of specific proteins in cytosolic, microsomal and
mitochondrial fractions. The changes in phosphorylation preceded the
increase in corticosterone and the degree of phosphorylation was dose-
dependent for ACTH and correlated well with corticosterone production.
Furthermore, cAMP was found to give an identical effect to ACTH,
whereas cGMP gave a pattern similar to the control. A comparative
study of the ACTH effect on phosphorylation-dephosphorylation in_ vivo
and in vitro was also performed where results obtained by injecting
32
P^ and ACTH into the intact animal were compared with results obtained
from experiments with rat adrenal quarters or isolated cells (Koroscil
and Gallant (1981)). Although fewer proteins were labelled in vivo
the patterns obtained were very similar to the in vitro experiments.
The phosphorylation-dephosphorylation effects in vitro were not
affected by protein synthesis inhibitors which completely inhibited
corticosterone production. Incubation of bovine adrenocortical plasma
r 321
membrane fractions with y- P ATP and ACTH or cAMP resulted m the
enhanced phosphorylation of several proteins within 10 s (Bristow,
Schulster and Rodnight (1981)).
The identities of all these proteins phosphorylated or dephosphorylated
in response to ACTH and cAMP in adrenal cortex are not known and so the
steroidogenically important phosphorylations have not been identified
in these studies. Although it was known from several studies that CEH
was modulated by phosphorylation in response to cAMP, the lack of a pure
preparation had prevented the identification of the enzyme protein
(Trzeciak and Boyd (1974), Wallat and Kunau (1976), Beckett and Boyd
(1977)).
1.2.7 The role of cholesterol ester hydrolase (CEH)
Haynes (1958) showed that incubation of bovine adrenocortical
slices with ACTH resulted in increased cAMP, and that the addition of
cAMP in vitro to rat adrenal slices stimulated corticoid production
similar to the effect of ACTH (Haynes, Koritz and Peron (1959)).
A cAMP-dependent protein kinase was discovered in adrenocortic aL
cytosol by Gill and Garren (1970), and this enzyme is now established
as an obligatory component for full ACTH-stimulated steroidogenesis
(Rae, Gutmann et al. (1979)). Cholesterol is stored in the adrenal
in cytoplasmic lipid droplets, mainly as the ester of long-chain
fatty acids (Moses, Davis et al. (1969), Beckett and Boyd (1975)).
It was known that ACTH caused a reduction in the cholesterol content
of the adrenal gland (Sayers, Sayers et al. (1944)) which was
subsequently shown to be due almost entirely to a decrease in esterified
cholesterol (Davis and Garren (1966)). It was then shown that rat
adrenal CEH activity could be significantly enhanced by the prior
injection of ACTH (Shima, Mitsunaga and Nakao (1972)). All these
experimental observations were linked together when Trzeciak and Boyd
(1973) showed that ether anaesthesia stress, which increases blood ACTH,
stimulated the activity of CEH in rat adrenal cytosol and also the
depletion of cholesterol esters in the lipid droplet fraction.
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Nearly 70% of the CEH was found in the cytosol and incubation of the
cytosol _in vitro with cAMP and ATP led to an activation of the enzyme.
The cAMP-dependent activation of cytosolic CEH in adrenal cortex
has been confirmed by several other studies (Trzeciak and Boyd (1979),
Naghshineh, Treadwell _et al. (1974), Wallat and Kunau (1976), Beckett
and Boyd (1977)) and was shown to be dependent upon cAMP-dependent
protein kinase (Trzeciak and Boyd (1974), Beckett and Boyd (1977),
Naghshineh, Treadwell _et al. (1978)). Incubation of partially purified
r 321 .CEH with y- P ATP and cAMP resulted m an increase m enzyme
. . 32
activity with concomitant transfer of P into the protein fraction.
Subsequent incubation of the phosphorylated enzyme with millimolar
2+ . 32
Mg revealed a decrease in activity with concomitant release of P-
phosphate from the phosphorylated protein (Trzeciak and Boyd (1974),
Wallat and Kunau (1976)). Addition of bovine liver alkaline phosphatase
greatly increased the dephosphorylation and deactivation of the enzyme
(Beckett and Boyd (1977)). This circumstantial evidence indicated that
CEH was phosphorylated and activated by cAMP-dependent protein kinase
in response to the ACTH stimulus, and dephosphorylated and deactivated
2+
by the action of a Mg -stimulated phosphoprotem phosphatase. The cAMP,
2+
Mg and ATP concentrations required for the activation and deactivation
are physiological (see Boyd and Gorban (1980)), but direct evidence
of the phosphorylation and its significance iri vivo requires pure
enzyme.
32 .
Beckett and Boyd (1977) reported P-incorporation into a protein
with Mr 41 000 that exhibited esterase activity. However this
preparation was only 57-fold purified, and a major assumption was
made in comparing the results obtained on native polyacrylamide gels
and SDS polyacrylamide gels. Furthermore, other proteins were
phosphorylated and esterase activity (an activity stain) was measured
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using 1-napthol propionate as substrate. Naghshineh, Treadwell et al.
(1978) claimed a 600-fold purification of CEH from bovine adrenal
cortex, but there was no SDS/PAGE evidence to support this and specific
phosphorylation of a single protein was not reported. There have been
no other reports on the purification of cytosolic CEH from adrenal
cortex.
To establish that an enzyme, such as CEH, undergoes physiologically
significant phosphorylation-dephosphorylation, certain criteria must
be satisfied (see Section 1.1). Ultimately, before all these criteria
can be met, a pure preparation of enzyme must be obtained so that
specific phosphorylation can be shown and correlated with changes in
activity. However, it may be possible to meet these criteria if the
enzyme can, at least, be identified on SDS/PAGE gels. This may be the
only way of identifying and correlating changes in activity and
phosphorylation _in vivo in response to different metabolic situations.
Further investigation of the phosphorylation process will also require
pure enzyme protein. The site of the phosphorylation in CEH is
unknown. Most phosphorylated proteins investigated were found to be
phosphorylated on a serine or threonine residue (see Krebs and Beavo
(1979)) although tyrosine residues have been found to be phosphorylated
by some virus-induced protein kinase activities (Eckhart, Hutchinson
and Hunter (1979), Hunter and Sefton (1980)). The amino-acid sequence
about the phosphorylation site in CEH is also unknown. Sequence studies
on proteins phosphorylated by cAMP-dependent protein kinase have
shown that the phosphorylated serine was always 2 or 3 residues
C-terminal to a pair of basic amino acids (see Krebs and Beavo (1979)).
Furthermore the number and possible stoichiometry of the phosphorylation(s)
and the specific biochemical effects, such as conformational changes,
are unknown in CEH, and pure enzyme would be required to study these aspects.
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Therefore, the urgent need in the study of adrenocorticol cytosolic CEH
was the identification and purification of the enzyme protein.
There was a possibility of obtaining information about the in vivo
regulation of CEH by ACTH without the purification of the enzyme.
It was known that both ACTH and adrenal corticoids show a diurnal
variation in their secretion in animals such as rats (Boissin,
Nouguier-Soule and Assenmacher (1976)). It could be expected that
adrenal CEH would also exhibit a diurnal rhythm in its activity in
response to the variation in ACTH. The only evidence to date, from
experiments where CEH was measured at two points in the 24 h cycle,
suggested no variation in the enzyme activity (Pederson and Brownie
(1979)). However more time points would be required before a clear
pattern could be elucidated, or not.
The role^/the cytosolic lipid droplets in ACTH-stimulated
steroidogenesis had not been fully investigated. The lipid composition
of the lipid droplets was well known (Moses, Davis et_ a_l. (1969),
Beckett and Boyd (1975)), and the effect of diet and ACTH on the lipids
in the droplets had been studied (Beckett and Boyd (1975), Trzeciak and
Boyd (1974)). However, little was known about the protein fraction
of the lipid droplets, although this was known to be about 2% by
weight of the total (Boyd and Trzeciak (1973)). The structure and
function of the protein component and its relationship to the cytosolic
CEH was unstudied. As the cholesterol esters in the lipid droplets are
the natural substrates for the enzyme in vivo there must be a close
association between the enzyme and the lipid droplets. Accordingly it
was considered essential to investigate the lipid droplet protein
fraction to elucidate whether this protein exerted a physiological
effect on the CEH activity.
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1,3 HORMONE-SENSITIVE LIPASE (HSL)
The effect of hormones such as adrenalin, noradrenalin, glucagon
and ACTH in stimulating adipose tissue lipolysis had been known for
several years (Vaughan and Steinberg (1963)). The rate-limiting step
in the hydrolysis of the stored triacylglycerols was known to be the
triacylglycerol lipase (Vaughan and Steinberg (1965)). This lipolytic
activity was found to be increased by adrenalin or cAMP (Rizack (1964)),
and was therefore termed the hormone-sensitive lipase (HSL) (Vaughan,
Berger and Steinberg (1964)). Subsequent studies demonstrated that
partially purified HSL was phosphorylated and activated by cAMP-
dependent protein kinase (Huttunen, Steinberg and Mayer (1970),
Corbin, Riemann et al. (1970), Khoo, Steinberg et al. (1976)) and
deactivated by phosphoprotein phosphatase (Severson, Khoo and Steinberg
(1977), Khoo, Steinberg and Lee (1978), Severson and Sloan (1980)).
Thus, the hormonal regulation of adipose tissue triacylglycerol lipase
(HSL) appeared to involve phosphorylation and dephosphorylation of the
lipase by a cAMP-dependent protein kinase and a phosphoprotein
phosphatase, respectively (reviewed Steinberg (1978)). Recently,
experiments with intact rat adipocytes have shown that the HSL enzyme
was phosphorylated in vivo and that the phosphorylation of the enzyme
and lipolysis were both increased by the addition of noradrenalin
and decreased by the addition of insulin (Belfrage, Fredrikson et al.
(1980), Nilsson, Stalfors et al. (1980)).
A CEH activity, that was activatable by cAMP and cofractionated
with HSL through limited purification, was found in rat adipose tissue
(Pittman, Khoo and Steinberg (1975)). The physiological role for a
high level of activatable CEH in adipose tissue was not known as the
role of cholesterol in adipose tissue was unclear, although there was
a fairly large amount of cholesterol present when expressed relative to
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cell protein (Farkas, Angel and Avigan (1973)). Similarly a triacylglycerol
lipase activity, that was activated by ACTH in. vivo, was found in rat
adrenals (Gorban and Boyd (1977)). This activity extensively
cofractionated with CEH activity and was activated by cAMP and ATP
in vitro (Pittman and Steinberg (1977)). The physiological role of a
high activity of activatable triacylglycerol lipase in adrenal cortex
was not known, although there are significant amounts of triacylglycerol
in the adrenal (Popjak (1944)). Both CEH and HSL activities found in
adrenals and adipose tissue have similar subcellular distribution and
are regulated in a similar manner. These activities also essentially
copurify and show concerted binding to the two different substrates.
Therefore, it was postulated that the two activities were catalysed by
the same enzyme protein (Gorban and Boyd (1977), Pittman and Steinberg
(1977)).
Some evidence to the contrary was also presented by Pittman and
Steinberg (1977), where CEH and triacylglycerol lipase in rat adrenal
appeared to show differing solubilities in ammonium sulphate and the CEH
activity was selectively inhibited by chloropyrifos oxone. However,
both activities in bovine adrenocortical cytosol were found to be
inactivated by chlorpyrifos oxone (Gorban (1980)). The earlier results
may be re-interpreted from recent findings suggesting that bovine
adrenocorticol cytosol may contain two triacylglycerol lipase activities
with the main activity being associated with CEH activity (Yeaman,
Cook and Lee (1980)). Therefore the relationship between CEH in the
adrenal and HSL in adipose tissue was unclear and required further
investigation.
1.4 PH0SPH0PR0TEIN PHOSPHATASES
The role of phosphoprotein phosphatases in the regulation of enzyme
activity by reversible phosphorylation reactions is less well known than
the role of protein kinases (see Krebs and Beavo (1979)). Much work has
been performed in recent years to rectify this situation. However this
area has proved to be even more complicated and confusing than the
protein kinase field. Most work on phosphoprotein phosphatases has
centred on glycogen metabolism using tissues such as liver, skeletal
muscle and cardiac muscle with phosphorylase a, or other glycogen
metabolising enzymes, as substrate (see Fischer and Brautigan (1982)).
It now appears that a major problem in elucidating the role of
phosphoprotein phosphatases will be associated with the purification
of the physiological forms of the enzyme. In many studies, phosphoprotein
phosphatase purifications revealed multiple molecular weight forms of
the enzymes from very high (300 000-200 000) to low (30 000)(Kalala,
Goris and Merlevede (1973), Kato, Kobayashi and Sato (1974),
Kobayashi and Kato (1977), Antoniw, Nimmo et al. (1977)). There was a
body of evidence suggesting that phosphorylase phosphatase had a
molecular weight of approximately 260 000 (Killilea, Mellgren et al.
(1979), Mellgren, Aylward et al. (1979)). It was also discovered that
the high molecular weight forms could be dissociated by treatment with
ethanol to yield a phosphoprotein phosphatase with Mr 30 000-35 000
(Brandt, Killilea and Lee (1974)). Several other harsh, denaturing
treatments could also lead to the production of the low molecular
weight phosphoprotein phosphatase, but increasing salt concentration
could also dissociate the Mr 260 000 phosphoprotein phosphatase
(Khandelwal, Zinman and Ng (1980)). The Mr 35 000 phosphoprotein
phosphatase was found to have low substrate specificity and generally
no ion requirements and has been termed the multifunctional phosphoprotein
phosphatase (Krebs and Beavo (1979)). It was postulated that the
Mr 35 000 phosphoprotein phosphatase was the catalytic subunit of many
of the high molecular weight, physiological forms of phosphoprotein
phosphatase, with the other subunits conferring substrate specificities,
ion requirements and other regulatory controls on the activity of the
catalytic subunit (Brandt, Capulong and Lee (1975), Kobayashi and Kato
(1977)). There have been studies investigating the structure of the
physiological, high molecular weight forms, but little is known about
the specific functions of the other subunits (Tamura and Tsuiki (1980),
Tamura, Kikuchi et_ al. (1980), Imazu, Imaoka et al. (1981)).
The dissociation of the high molecular weight forms to release the
Mr 35 000 subunit has been shown in liver (Killilea, Brandt et_ _al. (1976)),
heart (Li, Hsiao and Chan (1978)), adrenal (Li (1979)) and various other
tissues including skeletal muscle, brain, kidney and uterus (Li and
Chan (1981)). However, not all phosphoprotein phosphatases may contain
this catalytic subunit, as one group has purified, from skeletal
muscle, a catalytic subunit with Mr 70 000 (F ) which was activated by
a further subunit with Mr 50 000 (Fa)(Yang, Vandenheede et al. (1980b),
Vandenheede, Yang et al. (1980)). Although this activation required
2+
ATP-Mg , no phosphorylation was involved in the reaction (Yang,
Vandenheede _et al. (1980a)). This enzyme was first discovered in
adrenal cortex (Merlevede and Riley (1966)) and has since been found
in liver, skeletal and cardiac muscle from rat and rabbit (Yang,
Vandenheede _et al. (1980a)). The relationship of this phosphoprotein
phosphatase to the other phosphoprotein phosphatases is not fully
understood (Vandenheede, Yang and Merlevede (1981), Stewart, Hemmings
et al. (1981)).
Phosphoprotein phosphatases have been purified from adrenal cortex
resulting in high molecular weight forms (Kalala, Goris and Merlevede
(1973), Ullman and Perlman (1975)), or, after ethanol treatment, the
Mr 35 000 subunit (Li (1979)). These phosphoprotein phosphatases were
active towards enzymes of glycogen metabolism or synthetic phosphoprotein
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substrates such as phosphoprotamine, but no phosphoprotein phosphatase
purified from adrenal cortex had been studied with respect to its role
in the deactivation of CEH. It was known that incubation of CEH with
2+
millimolar Mg resulted in a deactivation of the enzyme (Trzeciak and
Boyd (1973)), and that adrenal phosphoprotein phosphatases were
2+ 2+
stimulated by Mg or Mn (Merlevede and Riley (1966), Ullman and
Perlman (1975)). Therefore it was postulated that the deactivation of
CEH was catalysed by a phosphoprotein phosphatase, and this was
confirmed when exogenous bovine liver alkaline phosphatase was shown
to deactivate CEH (Beckett and Boyd (1977)).
Partially purified phosphoprotein phosphatase from chicken adipose
2+
tissue was found to deactivate HSL from the same tissue in a Mg
dependent reaction (Severson, Khoo and Steinberg (1977)). Furthermore,
a low molecular weight phosphoprotein phosphatase had been purified
from rat adipose tissue and this was also found to deactivate HSL
(Severson and Sloan (1980)). However, there had been no investigation
of the role of endogenous, adrenocortical cytosolic phosphoprotein
phosphatase in the regulation of cytosolic CEH activity in the adrenal
cortex.
1.5 HEAT-STABLE INHIBITOR PROTEINS OF cAMP-DEPENDENT PROTEIN KINASE
AND PHOSPHOPROTEIN PHOSPHATASE
It was known that a heat-stable, trypsin-labile protein capable of
inhibiting cAMP-dependent protein kinase was present in many tissues
including adrenal cortex (Walsh, Ashby et al. (1971), Krebs and Beavo
(1979), Cochet, Job and Chambaz (1977b)). The inhibitor has a molecular
weight of 11 300 and binds to the catalytic subunit with a of about
-9
2 x 10 M and so blocks the activity (Krebs and Beavo (1979)).
The physiological role of this protein is not known but it may inhibit
the catalytically active protein kinase when cAMP concentrations are low.
30.
A second inhibitor of cAMP-dependent protein kinase, isolated from rat
testis, has a molecular weight of 21 600 and also inhibits cAMP
phosphodiesterase. A third inhibitor ("type II inhibitor") from brain,
inhibits protein phosphorylation catalysed by several protein kinases
including cAMP-dependent protein kinase (see Krebs and Beavo (1979))..
A heat-stable inhibitor protein of the cyclic nucleotide-independent
protein kinase that can use either ATP or GTP as a phosphate donor
(CKG) has been found in adrenal cortex (Job, Cochet et al. (1979)).
Heat-stable protein inhibitors of phosphoprotein phosphatase were
discovered in rabbit liver (Brandt, Lee and Killilea (1975)), skeletal
muscle (Huang and Glinsmann (1975)) and later in various tissues including
adrenal cortex (Huang, Tao and Glinsmann (1977)). Two types of inhibitor
are known to exist. Inhibitor - 1, purified to homogeneity from skeletal
muscle, had a molecular weight of about 20 000-26 000 and was found to be
phosphorylated by cAMP-dependent protein kinase, and only in this form
did it inhibit phosphoprotein phosphatase (Nimmo and Cohen (1978a&b)).
It was later found to be dephosphorylated by phosphoprotein phosphatase
and it did not inhibit its own dephosphorylation (Foulkes, Jefferson and
Cohen (1980)). In vivo experiments have shown that the degree of
phosphorylation of inhibitor - 1 was modulated by administration of
adrenalin in skeletal muscle (Tao, Huang et al. (1978), Foulkes and
Cohen (1979)) and adipose tissue (Belsham and Denton (1980)) and insulin
in skeletal muscle and adipose tissue (Foulkes, Jefferson and Cohen
(1980), Belsham and Denton (1980)). Inhibitor - 2 has also been
purified to homogeneity, has a molecular weight of about 33 000 in rabbit
skeletal muscle and is not modulated by phosphorylation (Huang and
Glinsmann (1976), Foulkes and Cohen (1980)). A physiological role for
inhibitor - 2 was postulated recently when it was discovered to be an
essential protein for the full activation of the F^ phosphoprotein
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phosphatase by the F activating protein (Vandenheede, Goris et al.
Si — ——■
(1981), Yang, Vandenheede et al. (1981)).
It was thought that the heat-stable inhibitors may be subunits of
the high molecular weight phosphoprotein phosphatases, that are released
by heat treatment, but destroyed by ethanol treatment. A recent study,
however, has provided evidence that the activity of the Mr 35 000
catalytic subunit was not related to destruction of the inhibitor
protein (Jett and Hers (1981)). A heat-stable protein, that prevented
2+
the deactivation of HSL by a Mg -dependent phosphoprotein phosphatase
was found in chicken adipose tissue (Severson and Sloan (1977)).
This inhibitor was isolated from chicken adipose tissue by a similar
procedure to that used for the isolation of bovine adrenal phosphoprotein
phosphatase inhibitors (Huang, Tao and Glinsmann (1977)). However it
is not known whether the adipose tissue phosphoprotein phosphatase
inhibitor is phosphorylatable.
The heat-stable protein inhibitor of cAMP-dependent protein kinase,
phosphoprotein phosphatase inhibitor - 1 and inhibitor - 2 have all
been demonstrated in adrenal cortex (Cochet, Job and Chambaz (1977b),
Huang, Tao and Glinsmann (1977)). The existence of cAMP-dependent
protein kinase, phosphoprotein phosphatase and their respective heat-
stable inhibitor proteins in adrenal cortex led Gorban and Boyd (1980)
to propose an integrated control system for cytosolic CEH as shown in
Fig. 1.3. In this system a rise in intracellular cAMP and the subsequent
activation of cAMP-dependent protein kinase would not only directly
activate CEH, but also "switch off" the deactivation of the enzyme by
phosphoprotein phosphatase through the phosphorylation and activation
of phosphoprotein phosphatase inhibitor - 1. There had been no
investigation of the role of phosphoprotein phosphatase or any of the
heat-stable inhibitor proteins in adrenocortical cytosol and so this


















































Utilised lor Utilised lor energy
pregnenolone synthesis purposes OR
OR extruded used lor prostaglandin
from cell biosynthesis
Fig. 1.3. Postulated control system for the regulation of CEH activity
in adrenal cortex.
(Taken from Gorban and Boyd (1980)).
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1.6 THE AIMS OF THE PRESENT STUDY
The urgent need in the study of adrenocortical cytosolic CEH is to
obtain a pure preparation of the enzyme. When this is achieved there
are three main areas to be investigated.
Firstly the. criteria formulated by Krebs (1972) and later modified
by Krebs and Beavo (1979) must be studied to establish whether the
phosphorylation-dephosphorylation is physiologically significant and
occurs iri vivo. Secondly, the phosphorylation process must be studied
in detail to elucidate the site(s) of phosphorylation, the amino-acid
sequence about the site(s), the number and stoichiometry of the site(s),
the order of phosphorylation of different sites and the precise
biochemical and molecular effects of the phosphorylation. Finally the
regulation of the enzyme must be investigated to establish whether the
posulated control mechanism (see Fig. 1.3) operates in vivo.
Considering these three areas of investigation as the ultimate
aim, it was hoped that the following lines of research might resolve
several of the main problems:
1. To further purify the cytosolic CEH from bovine adrenocortical cytosol
using three major protein separation techniques, not previously attempted
with this enzyme; detergent solubilisation, hydrophobic chromatography
and affinity chromatography.
2. To identify the CEH enzyme protein in bovine adrenocortical cytosol,
and investigate its relationship with the HSL of adipose tissue cytosol.
3. To purify a phosphoprotein phosphatase from bovine adrenocortical
cytosol and investigate its role in the dephosphorylation and deactivation
of bovine adrenocortical cytosolic CEH in vitro.
4. To investigate the regulation of CEH in rat adrenal by ACTH in vivo.
5. To identify the protein components of rat adrenal and bovine
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2.1 MATERIALS
Cholesterol oleate (99% pure), glycerol trioleate (98% pure), oleic
acid, essentially fatty acid-free bovine serum albumin, cholic acid,
cGMP, type II (bovine heart) cAMP-dependent protein kinase, catalytic
subunit of cAMF-dependent protein kinase, PAGE blue 83 and Coomassie
brilliant blue G were all obtained from Sigma (London) Chemical Co. Ltd.
(Poole).
Cholesterol [,"c] oleate (approximately 50 mCi.mmol *") , glycerol
tri- fl—^C J oleate (48 mCi.mmol "*") , N orthophosphate (1 mCi.ml \
carrier free), iodide (100 mCi.ml \ carrier free) and £i,3-^h|dFP
(6 Ci.mmol ^) were all obtained from The Radiochemical Centre Ltd.,
Amersham.
Phosphoglycerate kinase/glyceraldehyde 3-phosphate dehydrogenase
suspension from yeast/rabbit muscle, ATP and cAMP were obtained from
Boehringer Corporation (London) Ltd., Lewes.
ACTH (Acthar) was a product of Armour Pharmaceutical Co. Ltd.
(Eastbourne).
Dexamethasone sodium phosphate (Decadron) was a product of Merck
Sharp Dohme Ltd. (Hoddesdon).
NCS tissue solubiliser was obtained from G.D. Searle and Co. Ltd.
(High Wycombe).
Shaltiel hydrophobic chromatography test kits and crystalline
bovine serum albumin were obtained from Miles Laboratories, Slough.
Sepharose CL-4B, Sephadex G-25, Sephadex G-100, Sephacryl S-200,
DEAE-Sephadex A-50, QAE-Sephadex A-25 and Cibacron blue - Sepharose 4B
were obtained from Pharmacia (Great Britain) Ltd., Hounslow.
Hydroxylapatite (Bio-Gel HTP) was a product of Bio Rad Laboratories
Ltd. (Watford).
DEAE-Cellulose (DE52) was a product of Whatman Ltd. (Maidstone, Kent).
Ultragel AcA34 was obtained from LKB Instruments Ltd. (South Croyden, Surrey)
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C13 E^2 detergent (Berol 038) was a gift from Dr. Per Belfrage,
Department of Physiological Chemistry, University of Lund, Lund, Sweden.
All other common reagents and chemicals were obtained from Sigma
(London) Chemical Co. Ltd., BDH (Poole, U.K.) or Koch-Light (Bucks, U.K.)
and were of analytical grade.
2.2 BOVINE ADRENAL CORTEX
Bovine adrenals were obtained from the local abattoir and transported
to the laboratory on ice, arriving there within one hour of the animals'
death. The adrenal glands were trimmed of adhering fat, cut longitudinally
and the medulla removed and discarded. The cortex was scraped from the
capsule and immersed in ice cold 0.25 M sucrose containing 1 mM EDTA
and 10 mM potassium phosphate buffer pH 7.4. When phosphoprotein
phosphatase was to be prepared from the adrenal cortex, 10 mM Tris-HCl
buffer pH 7.4 at 4°C replaced the potassium phosphate buffer. A 20%
(w/v) homogenate was prepared using a Potter-Elvehjem glass/teflon
homogeniser. The homogenate was centrifuged and the 105 000 x g
supernatant prepared as described in Section 2.4.
2.3 ANIMALS AND ANIMAL PRETREATMENT
For experiments on the in vivo variation of CEH the experimental
animals were adult female rats (150-200 g) of the Wistar strain bred
in the Faculty Animal Facility, Hugh Robson Building, University of
Edinburgh. They were maintained on a stock diet consisting of 25%
skimmed milk powder, 5% dried yeast and 70% wholemeal flour. They were
given water ad libitum. The animals were divided randomly into two
groups. One group was kept in the normal light dark cycle (light
08.00-20.00 h), while the other group was maintained in the reversed




Adult female rats (150-200 g) of the Wistar strain were divided
randomly into two groups. One group received subcutaneous injections
of 8 i.u. ACTH (Acthar Coricotrophin (sterile)) dissolved in 0.2 ml
saline, 30 min before sacrifice, while the control group received
0.2 ml saline. The animals were killed by decapitation and blood
collected from the neck for serum corticosterone measurements as
described in Section 2.24. The adrenals were excised, decapsulated
and homogenised in 0.25 M sucrose containing 1 mM EDTA and 10 mM
potassium phosphate buffer pH 7.4. The homogenate was centrifuged
and the 105 000 x g supernatant prepared as described in Section 2.4.
2.3.2 Corticoid administration
Adult female rats (150-200 g) of the Wistar strain were divided
randomly into two groups. One group received subcutaneous injections
of 500 yg of corticoid in a total volume of 0.2 ml of the appropriate
carrier at 72 h and 24 h prior to killing. The control group received
0.2 ml of carrier. The animals were killed by decapitation. Blood
was collected and adrenals excised and processed as described in
Section 2.3.1.
2.4 PREPARATION OF 105 000 x g SUPERNATANT
The 105 000 x g supernatant from rat adrenal and bovine adrenal
cortex was prepared from the homogenate of the appropriate tissue
according to the procedure shown in Fig. 2.1.
The homogenate was centrifuged at 10 000 x g at 4°C for 10 min
to remove cell debri, nuclei, mitochondria, lysosomes and the floating
lipid layer. The 10 000 x g infranatant was centrifuged at 105 000 x g
for 1 hour at 4°C. The lipid droplets were removed by aspiration and
the clear infranatant was pooled, discarding the microsomes.
The 105 000 x g infranatant was used as the enzyme source for the
purification of CEH and was referred to as the tissue cytosol.
Tissue homogenate was prepared by homogenising the tissue in 10 mM
potassium phosphate (or Tris-HCl) buffer pH 7.4 containing 0.25 M
sucrose and 1 mM EDTA in a motorised Potter-Elvehjem glass-teflon
homogeniser
The 20% (w/v) homogenate was centrifuged at 10 000 x g for 10 min














Pooled for enzymic assay and/or further purification
Fig. 2.1. The flow diagram for the preparation of the soluble tissue
fraction (cytosol) from rat adrenal and bovine adrenal cortex.
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2.5 PREPARATION OF THE LIPID DROPLET FRACTION
The lipid droplet fraction from rat adrenal and bovine adrenal
cortex homogenates were prepared by harvesting the floating lipid
layer obtained at the 105 000 x g centrifugation step in the preparation
of tissue cytosol. The lipid layer was collected using the apparatus
shown in Fig. 2.2, which enabled the lipid droplets to be aspirated
off the surface of the liquid by suction. This minimised the
contamination of the lipid droplets by the infranatant material.
The lipid droplets were washed twice with 10 volumes ice-cold
0.25 M sucrose containing 1 mM EDTA and 10 mM potassium phosphate
buffer pH 7.4 by centrifugation at 105 000 x g for 90 min at 4°C.
The washed lipid droplets were dialysed overnight at 4°C against 500
volumes 10 mM potassium phosphate buffer pH 7.4.
2.6 PREPARATION OF EMULSIFIED CHOLESTEROL [l~14c] OLEATE AND GLYCEROL
tri-[i-14c Joleate
The emulsified substrate used for the assay of CEH and triacylglycerol
hydrolase was prepared according to Khoo, Steinberg et al. (1976) with
some modifications.
T 14 ~!A known quantity of cholesterol 1- C oleate m toluene was
added to unlabelled cholesterol oleate dissolved in the same solvent.
The toluene was evaporated by a stream of nitrogen, and the dried
pellet was dissolved in warm absolute ethanol. This solution was
injected in small batches into an ice-cold mixture of fatty acid-free
bovine serum albumin, EDTA and potassium phosphate buffer pH 7.4.
The mixture was left to stir for 15 min before storing at 4°C.
Before use the solution was stirred for 2-3 min. The substrate was
prepared in batches of 20 ml and used within 2 weeks of preparation.
f 14The final constitution of the mixture was: 500 pM cholesterol 1- C
oleate (specific activity 1.0-2.0 pCi.pmol ^) , 5% (w/v) fatty acid-free
FLEXIBLE, PLASTIC TUBE
i
Fig. 2.2. Apparatus for the collection of lipid droplet fractions.
The apparatus was used to aspirate off and collect the floating lipid
droplet fraction obtained at the 105 000 x g centrifugation step in the
preparation of tissue cytosol.
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bovine serum albumin, 5% (v/v) ethanol, 10 mM EDTA and 100 mM potassium
phosphate buffer. The final pH was 7.2-7.4.
Glycerol tri- oleate was prepared for use in the same way
and in the same concentration of 500 yM.
2.7 THE ASSAY OF CEH AND TRIACYLGLYCEROL HYDROLASE
To an enzyme solution in potassium phosphate (or Tris-HCl) buffer
pH 7.4 in a final volume of 0.2 ml was added 0.2 ml of emulsified
r 141 r 141
cholesterol 1- C oleate or glycerol tri- 1- C oleate substrate.
The incubation was carried out at 37°C for 30-45 min, as appropriate.
Final concentrations in the incubation mixture were: 250 yM
bovine serum albumin, 2.5% (v/v) ethanol, 5 mM EDTA and 50 mM potassium
phosphate buffer. The enzyme protein concentration did not exceed
0.5 mgml ^ per incubation and the final pH of the incubation was
routinely checked and found to be 7.1-7.4. Blank incubations, omitting
the enzyme were always run in parallel.
The enzymic hydrolysis of the cholesterol ester substrate was
terminated by the addition of 1.5 ml fatty acid extraction mixture
(Khoo and Steinberg (1975)) which contained chloroform/methanol/toluene
(2:2.4:1, v/v) with 0.29 mM unlabelled oleic acid as a carrier.
After the addition of 50 yl 1.0 M NaOH the tubes were vortexed for 15 s
and centrifuged at 1500 x g for 20 min at room temperature. A 500 yl
sample from the upper aqueous phase (1 ml total) was taken into 10 ml
Triton X-100/toluene scintillation cocktail (0.33 1 Triton X-100,
0.67 1 toluene containing 4 gl ^ 2'5'-diphenyloxazole(PP0) and 0.03 gl
1'4'-bis-5-phenyloxazyl-2-benzene (P0P0P)).
T 14 1
The estimation of 1- C oleic acid was carried out m a Packard
r 141Tri-Carb liquid scintillation spectrometer. Recovery of 1- C oleic
acid from the incubation by the extraction was found to be 76-80%
(100 nmol, 0.1 yCi), 2.5% (w/v) (0.38 mM)
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(Gorban (1980)). Counting efficiency for oleic acid was 80%
and quenching was monitored by an external standard.
In some assays the amount of substrate was reduced to 0.1 ml in a
[>14c]total volume of either 0.2 ml or 0.4 ml giving final cholesterol
oleate concentrations of 250 yM and 125 yM, respectively. In the
former case 250 yl 0.2 M NaOH was added to the tubes after the fatty
acid extraction mixture to keep the solvent ratios and NaOH concentration
identical to the basic assay. The effect of enzyme protein and
incubation time on the CEH assay had been investigated in a previous
study (Gorban (1980)).
2.8 IN VITRO ACTIVATION AND DEACTIVATION OF CEH
To an enzyme solution in potassium phosphate (or Tris-HCl) buffer
pH 7.4 containing a maximum of 250 yg protein in a total volume of
100 yl was added 100 yl of a mixture of magnesium chloride, ATP and cAMP
in Tris-HCl buffer pH 7.4 at 37°C. The final concentrations in the
incubation were: 5 mM magnesium chloride, 5 mM ATP, 20 yM cAMP and
20 mM Tris-HCl. These were the optimum concentrations of ATP and cAMP
for the in vitro activation of cytosolic CEH as determined by Gorban
(1980). The CEH activation reaction was carried out for 10 min at 37°C
after which time it was terminated by the addition of substrate emulsion
containing excess EDTA. Deactivation of the enzyme was carried out in
a similar way to the activation but with the omission of ATP and cAMP.
The incubation mixture for the basal activity of the enzyme contained
no magnesium chloride, no ATP and no cAMP.
2.9 PREPARATION OF ,Y~32P J ATP
r 32 "i
y- P ATP was prepared by a modification of the procedure of
Glynn and Chappell (1964). This method utilises the exchange reaction
r 321
between ATP and P orthophosphate that occurs m the presence of
phosphoglycerate kinase, glyceraldehyde 3-phosphate dehydrogenase and
suitable substrates.
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3-phosphoglycerate + ATP v 1,3-diphosphoglycerate + ADP
l,3,diphosphoglycerate +
glyceraldehyde 3-phosphate **• 3-phosphoglyceroylenzyme + P.
dehydrogenase
The reaction mixture contained 40 pi 1.0 M magnesium acetate,
100 pi 0.1 M ATP, 10 pi 0.1 M EDTA, 10 pi 2-mercaptoethanol, 40 pi
0.2 M 3-phosphoglycerate and 775 pi 1.0 M Tris-HCl buffer pH 8.0 at
room temperature. The reaction was initiated by the addition of 2 ml
r 32 ~i
carrier-free P orthophosphate (2 mCi) in dilute HC1 followed by
25 pi of phosphoglycerate kinase/glyceraldehyde 3-phosphate dehydrogenase
enzyme mixture (Boehringer Corporation (London) Ltd., Lewes).
The incubation was for 3 h at room temperature. For certain experiments
T 32 1the specific activity of the y- P ATP was increased 2.5 fold by
reducing the amount of ATP added to 4 pmoles in 100 pi.
To calculate the yield of the reaction, 5 pi of the mixture was
added to 5 ml distilled water and the solution vortexed. Samples of
10 pi of this solution were added to 10 ml Triton X-100/toluene
scintillation cocktail and the radioactivity estimated in a Packard
Tri-Carb liquid scintillation spectrometer. Excess activated charcoal
was added to the sample solution which was vortexed and centrifuged
at 1000 x g. Samples of 10 pi of the supernatant were taken and
T 32 1counted as above. The yield of y- P ATP was calculated from
100 - (cPm charcoal x 100) and was routinely 98-99% when thecpm before charcoal
specific activity was 0.2 mCi.pmol ^ (400 cpm.pmol ^) and 94% when
the specific activity was 0.5 mCi.pmol ^ (1000 cpm.pmol ^).
2.10 PREPARATION OF 32P~LABELLED PH0SPH0HISTONE
32 ...
P-labelled phosphohistone was prepared by a modification of the
basic method of Meisler and Langan (1969).
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The concentrations in 3 ml final incubation mixture were 670 yM
32 1 -1 -1
y- P ATP (0.2 mCi.ymol ), 2.2 mgml calf thymus his tone, 8 mM
magnesium acetate, 2 yM cAMP, 0.33 mgml ^ cAMP-dependent protein kinase
(type II from bovine heart) and 50 mM TES buffer pH 7.0. The reaction
was initiated by the addition of the cAMP-dependent protein kinase and
the incubation continued for 4 h at 30°C.
The reaction was terminated by the addition of ice-cold 25% (w/v)
TCA to give a final TCA concentration of 2.5% (w/v). The solution was
centrifuged at 1000 x g for 10 min and the precipitated protein kinase
removed. To the clear supernatant was added ice-cold 50% (w/v) TCA to
give a final TCA concentration of 25% (w/v). The mixture was centrifuged
at 1000 x g for 10 min and the supernatant discarded. The pellet was
redissolved in distilled water, reprecipitated with ice-cold 25% (w/v)
TCA and the pellet collected by centrifugation as before. The pellet
was washed twice with ethanol/diethyl ether (1:4, v/v), then twice with
ethanol/diethyl ether (1:4, v/v) containing 0.1 M HC1. The product was
dried overnight by vacuum desiccation, redissolved in 5 ml 50 mM TES
buffer pH 7.0 and divided into 1 ml portions for subsequent use.
32 .
Samples of 20 yl were taken and P incorporation into protein
was measured (see Section 2.11). The preparation was routinely found
32 ....
to be approximately 97% P-labelled phosphoprotem with a specific
activity of 4-5 yCi.mg protein ^ indicating about 8% incorporation of
32
P into protein.
2.11 32P-LABELLED PHOSPHOPROTEIN ASSAY
32 ...
The assay of P-labelled phosphoprotein was carried out similar to
the method of Walsh,Perkins et al. (1971).
32
To 0.4 ml P-labelled phosphoprotein was added 0.1 ml bovine
serum albumin (12.5 mgml 3) followed by 0.5 ml ice-cold 10% (w/v) TCA.
The mixture was left for 10 min at 4°C and then centrifuged at 1500 x g
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for 10 min at 4°C. An aliquot of the supernatant was taken into 10 ml
Triton X-100/toluene scintillation cocktail (see Section 2.7) and the
non-TCA precipitated radioactivity estimated in a Packard Tri-Carb
liquid scintillation spectrometer. The remaining supernatant was
decanted and the pellet redissolved in 50 yl 0.1 M NaOH, reprecipitated
quickly with 1 ml ice-cold 10% (w/v) TCA, left for 10 min at 4°C and
recentrifuged. The pellet was washed twice with 1 ml ice-cold 5% (w/v)
TCA, dissolved in 50 yl 23 M formic acid and decanted into 5 mi
Triton X-100/toluene scintillation cocktail. The tube was then washed
with a further 5 ml scintillation cocktail to ensure maximum recovery.
2.12 PROTEIN KINASE ASSAY
Protein kinase activity was assayed by a modification of the method
of Walsh, Perkins and Krebs (1968).
The assay mixture contained 125 mM 2-glycerophosphate (disodium
salt), 6 mgml ^ calf thymus histone, 50 mM sodium fluoride, 5 mM
theophylline, 9 mM magnesium acetate and 0.75 mM EGTA. To this was
added cAMP, cGMP or calcium chloride up to final concentrations of
250 yM, 250 yM and 2 mM, respectively. A portion of assay mixture,
without these additions, was kept for control incubations and all four
solutions were adjusted to pH 6.0 with HC1.
To 40 yl of the assay mixture (with and without additions) was
added 10 yl 1.2 mM £y-^pj ATP (0.2 mCi.ymol ^) and 50 yl of protein
solution or buffer. Incubation was for 10 min at 30°C and the assay
was terminated by the addition of 0.1 ml 12.5 mgml ^ bovine serum
32
albumin and 0.5 ml ice-cold 10% (w/v) TCA. The P-labelled
phosphoprotein was determined as described in Section 2.11.
2.13 PHOSPHOPROTEIN PHOSPHATASE ASSAY
32
To 20 yl P-labelled phosphohistone (0.1 yCi, 20 yg) or an
32
appropriate amount of other P-labelled phosphoprotein was added 50 yl
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phosphoprotein phosphatase preparation (see appropriate sections for
description) and the volume made up to 0.4 ml with buffer. The incubation
o 32
period was 10 min at 37 C. The reaction was terminated and P-
32
orthophosphate release and P-labelled phosphoprotein determined as
described in Section 2.11.
2.14 ALKALINE PHOSPHATASE ASSAY
Alkaline phosphatase activity was assayed essentially as described
by Li (1979) with some modification.
To 0.25 ml phosphatase preparation (see Section 7) was added
0.25 ml assay reagent which contained 20 mM p-nitrophenyl phosphate,
20 mM magnesium chloride, 1 mM DTT and 50 mM Tris-HCl buffer pH 8.6 at
30°C. The incubation period was 20 min at 30°C and the reaction was
terminated by the addition of 0.5 ml 1.0 M sodium carbonate.
The phosphatase activity was measured spectrophotometrically by the
absorbance at 410 nm of the p-nitrophenol released from p-nitrophenyl
phosphate using a control,omitting enzyme,as a blank (absorption
. . . 4 -1 -1
coefficient for p-nitrophenolate ion 1.75 x 10 M cm ).
2.15 PREPARATION OF HIGH-DENSITY LIPOPROTEIN (HDL) FROM HUMAN SERUM
High-density lipoprotein (HDL) was prepared from human serum by
phosphotungstate precipitation (Burstein and Scholnick (1973)) and
density gradient ultracentrifugation.
To 1 litre human serum was added 100 ml 4% (w/v) sodium
phosphotungstate (adjusted to pH 7.0 with NaOH) and 25 ml 2.0 M
magnesium chloride. The material was immediately centrifuged at
6000 x g for 10 min and the precipitated very low density lipoprotein
(VLDL) and low density lipoprotein (LDL) discarded. To the supernatant
was added 900 ml 4% (w/v) sodium phosphotungstate and the precipitated
y-globulins removed by immediate centrifugation at 6000 x g for 10 min.
The supernatant had 175 ml 2.0 M magnesium chloride added to it and
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was left for 2 h at room temperature before centrifugation at 20 000 x g
for 20 min. The precipitate was washed with 500 ml of a solution
containing 0.4% (w/v) sodium phosphotungstate, 0.1 M magnesium chloride
and 1% (w/v) sodium chloride and centrifuged at 6000 x g for 10 min.
The precipitate was resuspended in 70 ml 1% (w/v) sodium chloride and
solubilisation achieved by the dropwise addition of 10% (w/v) sodium
carbonate, with stirring.
To the concentrated, neutral solution of HDL was added potassium
bromide up to a final density of 1.21 and the resultant solution was
centrifuged at 100 000 x g for 20 h at 4°C. The floating layer of HDL
was removed using a Pasteur pipette.
2.16 PREPARATION OF AP0LIP0PR0TEIN A-I FROM HUMAN HDL
HDL was delipidated according to Scanu (1966). The delipidated
protein (approximately 30 mg) was dissolved in 15 ml 10 mM Tris-HCl
buffer pH 8.0 at 4°C containing 6 M urea and 1 mM EDTA and subjected to
chromatography on a Sephacryl S-200 column (3 x 50 cm) equilibrated in
the same buffer. The fractions were assayed for apolipoprotein A-I by
SDS/PAGE (see Section 2.18) and the pooled fractions were applied to a
Sephadex G-100 column (3 x 75 cm) equilibrated in the same buffer.
The fractions containing apolipoprotein A-I were pooled, but were still
contaminated by albumin and several other proteins (Fig. 2.3a).
The main contaminant was albumin and it was expected that it could
be removed by utilising its multi-functional binding properties,
in particular its affinity for dyes. The pooled sample was dialysed
against 20 mM ammonium bicarbonate containing 0.1 M sodium chloride,
and loaded onto a Cibacron Blue-Sepharose 4B column (3 x 15 cm)
equilibrated with the buffer. The fractions were assayed by SDS/PAGE
as before, and both albumin and apolipoprotein A-I bound to the column.
This was expected as this column had been used in purifications of both
a b
Fig. 2.3. Purification of apolipoprotein A-I from delipidated human
HDL. Samples of approximately 100 yg protein from the pooled fractions
after a) Sephadex G-100 chromatography and b) Cibacron Blue -
Sepharose 4B chromatography weresubjected to SDS/PAGE in 10% gels as
described in Section 2.18.
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albumin and lipoproteins (see Gianazza and Arnaud (1982)). The other
contaminants were eluted at this stage. The column was washed with
several volumes 2.0 M sodium chloride, in the column buffer, and a
portion of the albumin was eluted. Finally 6 M urea was included in
the buffer eluting the remaining albumin in a broad peak. However,
apolipoprotein A-I was eluted in a sharp peak and subsequent analysis
of the pooled fractions by SDS/PAGE indicated only minor contamination
by albumin (Fig. 2.3b). The apolipoprotein A-I was extensively dialysed
against 20 mM ammonium hydrogen carbonate, lyophilised and stored at
-20°C for subsequent use.
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2.17 I-LABELLING OF APOLIPOPROTEIN A-I
Apolipoprotein A-I was labelled with [«*i] iodide by a method
essentially as described by Bolton (1977).
Apolipoprotein A-I (1 mg in 0.5 ml) in 50 mM sodium phosphate
buffer pH 7.4 was incubated with 0.25 ml 40 mM chloramine-T (in the
above buffer) and 10 pi iodide for 10 min at 0°C. The reaction
was terminated by the addition of 0.25 ml 100 mM sodium metabisulphite
in the above buffer and the mixture desalted on a Sephadex G-25 column
(1 x 16 cm) equilibrated in the same buffer.
The incorporation was calculated to be 90% and the specific activity
of the peak fraction was approximately 2.2 pCi.yg protein ^.
2.18 SODIUM DODECYL SULPHATE-POLYACRYLAMIDE GEL ELECTROPHORESIS (SDS/PAGE)
Slab gel electrophoresis was performed according to the method of
Laemmli (1970) with the modification of Douglas and Butow (1976) and
other modifications as stated.
2.18.1 Solutions for SDS/PAGE
A. Separating gel buffer: 1.5 M Tris-HCl buffer, 8 mM EDTA, 0.4% (w/v)
SDS, pH 8.8.
B. Stock acrylamide: 30% (w/v) acrylamide and 0.8% (w/v) N,N'-methylene
bisacrylamide, dissolved in water, filtered through glass wool and
stored at 4°C in the dark.
45.
C. Stacking gel buffer: 0.5 M Tris-HCl buffer, 8 mM EDTA, 0.4% (w/v)
SDS, pH 6.8.
D. Polyacrylamide: 1.5% (w/v) polyacrylamide dissolved slowly in water
and containing 1 mM sodium fluoride and 1 mM sodium azide.
E. Concentrated sample buffer: 0.2 M Tris-HCl buffer, 8 mM EDTA,
8% (w/v) SDS, 40% (v/v) glycerol, 4% 2-mercaptoethanol, 0.0025% (w/v)
bromophenol blue, pH 6.8. This was four times concentrated and was
added to samples in solution or used to dissolve solid samples but was
always diluted 4 fold in the final sample.
F. Electrode buffer: 50 mM Tris-glycine buffer, 2 mM EDTA, 0.1% (w/v)
SDS, pH 8.6.
2.18.2 Preparation of gel cassette and spacer gel
The glass plates (18.5 x 20 cm) were washed thoroughly, rinsed
with distilled water and wiped with tissue soaked in acetone. The plastic
spacers (approximately 1 mm thick), cleaned with acetone, had a thin
coat of high vacuum silicone grease applied down one edge on both sides.
They were applied to the edges of one plate with grease-coated edge to
the outside and the cassette completed by the application of the second
plate on top.
To seal the bottom of the cassette, a trough made with aluminium
foil was placed around the bottom of the cassette and 12 ml of a 20% (w/v)
acrylamide solution containing 0.2% (w/v) SDS and 0.4 M Tris-HCl buffer
pH 8.8, with 10 yl TEMED and 0.23 ml 10% (w/v) ammonium persulphate
added, was poured in. After polymerisation, the trough and excess gel
were removed from the bottom of the cassette.
2.18.3 Preparation of separating gels
For 30 ml of 10% acrylamide gel, 10 ml solution B was mixed with
7.5 ml solution A, 5 ml solution D and 7.2 ml distilled water. For other
concentrations of acrylamide the amount of solution B was varied and
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the final volume made up to 30 ml with distilled water. Polymerisation
was initiated by the addition of 15 yl TEMED and 0.3 ml 10% (w/v)
ammonium persulphate. The solution was quickly poured into the gel
cassette, leaving space for the stacking gel, overlaid with water-
saturated secondary butanol, and left for 1 h to set.
2.18.4 Preparation of exponential gradient separating gel (6-12%)
A small mixing chamber was filled with 15 ml 12% acrylamide gel
solution, made by the procedure described in Section 2.18.3, and 7.5 yl
TEMED and 80 yl 10% (w/v) ammonium persulphate were added. Into this
was pumped 15 ml 6% acrylamide gel solution containing 7.5 yl TEMED and
80 yl 10% (w/v) ammonium persulphate at the same rate as the diluted
mix was delivered to the cassette (twin-channel pump). The total pouring
time was 20 min and the gel was overlaid with water-saturated secondary
butanol and left for 1 h to set.
2.18.5 Preparation of stacking gel
The stacking gel was 4.5% acrylamide and was prepared by mixing
1.2 ml solution B, 2.0 ml solution C, 1.3 ml solution D, 3.4 ml distilled
water, 5 yl TEMED and 75 yl 10% (w/v) ammonium persulphate. The water-
saturated secondary butanol was washed off the separating gel,
the stacking gel poured in and the spacer comb inserted. After 30 min
the spacer comb was removed and the cassette was clamped in the
electrophoresis tank and used that day.
2.18.6 Sample preparation for SDS/PAGE
Samples containing 50-100 yg protein had an equal volume of 20% (w/v)
TCA added to them, were vortexed and left for 10 min before centrifugation
at 1000 x g for 10 min. The pellets were washed with 10% (w/v) TCA and
then acetone before drying by vacuum desiccation for 3-4 h. The pellets
were dissolved in 50 yl diluted solution E and heated in a boiling water
bath for 5 min. Some pellets from very hydrophobic proteins were
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dissolved in 45 yl of a solution of 10% (w/v) SDS and 8 M urea, with
15 yl solution E added, followed by boiling as above. Standards used
were g-galactosidase (Mr = 125 000), phosphorylase a (92 000), bovine
serum albumin (66 000), y-globulin (50 000 and 23 500), ovalbumin
(43 000) and cytochrome c (11 700).
2.18.7 Fixing, staining, destaining and drying of gels
Gels were fixed in 10% (v/v) glacial acetic acid, 10% (v/v) methanol
for 30 min at 37°C, followed by staining for 30 min at 37°C in 7.5%
(v/v) glacial acetic acid, 50% (v/v) methanol containing 0.25% (w/v)
PAGE Blue 83 (Sigma). Gels were then destained with 7% (v/v) glacial
acetic acid, 10% (v/v) methanol for about 2 h at 55°C, with some pure
white wool included to accelerate the process.
The destained gels were applied to wet 3 MM Whatman chromatography
paper and dried on a gel drier (Hoefer Scientific Instruments).
2.19 32P-LABELLING OF PROTEIN
Samples containing about 100-200 yg protein in 10 mM Tris-HCl buffer
pH 7.0 at 37°C containing 0.5 mM DTT were incubated with a labelling
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mixture containing 1.3 mM y- P | ATP, 10 mM magnesium acetate, 100 yM
cAMP and 50 mM Tris-HCl buffer pH 7.4 at 37°C for 20 min at 37°C.
In some cases exogenous cAMP-dependent protein kinase (ilO yg, type II
bovine heart) in 20 mM Tris-HCl buffer pH 7.4 at 37°C containing 1 mM
DTT, or catalytic subunit of cAMP-dependent protein kinase (^100-150 units)
in a 0.3 M DTT solution were also included in the incubations.
The reactions were terminated by the addition of an equal volume of
ice-cold 25% (w/v) TCA and the samples prepared for SDS/PAGE as described
in Section 2.18.6.
2.20 |j,3-3H ] DFP-LABELLING OF PROTEIN
Samples containing 100-200 yg protein in 10 mM potassium phosphate
buffer pH 7.4 containing 0.2 mM DTT had 1,3-3H DFP in propylene glycol
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added to them to a final concentration of about 100 pM. The incubation
was for 30 min at 37°C and the reaction terminated by the addition of an
equal volume of ice-cold 25% (w/v) TCA and the samples prepared for
SDS/PAGE as described in Section 2.18.6.
2.21 DETERMINATION OF RADIOACTIVITY IN GELS BY AUTORADIOGRAPHY
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For P-labellmg experiments, the dried gels were exposed to
Agfa-Gevaert Curix RP1 X-ray film for periods of 24 h to 1 week depending
upon intensity of labelling. In some cases the process was accelerated
by presensitising the film (Rogers (1979)) with a single flash from a
Braun Hobby 17B flashgun through a Wratten No. 22 filter at a distance
of 1 metre, followed by exposure to the gel between calcium tungstate
sheets (Dupont Cronex lighting plus intensifying screens, Dupont (U.K.),
Stevenage, Herts.) at -70°C (Laskey and Mills (1977), Swanstrom and
Shank (1978), Rogers (1979)).
3
For H-labelling experiments, the radioactivity was detected by
fluorography and autoradiography (Chamberlain (1979)). The gels were
fixed, stained and destained as described in Section 2.18.7 and then
soaked in 10 volumes distilled water for 1 h. The gels were then soaked
in 10 volumes 1.0 M sodium salicylate for 1 h and dried as described
in Section 2.18.7. The gels were exposed to presensitised X-ray film
with intensifying screens at -70°C (as above) for 1 month.
The films were developed for 5 min with Agfa-Gevaert G150 developer,
soaked in 5% (v/v) acetic acid stopper for 5 min and fixed with Agfa-
Gevaert G33A/Aditan for 5 min.
2.22 DETERMINATION OF RADIOACTIVITY IN GEL SLICES
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For P-labelling experiments, the appropriate tracks on the dried
gel were cut out and divided into 1 mm slices using a sharp scalpel.
The slices were placed on the bottom of scintillation vials (2.5 x 5.5 cm),
covered with 500 yl distilled water and left to soak for 4 h.
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The vials had 10 ml Triton X-100/toluene scintillation cocktail added
to them and the radioactivity determined in a Packard Tri-Carb liquid
scintillation spectrometer.
3
For H-labellmg experiments, the radioactivity was estimated
essentially as described by Basch (1968).
The gels were fixed, stained and destained as described in
Section 2.18.7. The appropriate tracks were cut from the wet gel and
sliced into 1 mm sections by a Mickle gel slicer. The slices were
placed on the bottom of scintillation vials (2.5 x 5.5 cm) and covered
with 500 yl of a mixture of 90% NCS tissue solubiliser/10% water (v/v).
The vials were capped and incubation continued for 3 h at 65°C.
After cooling, 10 yl concentrated HC1 was added to the vials to
neutralise the strongly basic NCS solution followed by 15 ml toluene
scintillation cocktail (toluene containing 4 gl ^ PP0 and 0.03 gl ^
P0P0P). The vials were stored for 7-10 days in the dark to allow
chemiluminescence to subside (Peng (1977)) and the radioactivity
estimated in a Packard Tri-Carb liquid scintillation spectrometer.
2.23 PURIFICATION AND RECRYSTALLISATION OF CHOLATE
Cholic acid (2.5 g) was added to 1 litre 30% (v/v) ethanol and the
mixture heated to dissolve the cholic acid. Activated charcoal (0.5 g)
was added and the mixture refluxed for 10 min. The mixture was removed
from heat and celite (1 g) added. About 100 ml 30% (v/v) ethanol
containing celite (100 mg) was heated, poured onto a large glass
sinter and the hot cholate mixture poured over. The filtered cholate
solution was cooled overnight at 4°C. The cholate crystals were
filtered (Whatman No. 1) and dried by vacuum desiccation. The yield
was calculated to be 80%.
Purified cholic acid (5 g) was heated with 10 ml distilled water
and 5 M NaOH added dropwise to convert the acid to the sodium salt.
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The resulting, clear solution of sodium cholate (^500 mgml had a
pH of 7.6, and was used as a stock for preparing the buffers described
later.
2.24 SERUM C0RTIC0STER0NE MEASUREMENTS
Serum corticosterone was measured by radioimmunoassay (Ruder, Guy
and Lipsett (1972)).
2.25 MEASUREMENT OF THE CHOLESTEROL CONTENT OF BOVINE ADRENOCORTICAL
LIPID DROPLETS
Total cholesterol was determined by the cholesterol oxidase method
(Richmond (1973)).
2.26 PROTEIN DETERMINATION
Protein concentrations were estimated by the method of Bradford
(1976), or in some early experiments, by the method of Lowry, Rosebrough
et al. (1951). Crystalline bovine serum albumin was the protein standard
in every determination.
2.27 STATISTICAL ANALYSIS
Where indicated, the statistical significance of the difference was
tested using the Student t test. Unless otherwise indicated, the
difference between groups was significant at p<0.05.
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PURIFICATION OF CHOLESTEROL ESTER HYDROLASE FROM BOVINE
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Cholesterol ester hydrolase (CEH) from bovine adrenocortical cytosol
has been found to be very difficult to purify (Gorban (1980)). One of
the main reasons for this is that, although the enzyme is cytosolic, and
thus 'soluble', it was found to be associated with lipids and heavily
aggregated giving the enzyme an apparently high molecular weight
(Beckett (1975), Beckett and Boyd (1977), Naghshineh, Treadwell et al.
(1978)). Gel permeation chromatography of the enzyme on Sepharose 4B
(Beckett and Boyd (1977), Wallat and Kunau (1976)), 6% agarose gel
(Pittman and Steinberg (1977)), Sephadex G-200(Wallat and Kunau (1976))
and Biogel A150 m (Gorban (1980)) resulted in the activity being divided
between peaks in the void volume and within the fractionation range of
the column. The relative proportion of the enzyme activity in each peak
depended upon the particular gel matrix used. In all cases in which gel
permeation chromatography was used the void volume fraction had higher
specific activity, however pooling this fraction resulted in poor
recoveries. Mild delipidation of the enzyme by cold butanol/acetone
did not significantly alter the elution profile on Biogel A150 m or
provide any increased purification, but 50% of the enzyme activity was
lost after 4 days storage at -18°C (Gorban (1980)). The relationship
between the two peaks has not been fully investigated but they probably
represent aggregates of different size where the lipid:protein ratio is
different. Pittman, Golanty and Steinberg (1972) reported that hormone-
sensitive lipase (HSL) from rat adipose tissue was eluted from a 4%
Biogel column in two peaks with the excluded peak having a density
(d<1.2) that was less than the retarded peak. Later Pittman and Steinberg
(1977) found that CEH and triacylglycerol lipase in rat adrenal cytosol
were eluted from a 6% Biogel column in two peaks and the density of the
retained fraction was greater than that of the excluded peak.
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Gorban (1980) showed that CEH and triacylglycerol lipase activities
from bovine adrenocortical cytosol were eluted, in parallel, from
Biogel A150 m in two peaks, and the excluded peak was found to float
at a density of d 1.2 in a sucrose gradient. From all these studies
it was concluded that CEH in bovine adrenocortical cytosol was present
in protein:lipid aggregates with a wide range of molecular weights
and differing densities. The poor recoveries also seriously hampered
purification by gel permeation and flotation techniques.
Detergents have been used for many years to solubilise membrane
proteins (reviewed Helenius and Simons (1975), Tanford and Reynolds
(1976)) but the use of detergents with cytosolic proteins was rare.
However a monoacylglycerol lipase activity from rat adipose tissue
cytosol had been purified 2 500-fold by a method including detergent
solubilisation(Tornqvist and Belfrage (1976)). In this case a pH 5.2
precipitate prepared from the cytosol was sonicated with the non-ionic
detergent Nonipol TD 12. This solubilisation procedure was then used
with some success in the purification of HSL from rat adipose tissue
cytosol (Belfrage, Jergil et al. (1977)). Solubilisation of HSL by
Triton X-100 has also been used in the purification of the enzyme from
chicken adipose tissue cytosol (Berglund, Khoo and Steinberg (1979)).
However detergent solubilisation had not been attempted in the
purification of CEH from adrenocortical cytosol. The aim of this section
of work was to investigate the effect of detergents upon CEH activity
from bovine adrenocortical cytosol, and to develop a purification
procedure involving detergent solubilisation.
The enzyme preparation used in this work was an ammonium sulphate
(0-40%) precipitate prepared from the cytosol. Ammonium sulphate
precipitation had been shown to be an effective early, batch-wise step
in the purification of the enzyme from bovine adrenal cortex
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(Trzeciak and Boyd (1979), Beckett and Boyd (1977), Naghshineh, Treadwell
et al. (1978)) giving up to 4-fold purification with at least 50%
recovery. Many researchers studying HSL in adipose tissue use a pH 5.2
precipitation as the early batch-wise step (Huttunen, Steinberg and
Mayer (1970), Belfrage, Jergil et al. (1977)). However Wallat and
Kunau (1976) compared ammonium sulphate precipitation with acid
precipitation in the purification of CEH from bovine adrenocortical
cytosol and the results showed that ammonium sulphate precipitation was
more effective in both purification and recovery. Therefore the
ammonium sulphate precipitation method was used in all purifications
investigated in this study. This method consistently gave purifications
of about 4-fold with recoveries of 65% or higher (see Tables 3.1 and 5.1).
3.2 PRELIMINARY INVESTIGATION OF A RANGE OF DETERGENTS
One method to investigate the effectiveness of a detergent at
solubilising CEH would be the elution profile of the enzyme activity
after gel permeation chromatography before and after treatment with
detergent. This would be time consuming as each column would have
to be equilibrated in buffer containing the appropriate detergent.
Furthermore this method does not account for the many problems
associated with the use of detergents. Firstly, the detergent may
inhibit the enzyme activity. Secondly, the detergent may disrupt the
cholesterol oleate substrate emulsion and make assay of the enzyme
difficult. Lastly the detergent may solubilise the unhydrolysed
T 14 ~1
cholesterol 1- C oleate during the extraction phase of the enzyme
assay and hence interfere with the assay. For these reasons it was
decided to use a quick and simple test for the suitability of the
detergents.
A range of detergents including anionic, cationic and various
types of non-ionic detergents were investigated to determine their
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effect on the enzyme. The enzyme preparation used was the ammonium
sulphate (0-40%) precipitate prepared from bovine adrenocortical cytosol.
The cytosol had 80% saturated ammonium sulphate solution in 50 mM
potassium phosphate buffer pH 7.4 added slowly and with stirring, at
4°C, to a final ammonium sulphate saturation of 40%. The precipitate
was collected by centrifugation at 6000 x g for 20 min, resuspended in
20 mM potassium phosphate buffer pH 7.4 containing 0.2 mM EDTA and
1 mM DTT and dialysed overnight against 250 volumes of this buffer.
Samples of this preparation were mixed with detergent at a range of
detergent:protein (mg:mg) ratios from 0-2 which is the range in which
most solubilisations are effective (Helenius and Simons (1975)).
The samples were sonicated by a Rapidis 150, power rating 3 for 80s
(4 x 20s) at 4°C. Aliquots were taken and assayed for CEH activity, and
the results are shown in Fig. 3.1.
A wide range of detergent effects were observed. Detergents like
Tween 40 inhibited the enzyme even at the lowest detergent:enzyme ratios
and other detergents such as Triton X-100 and Nonidet P42 inhibited
the enzyme at higher ratios of detergent:enzyme. Finally detergents
such as sodium cholate and nonyl glucoside increased the enzyme activity
over a wide range of detergent:enzyme ratios. The increased enzyme
activity could be due to solubilisation of the enzyme resulting in an
increase in effective enzyme concentration. However it could also be
due to the detergent assisting in the presentation of the substrate to
the enzyme by affecting the interactions between the enzyme particles
and the emulsion particles. It was not known why some detergents were
inhibitory, they may be adversely affecting the protein-substrate
interactions or altering the conformation of the enzyme.
Sodium cholate (subsequently denoted simply as cholate) was chosen






Legend to Fig. 3.1. Effect of various detergents on the activity of
CEH.l ml samples of an ammonium sulphate (0-40%) precipitate
(5.1 mgml ^ in 20 mM potassium phosphate buffer pH 7.4 containing
0.2 mM EDTA and 1 mM DTT) prepared from bovine adrenocortical cytosol
had various detergents (20 mgml ^ in the above buffer) added to them to
the final mg detergent:mg protein ratios shown. The samples were
sonicated as described in the text and then assayed for CEH activity as
described in the methods section.
O, Cholate; • , Nonidet P42; □ , Nonyl-glucoside; ■ , Triton X-100;
a, Deoxycholate; a, Tween 40; v, Lubrol PX; t , Brij 36T;
O, Saponin.
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gave increased CEH activity over the widest range of detergent:enzyme
ratios. Also, as an ionic detergent it is more easily removed than a
non-ionic detergent such as nonyl glucoside. Overnight dialysis against
100-fold buffer containing ion-exchange beads (Amberlite XAD-2) was
found to be effective at removing cholate (Furth (1980)), whereas
non-ionic detergents are notoriously difficult to remove (Helenius and
Simons (1975), Tanford and Reynolds (1976)). The cholate used in the
following experiments was purified and recrystallised as described
in the methods section.
3.3 FURTHER INVESTIGATION OF CHOLATE SOLUBILISATION
3.3.1 Effect of sonication
If sonication of the enzyme with cholate resulted in breaking up
the enzyme:lipid aggregates, then varying the time of sonication may
have an effect on the degree of solubilisation. A sample of an ammonium
sulphate (0-40%) precipitate from bovine adrenocortical cytosol prepared
in 20 mM potassium phosphate buffer pH 7.4 containing 0.2 mM EDTA and
1 mM DTT had cholate added to 0.8 mg cholatermg protein. This was found
to be the most effective solubilisation ratio (Fig. 3.1). The mixture
was sonicated, as before, and samples removed at various times and
assayed for CEH.
Fig. 3.2 shows that enzyme activity increased with increasing
sonication up to 60 s, but after this point no change in activity was
seen with further sonication. It was possible that the initial
increase in activity over the first 60 s sonication was due to
increasing solubilisation.
3.3.2 Stability of the enzyme in buffers containing cholate
Although CEH was not inhibited by cholate treatment in these short
term experiments, any purification procedure would require the enzyme
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Fig. 3.2. Effect of time of sonication with cholate on CEH activity.
An ammonium sulphate (0-40%) precipitate prepared from bovine
adrenocortical cytosol in 20 mM potassium phosphate buffer pH 7.4
containing 0.2 mM EDTA and 1 mM DTT had cholate (500 mgml ^ in distilled
water) added to it to a final ratio of 0.8 mg cholatermg protein.
The mixture was sonicated for 120s in 10s intervals. After each
interval triplicate samples were assayed for CEH activity.
Each point is the mean - S.E.M. from two experiments.
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periods. To investigate the stability of the enzyme under such conditions,
a sample of an ammonium sulphate (0-40%) preparation had cholate added
to 0.8 mg cholate:mg protein and was sonicated for 80 s as described
in Section 3.2. Samples were withdrawn and the CEH activity measured
at various times up to 72 h after sonication and storage at 4°C or
-20°C (see Fig. 3.3). Parallel incubations containing no cholate and
cholate plus 10% (v/v) and 20% (v/v) glycerol in the buffers were also
performed.
Fig. 3.3 shows that short term exposures to cholate of up to 6 h
had relatively little effect on the enzyme activity but by 24 h the
activity was reduced by 35%. The loss was about 70% and 90% after
48 h and 72 h respectively. In the control sample without cholate only
10% of the CEH activity was lost over the 72 h period. However the
inclusion of glycerol in the buffer protected the enzyme against the
inhibitory effects of cholate. In the experiment shown no loss of
enzyme activity was observed when glycerol was included. In fact, after
72 h the enzyme activity was slightly higher and on repeating the
experiment the loss of activity due to cholate in the presence of
glycerol was never more than about 10% compared to the control without
cholate. There was very little difference between 20% (v/v) and
10% (v/v) glycerol although 20% glycerol was slightly more effective
in the long term. In all subsequent work with cholate, glycerol
(10% or 20%) was included in all the buffers used.
3.3.3 Effect of cholate upon the activation and deactivation of CEH
One main reason for purifying CEH was to study the modulation of
its activity in vitro using purified components and therefore it was
essential that the purification of the enzyme did not result in a
preparation that could not be phosphorylated. This may occur if the











Fig. 3.3. Stability of CEH in buffers containing cholate.
An ammonium sulphate (0-40%) precipitate prepared from bovine
adrenocortical cytosol in 20 mM potassium phosphate buffer pH 7.4 was
sonicated for 80s at 4°C with cholate (20 mgml ^ in above buffer) at a
ratio of 0.8 mg cholate:mg protein. Samples were assayed for CEH
activity at various time intervals. Parallel experiments, in which the
buffers also contained 10% (v/v) or 20% (v/v) glycerol and a control
without cholate were also carried out. The incubations were maintained
at 4°C during the sampling period and at -20°C between the longer
time periods.
□
, Control; ■ , Cholate; O , Cholate plus 10% (v/v) glycerol;
• , Cholate plus 20% (v/v) glycerol.
for catalytic activity and regulation of activity. To investigate the
effect of cholate treatment on the modulation of the enzyme activity a
sample of an ammonium sulphate (0-40%) precipitate from bovine
adrenocortical cytosol was sonicated with cholate at a ratio of
0.8 mg cholate:mg protein for 80 s at 4°C. Samples were taken
immediately and also after 48 h and the CEH activity measured after
preincubation in basal, deactivation and activation buffers as described
in the methods section.
Fig. 3.4 shows that the presence of cholate did not affect the
deactivation of the enzyme compared to the control sample even after
48 h. Conversely the activation of the enzyme was reduced in the
presence of cholate. However these results suggest that cholate does
not dissociate the catalytic activity from the phosphorylation site
2+ ...
as incubation with Mg significantly lowered the specific activity.
The effect of cholate on the activation process might reflect the
effect of the detergent upon the activity of cAMP-dependent protein
kinase but this aspect of the problem was not studied further.
3.3.4 Sepharose CL-4B chromatography
The experiments so far had indicated that cholate solubilised CEH
and that it could be useful in future purifications. To obtain
direct evidence that the enzyme activity was solubilised by cholate
treatment it was necessary to investigate the elution profile of the
enzyme when subjected to gel permeation chromatography on an appropriate
gel medium. An ammonium sulphate (0-40%) precipitate from bovine
adrenocortical cytosol prepared in 20 mM Tris-HCl buffer pH 7.4 at 4°C
containing 1 mM EDTA, 0.1 mM DTT and 10% (v/v) glycerol (buffer A) had
cholate added to it to a ratio of 0.8 mg cholateimg protein. The solution
was mixed and sonicated on a Rapidis 150, power rating 7 for 40 s



















































Fig. 3.4. Effect of cholate upon activation and deactivation of CEH.
An ammonium sulphate (0-40%) precipitate prepared from bovine
adrenocortical cytosol in 20 mM potassium phosphate buffer pH 7.4
containing 0.2 mM EDTA, 1 mM DTT and 10% (v/v) glycerol was sonicated
for 80s at 4°C with cholate (20 mgml ^ in above buffer) at a ratio of
0.8 mg cholate:mg protein. CEH activity was assayed immediately after
sonication and after 48 h, following preincubation of the solution
2+
with basal, deactivation (Mg ) or activation (cAMP) buffers as
described in the methods section. A control sample without cholate
was assayed in the same way.
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column at 4°C, equilibrated in 20 mM Tris-HCl buffer pH 7.4 at 4°C
containing 1 mM EDTA, 0.1 mM DTT, 10% (v/v) glycerol and 0.1% (w/v)
cholate (buffer B) and eluted with this buffer.
Fig. 3.5a shows that in the absence of cholate the CEH activity
was eluted partly in the void volume and partly in a broad peak spread
throughout the fractionation range of the column. After cholate
treatment and gel filtration in the presence of cholate virtually all
the CEH activity eluted from the column in a peak at about 1.8 x Vo
(Fig. 3.5b). The protein elution profile was also altered with the
void volume peak observed in the absence of detergent, greatly reduced
leaving,in the presence of detergent,a single, large broad peak at
about 2.0 x Vo. The CEH activity eluted before the peak fractions of
protein and showed a 2-3 fold increase in specific activity compared
to the ammonium sulphate precipitate before the addition of cholate
(Table 3.1). The fractions indicated were pooled and termed "cholate
solubilised enzyme". This was used in the following purification
procedure.
3.4 PURIFICATION OF CEH FROM BOVINE ADRENOCORTICAL CYTOSOL USING
CHOLATE SOLUBILISATION AND CONVENTIONAL CHROMATOGRAPHIC TECHNIQUES
The results obtained with Sepharose CL-4B chromatography indicated
that cholate solubilised the CEH activity and suggested that a
purification procedure using conventional techniques with buffers
containing cholate could be successful. A related enzyme, HSL from
chicken adipose tissue had been substantially purified using techniques
similar to this (Berglund, Khoo and Steinberg (1979)). In the following
procedure the cholate solubilised enzyme was chromatographed on
hydroxylapatite and DEAE-cellulose and the overall purification is
summarised in Table 3.1. Steps I-IV were performed as described in
Section 2 (I), Section 3.2 (II) and Section 3.3.4(III and IV) and all
steps were carried out at 4°C.
Fraction No.
Fig. 3.5. Elution of CEH activity on Sepharose CL-4B before and
after cholate treatment.
a) An ammonium sulphate (0-40%) precipitate (17 mg) prepared from
bovine adrenocortical cytosol in 20 mM Tris-HCl buffer pH 7.4 at 4 C
containing 1 mM EDTA, 0.1 mM DTT and 10% (v/v) glycerol was applied
to a Sepharose CL-4B column (2 x 96 cm) equilibrated and eluted with
this buffer.
b) An ammonium sulphate (0~40%) precipitate (10 mg) prepared as above
had 0.8 mg cholate per mg protein added, and was sonicated as described
in the text. The sample was applied to a Sepharose CL-4B column
(2 x 96 cm) equilibrated and eluted with the above buffer containing
0.1% (w/v) cholate.
O
, CEH activity; a , A^g^; I 1 , Fractions pooled.





I. 105 000 x g
Supernatant
1510 0.72 1081 - 100
II. Ammonium
Sulphate (0-40%) 234 2.89 676 4.0 63
Precipitate
Ill . Solubilised




48.6 4.97 241 7.0 22
V. Hydroxylapatite 20.9 3.32 69 - 6
VI. DEAE-Cellulose I 16.3 2.10 34 - 3
VII .DEAE-Cellulose II 10.2 2.02 21 — 2
Table 3.1. Purification of bovine adrenocortical cytosolic CEH using
cholate solubilisation. Details of each step are given in the text.
Protein concentration was determined by the method of Lowry, Rosebrough
et_ a_l. (1951). The enzyme activity was measured as described in the




Step V - Cholate solubilised enzyme was loaded onto a hydroxylapatite
column. The column was washed with 2 volumes of buffer B and the enzyme
was eluted with a linear gradient of potassium phosphate (0-0.25 M).
CEH activity appeared as a broad peak from 0.15 M to 0.2 M potassium
phosphate (Fig. 3.6a). The fractions indicated were pooled and dialysed
against buffer B to remove potassium phosphate.
Step VI - The dialysed sample was then applied to a DEAE-cellulose column
equilibrated in buffer B. The column was washed with 2 bed volumes of
the same buffer and the enzyme eluted by a linear gradient of sodium
chloride (0-0.5 M). The CEH activity eluted at 0.3 M sodium chloride
and the fractions indicated were pooled (Fig. 3.6b). The sample was
diluted 1:1 with buffer B to reduce the sodium chloride concentration
to 0.15 M.
Step VII - The diluted sample was applied to a second DEAE-cellulose
column equilibrated in buffer B containing 0.15 M sodium chloride.
The column was washed with 2 bed volumes of the same buffer and the
enzyme eluted with a linear gradient of sodium chloride (0.15 M-0.6 M).
The CEH activity eluted at 0.33 M sodium chloride and the active
fractions were pooled and dialysed against buffer A to remove sodium
chloride and cholate (Fig. 3.6c).
The results of the purification procedure showed that cholate
solubilisation was only partly successful when used with ion-exchange
techniques. The first four steps led to the production of cholate
solubilised enzyme where all the activity was present as aggregates of
much lower and more uniform molecular weight. At the same time the
specific activity of the enzyme was increased 7-fold, with the ammonium
sulphate precipitation step consistently giving a 3-4-fold increase
and the gel permeation step giving a further doubling of the specific





























Legend to Fig. 3.6. Chromatography of cholate solubilised enzyme.
a) Hydroxylapatite chromatography - The column (1.6 x 8 cm) was
equilibrated with buffer B and eluted with a linear gradient of
potassium phosphate (0 —0.25 M) in buffer B in a total volume of
150 ml. The flow rate was 50 ml.h ^ and fractions of 5 ml were
collected.
b) DEAE-cellulose chromatography I - The column (2.5 x 7.5 cm) was
equilibrated with buffer B and the enzyme eluted with a linear
gradient of sodium chloride (0-0.5 M) in buffer B in a total volume
of 180 ml. The flow rate was 50 ml.h ^ and fractions of 6 ml were
collected.
c) DEAE-cellulose chromatography II - The column (1.5 x 7.5 cm) was
equilibrated with buffer B containing 0.15 M sodium chloride and the
enzyme eluted with a linear gradient of sodium chloride (0.15-0.6 M)
in buffer B in a total volume of 100 ml. The flow rate was 50 ml.h ^
and fractions of 4 ml were collected.
O , CEH activity; a , A ; , Salt concentration;ZoU
i 1 , Fractions pooled.
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ion-exchange columns resulted in the specific activity of CEH decreasing
at each step. This was in contrast to the elution profiles shown in
Fig. 3.6 in which the CEH activity eluted in reasonably sharp peaks not
fully coinciding with the protein profile. This was clearly the
situation on the hydroxylapatite column (Fig. 3.6a), but SDS/PAGE of
samples taken from each stage show that only minor purification had
been achieved at steps V-VII (Fig. 3.7).
Taken together the results indicate that there were two main
reasons for these results. Firstly, the SDS/PAGE of the samples and
the elution profiles indicated that cholate, as an ionic detergent,
severely interfered in the functioning of the ion-exchange columns used.
This resulted in the entire preparation binding to the columns and
also eluting virtually en masse, particularly in the DEAE-cellulose
steps, with very little difference in the overall protein pattern.
Secondly, although the hydroxylapatite step did not appear to be
adversely affected by the presence of cholate, the specific activity
dropped. This indicated substantial inactivation of the enzyme occurred
throughout the later steps. This could be due to prolonged exposure
to cholate during both the chromatographic steps and intermediary
dialyses, possibly aggravated by the increased detergent:protein ratio
in these fractions. This was in contrast to the results obtained in
Section 3.3.2, although in that study the enzyme was maintained in a
constant environment without the column chromatography effects,
increased ionic strength and dialysis that occurred over the 5 day
period needed for the purification procedure discussed in this section.
The procedure was repeated, using columns of different dimensions
and with QAE-Sephadex A-50 replacing the second DEAE-cellulose step,
in an attempt to increase the resolution, but this did not give better





Fig. 3.7. SDS/PAGE of samples from each stage of the purification
procedure using cholate solubilised enzyme. Samples containing about
100 pg protein from each stage were subjected to SDS/PAGE-on a 10%
gel and stained for protein as described in the methods section.
The arrows indicate the position on the gel of molecular weight standards,
1, Tissue cytosol; 2, Ammonium sulphate (0-40%) precipitate;
3, Sepharose CL-4B; 4, Hydroxylapatite; 5, DEAE-cellulose I;
6, DEAE-cellulose II.
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inactivation of the enzyme by reducing the cholate concentration in the
buffers from 0.1% to 0.02%. This did not affect the elution profiles,
and it did not alter the pattern of decreasing specific activity after
step IV.
These results indicated that conventional ion-exchange techniques
were not compatible with the use of cholate solubilised enzyme in the
purification of CEH. Some of the problems associated with using ionic
detergents and ion-exchange chromatography had been noted previously
(Tanford and Reynolds (1976)). However, despite the problems associated
with the use of cholate in lengthy procedures, the cholate solubilisation
step was still useful and was used in later experiments (see Section 4).
3.5 THE USE OF HUMAN HDL AND PURIFIED AP0LIP0PR0TEIN A-I TO SOLUBILISE CEH
Respite the overall failure of the purification procedure described
in Section 3.4, the solubilisation of the enzyme remained a crucial
step in any purification method. Cholate effectively solubilised the
enzyme but there were problems associated with its use.
HSL in the cytosol of adipose tissue was known to be associated
with large, lipid-rich complexes, which also contain diacylglycerol,
monoacylglycerol and cholesterol ester hydrolase activities (Khoo,
Drevon and Steinberg (1980)). These activities cofractionated through
limited purification (Berglund, Khoo et_ a_l. (1980), Fredrikson,
Stralfors et al. (1981a)), and during gel permeation chromatography of
crude homogenates on 2% agarose, they all eluted in the void volume
(Khoo, Drevon and Steinberg (1980)). However, it had been reported
that incubation of crude homogenates from chicken adipose tissue with
purified human HDL (hHDL) or apolipoprotein A-I prepared from delipidated
hHDL, resulted in dissociation of the large, lipid-rich complexes
(Khoo, Drevon and Steinberg (1980)). The HSL activity was now mostly
125
retained and coeluted with I-labelled hHDL. The diacylglycerol and
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monoacylglycerol hydrolase activities were also largely retained but
less so than HSL (74% and 68% retained, respectively). Furthermore,
CEH activity was also dissociated from the large aggregates and
appeared to elute just prior to HSL. These results suggested that
this may be a useful technique to apply to the purification of CEH
from bovine adrenocortical cytosol as the enzyme was also present in
large, lipid-rich complexes in this tissue (Beckett (1975), Beckett
and Boyd (1977)).
HDL was prepared from human serum by sodium phosphotungstate/
magnesium chloride precipitation followed by preparative density
ultracentrifugation as described in the methods section. To prepare
apolipoprotein A-I, a portion of hHDL was delipidated and the crude
protein subjected to chromatography on Sep'nacryl S-200, Sephadex G-100
and Cibacron Blue - Sepharose 4B as described in the methods section.
3.5.1 Effect of hHDL and apolipoprotein A-I on CEH elution profile on
gel permeation chromatography
Sepharose CL-4B (4% agarose) had been used in previous purifications
of the enzyme and the elution profile of CEH activity using this gel
was known (Fig. 3.5a). Therefore this gel was used in the following
experiments.
Samples of ammonium sulphate (0-40%) precipitate from bovine
adrenocortical cytosol were incubated with hHDL for 4 h at 37°C or with
apolipoprotein A-I for 20 h at 4°C and then chromatographed on a
Sepharose CL-4B column equilibrated and eluted with 20 mM Tris-HCl
buffer pH 7.4 at 4°C containing 1 mM EDTA and 10% (v/v) glycerol.
A control sample of ammonium sulphate precipitate without any
preincubation was also chromatographed.
Fig. 3.8a shows that with no preincubation the CEH activity was
divided between a large, sharp peak in the void volume and a broad
 
Legend to Fig. 3.8. Effect of hHDL and apolipoprotein A-I on the elution
of CEH from Sepharose CL-4B. The column (1 x 70 cm) was equilibrated and
eluted with 20 mM Tris-HCl buffer pH 7.4 at 4°C containing 1 mM EDTA and
10% (v/v) glycerol (flow rate, 5 ml.h ; fraction size, 1.5 ml).
a) 1 ml ammonium sulphate (0-40%) precipitate (17 mgml ^) prepared
from bovine adrenocortical cytosol in 20 mM Tris-HCl buffer pH 7.4 at
4°C was applied to the column.
b) 1 ml ammonium sulphate precipitate (as above) was incubated with
350 pi hHDL (8 mg protein) for 4 h at 37°C and then applied to the
column.
c) 1 ml ammonium sulphate precipitate (as above) was incubated with
2 mg apolipoprotein A-I dissolved in 400 pi of 20 mM Tris-HCl buffer
pH 7.4 at 4°C for 20 h at 4°C and then applied to the column.
O, CEH activity; a, A28q.
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peak eluting at about 1.8 x Vo. Prior incubation with hHDL resulted
in an increased amount of CEH eluted in the retarded peak but there
was still a substantial amount of activity in the void volume peak,
which had been broadened (Fig. 3.8b). Incubation with apolipoprotein
A-I caused a reduction in the amount of activity appearing in the
retarded peak (Fig. 3.8c). Apolipoprotein A-I, due to its hydrophobic
nature, may increase the amount of aggregation of CEH forming an
increased number of particles of very high molecular weights.
When this experiment was performed using adipose tissue a centrifugation
step was included after incubation with apolipoprotein A-I to remove
precipitated material (Khoo, Drevon and Steinberg (1980)). When the
subsequent chromatography was carried out, virtually no activity was
found in the void volume. However, only diacylglycerol hydrolase
activity was measured. This result suggested that there may be
increased aggregation upon treatment of the enzyme with apoprotein A-I.
Comparison of Fig. 3.8a with Figs. 3.8b and c showed that the
activity of CEH was reduced by about 50% after incubation with hHDL
or apolipoprotein A-I. Therefore the lower activity observed in the
retarded peak could be due to inhibition by the apolipoprotein A-I
125
present (not shown Fig. 3.8, for I-labelled apolipoprotein A-I
elution profile on Sepharose CL-4B, see Figs. 3.10a and b). It is
possible that Khoo, Drevon and Steinberg (1980) may also have observed
this inhibitory effect as all their results were expressed as percentage of
peak fraction activity and not in absolute activity. The solubilisation
effect had proved to be less effective in bovine adrenal cortex than
in adipose tissue. However the inhibitory effect of hHDL and
apolipoprotein A-I on CEH activity was interesting, hence it was decided
to investigate this more fully to elucidate the mechanism.
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3.5.2 Effect of hHDL and apolipoprotein A-I on CEH activity
Samples of an ammonium sulphate (0-40%) precipitate prepared from
bovine adrenocortical cytosol were incubated with various amounts of
hHDL to final hHDL protein:CEH protein ratios (mg:mg) of 0, 1:2, 1:1,
3:2 and 2:1. The mixtures were incubated at 37°C and aliquots assayed
for CEH activity at 2 h and 4 h. A further sample of ammonium sulphate
precipitate was incubated at 4°C as an additional control. Table 3.2
shows that incubation of the enzyme alone at 37°C was sufficient to
cause a time-dependent loss of CEH activity. The less was over 50%
after 4 h and may be due to the action of endogenous phosphoprotein
phosphatases that have relatively little divalent cation requirements
or to the action of proteases. Therefore the decreased activity
observed in Fig. 3.8b could be explained in these terms. However,
addition of hHDL to the incubation greatly increased the inactivation.
The inactivation was almost complete by 2 h and subsequent decreases
in activity were probably due to the reasons stated previously.
The incubation appeared to be maximal at an hHDL protein:ammonium
sulphate protein ratio approaching 1:1.
HDL is composed of 50% protein and 50% lipid by weight and of the
total lipid composition, about 40% is cholesterol ester and 20% is free
cholesterol (Chapman (1980)). Therefore for every 1 mg of HDL protein
there will be approximately 400 yg cholesterol ester and 200 yg free
cholesterol. The amount of hHDL-derived free and esterified cholesterol
present in each incubation, and the amount introduced into the CEH
assay system is shown in Table 3.3. The concentration of cholesterol
oleate in the substrate emulsion was 183 nmol/0.2 ml aliquot, and
therefore 120 yg of labelled substrate was added to each assay.
Furthermore, much of the hHDL derived cholesterol ester will be esterified
to linoleic acid which is a better substrate for CEH (Gorban (1980)).
hHDL protein: CEH Activity
CEH protein (pmol oleic acid produced.min .mg protein )
(mg:mg)
2 h 4 h
0 1999 - 18 1471 - 30
1:2 109 - 10 35-3
1:1 90-6 27 - 1
3:2 370 - 36 236 - 28
2:1 297 - 31 173 - 16
Table 3.2. Inhibition of CEH activity by hHDL. Samples of 1 ml
ammonium sulphate (0-40%) precipitate (1 mgml in 20 mM Tris-HCl
buffer pH 7.4 at 37°C were incubated at 37°C with hHDL (30 mg
protein.ml in 10 mM Tris-HCl buffer pH 7.0 containing 150 mM
sodium chloride and 0.1 mM EDTA, at the ratios shown above.
After 2 and 4 h,portions were withdrawn and the CEH activity measured.
The CEH activity after incubation at 4°C for 4 h was 3283 - 61
pmol oleic acid produced.min \ mg protein The results are









In Incubation In CEH Assay
0 0 0 0 0
1:2 200 20 100 10
1:1 400 40 200 20
3:2 600 60 300 30
2:1 800 80 400 40
Table 3.3. The amount of hHDL-derived cholesterol ester and free
cholesterol in each incubation tube (CEH + hHDL) and consequently
the amount present in the CEH assays (total volume in each incubation
tube was 1.07 ml and 100 yl was assayed).
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In addition to substrate competition, the amounts of hHDL-derived free
cholesterol may also result in product inhibition. How important these
factors are considering the already high lipid content of similar CEH
preparations from bovine adrenocortical cytosol (Wallat and Kunau (1976))
was difficult to estimate but it was possible that these factors
contributed to the decreased CEH activity observed.
The protein moiety of hHDL consists of over 70% apolipoprotein A-I,
25% apolipoprotein A-II and small amounts of apolipoproteins C and E.
These proteins not only function as structural components of the
lipoprotein particle but also apolipoprotein A-I is an activator of
lecithin: cholesterol acyl transferase (LCA.T) and apolipoprotein C-II
is an activator of lipoprotein lipase. Therefore it was possible
that the main effector in hHDL that inhibits CEH was an apoprotein.
This possibility was supported by the result observed in Fig. 3.8c
where the presence of apolipoprotein A-I alone caused a reduction in
CEH activity. In this case the incubation was performed at 4°C and
so inactivation due to phosphoprotein phosphatase and protease
activities would be reduced. To investigate the hypothesis that
apolipoprotein A-I inhibits CEH, samples of an ammonium sulphate (0-40%)
precipitate prepared from bovine adrenocortical cytosol were incubated
with various amounts of purified apolipoprotein A-I, for up to 6 h at
both 4°C and 37°C.
Table 3.4 shows that in the absence of apolipoprotein A-I the CEH
activity decreased in a time and temperature-dependent manner. This
suggests that this inactivation of CEH may be due to the activity of
endogenous phosphoprotein phosphatases and proteases in the enzyme
preparation. Addition of apolipoprotein A-I resulted in an immediate
decrease in CEH activity of 75% and 85% at the 1:2 and 1:1 apolipoprotein
A-I:ammonium sulphate (CEH) protein ratios (mg:mg), respectively.
Temp. AI protein: CEH Activity
,o_. CEH protein (pmol oleic acid produced.min .mg protein )( C)
37
(mg:mg)
Oh 2 h 4 h 6 h
0 2342 - 61 1433 - 89 1257 - 19 1179 - 92
1:2 629 - 51 367 - 10 318 - 31 338 - 3
1:1 395 - 3 267 - 31 282 ^ 5 200 - 4
0 2342 - 61 1383 - 12 849 - 10 567 - 15
1:2 629 - 51 263 - 29 194 - 25 235 - 22
Table 3.4. Effect of apolipoprotein AI on the activity of CEH.
Samples of ammonium sulphate (0-40%) precipitate (1 mgml prepared
from bovine adrenocortical cytosol in 20 mM Tris-HCl buffer pH 7.4
at 37°C or 4°C were incubated with apolipoprotein AI (0.5 mgml ^ in
20 mM Tris-HCl buffer pH 7.4 at 37°C) in the various ratios and at
the two temperatures shown. The CEH activity was determined at 2 h
intervals. The results are expressed as means - S.E.M. of triplicate
assays.
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The inhibition was increased slightly by 2 h but not significantly
after this indicating that the inhibition was almost instantaneous on
mixing. Small decreases with time or temperature probably reflects
the additive effects of phosphoprotein phosphatase and protease
activity described previously.
A further experiment was performed to investigate the kinetics of
the deactivation. Samples of ammonium sulphate (0-40%) precipitate
prepared from bovine adrenocortical cytosol were assayed for CEH
activity in the presence of increasing amounts of apolipoprotein A-I.
Other samples of enzyme were activated by preincubation with cAMP and
2+
ATP/Mg before addition of apolipoprotein A-I. The results are shown
in Fig. 3.9. The amounts of apolipoprotein A-I used in this experiment
were considerably lower, in terms of both yg/assay and apolipoprotein
A-I:enzyme protein ratio, than those used in the previous experiment.
In this experiment a dose-dependent inhibition was seen with both the
control (basal) and activated enzymes. In the case of the activated
enzyme, the apolipoprotein A-I inactivation was more pronounced but
it appeared that as the amount of apolipoprotein A-I increased the
activity of CEH decreased to a similar level in both cases. Therefore
as the inactivation was dependent on both the amount of apolipoprotein
A-I and the phosphorylation state of the CEH, one possible explanation
was that apolipoprotein A-I possessed phosphoprotein phosphatase
activity and was acting by dephosphorylation of CEH. Another possibility
was that apolipoprotein A-I may stimulate an endogenous phosphoprotein
phosphatase. To investigate these hypotheses it was decided to
investigate these possible enzymic activities of apolipoprotein A-I.
3.5.3 Investigation of possible phosphoprotein phosphatase activity of
apolipoprotein A-I
To investigate the possibility of apolipoprotein A-I possessing
32
phosphoprotein phosphatase activity, samples of P-labelled phosphohistone
—I , I ,






Fig. 3.9. Effect of increasing doses of apolipoprotein A-I on CEH
activity. Samples of 100 yl of an ammonium sulphate (0-40%) precipitate
(2.58 mgml prepared from bovine adrenocortical cytosol in 20 mM
Tris-HCl buffer pH 7.4 at 37°C containing 1 mM EDTA and 0.1 mM DTT
were mixed with various amounts of apolipoprotein A-I (0.5 mgml ^ in
20 mM Tris-HCl buffer pH 7.4 at 37°C) and then assayed in triplicate
for CEH activity. A parallel experiment was performed in which CEH
was previously activated by incubation of the ammonium sulphate
2+
precipitate with ATP/Mg and cAMP as described in the methods section.
Each point is the mean - S.E.M. from two experiments.
O, Control enzyme; • , Activated enzyme.
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(50 yl) containing 50 yg protein and 0.2 yCi radioactivity were incubated
for 30 min at 37°C with various amounts of apolipoprotein A-I.
The release of radioactive phosphate was measured as described in the
methods section. Table 3.5 shows that there was no significant
32
difference between the P content of the TCA supernatant after
incubation with apolipoprotein A-I compared to control incubations with
32
P-labelled phosphohistone alone. This was also the case when the
radioactivity in the protein pellet was measured. Inclusion of 5 mM
2+ , . .
Mg m the incubations had no effect on the phosphoprotein phosphatase
results.
Although phosphohistone is a commonly used artificial substrate
for phosphoprotein phosphatases, there are examples in the literature
of phosphoprotein phosphatases that have a low or no activity towards
this substrate (Gratecos, Detwiler and Fischer (1974)). The substrate
for the postulated phosphoprotein phosphatase activity of apolipoprotein
32
A-I is phospho-CEH. Therefore, P-labelled phospho-CEH was prepared
from an ammonium sulphate (0-40%) precipitate from bovine adrenocortical
cytosol by the procedure outlined in the methods section. This enzyme
sample is impure and several proteins are known to be phosphorylated
in this preparation. Samples of this preparation containing 125 yg
protein and 34 nCi radioactivity were incubated with various amounts
of apolipoprotein A-I for 30 min at 37°C and the phosphoprotein
phosphatase activity assayed as before. Table 3.6 shows there was
32 ...
no significant increase in the P released after incubation with
apolipoprotein A-I compared to the control incubation. The radioactivity
in the protein pellet also showed no significant difference upon
2+
incubation with apolipoprotein A-I. No Mg was included m these
experiments but in the previous experiments where CEH activity was
measured (see Fig. 3.9), no divalent cations were present and so any
























Table 3.5. Incubation of P-labelled phosphohistone with apolipoprotem
AI. Various amounts of apolipoprotein AI (0.5 mgml in 20 mM Tris-HCl
3 2
buffer pH 7.4 at 37°C were incubated for 30 min at 37°C with 50 yl P-
labelled phosphohistone (1 mgml \ 4.3 yCi.ml ^") in 50 mM TES buffer
pH 7.0. Phosphoprotein phosphatase activity was measured as described in
the methods section. Results are means - S.E.M. of triplicate assays.
























Table 3.6. Incubation of P-labelled phosphoCEH preparation with
apolipoprotein AI. Apolipoprotein AI was as described in the legend
to Table 3.5. An ammonium sulphate (0-40%) precipitate from bovine
T 32 1adrenocortical cytosol was phosphorylated with y- P ATP as described
in the methods section and desalted on Sephadex G-25 equilibrated in
20 mM Tris-HCl buffer pH 7.4 at 37°C containing 1 mM EDTA and 0.1 mM DTT.
100 yl samples of this preparation were incubated with various amounts
of apolipoprotein AI for 30 min at 37°C and the phosphoprotein phosphatase
activity measured as described in the methods section. Results are
means - S.E.M. of triplicate assays.
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putative phosphoprotein phosphatase activity would have to be independent
of divalent cations. These results indicated that apolipoprotein A-I
did not possess any detectable phosphoprotein phosphatase activity.
It was possible that it was very specific towards phospho-CEH and the
32
P radioactivity released was, therefore, too small to be detected in
such an impure enzyme preparation containing many phosphoprotein
species. This would be a most unlikely conclusion as no phosphoprotein
phosphatase had been found with such a high degree of specificity.
However, a pure preparation of CEH would be required before this
possibility could be completely excluded. This experiment also showed
that apolipoprotein A-I did not stimulate an endogenous phosphoprotein
phosphatase in the ammonium sulphate preparation.
3.5.4 Interaction of apolipoprotein A-I with cholesterol
oleate substrate emulsion
[l-14c]
In HDL particles apolipoprotein A-I interacts with, and is in close
association with, the other components of the particle. These components
include a large amount of cholesterol ester, cholesterol and phospholipid
and a small amount of triacylglycerol and other apolipoproteins
(Chapman (1980)). Therefore it was likely that apolipoprotein A-I
r 141
would interact with the cholesterol 1- C oleate substrate emulsion
forming an apolipoprotein A-I:cholesterol oleate complex. The formation
of this complex may result in the cholesterol oleate being no longer
freely available for hydrolysis by CEH. However, any such complex may
have similar structure to HDL, and the lipids of HDL are available to
lipase activity in the tissues that utilise HDL. It had also been
shown that neutral CEH activity in adipose tissue cytosol can effectively
hydrolyse the cholesterol esters in native rat plasma HDL (Khoo, Drevon
and Steinberg (1979)). However the complexes formed in vitro may be
sufficiently different to prevent effective hydrolysis, and so the
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interaction between apolipoprotein A-I and the cholesterol oleate
substrate emulsion was investigated.
The technique chosen to study the interaction was gel filtration
chromatography. It was known that the cholesterol oleate substrate
emulsion particles were eluted in the void volume of Sepharose CL-4B,
and apolipoprotein A-I with a molecular weight of just over 28 000
should be maximally retained by this column and so be eluted much later.
r 14 "i
By using the cholesterol 1- C oleate labelled substrate emulsion and
125
I-labelled apolipoprotein A-I (see methods section) the elution
profiles of both components were determined. In each interaction
experiment two columns were run, one using labelled substrate emulsion
and unlabelled apolipoprotein A-I and one with unlabelled substrate
emulsion and labelled apolipoprotein A-I. One possible problem with
this method was that, in the aqueous medium of the experiments, the
apolipoprotein A-I may aggregate into large molecular weight particles
that would also be excluded from the gel. Figs. 3.10a and b show that
this did not occur, and whereas the cholesterol oleate substrate
emulsion droplets were eluted in the void volume, the apolipoprotein A-I
eluted at 2.4 x Vo. The A„0^ profile in Fig. 3.10a shows, firstly,ZoU
scattering due to the emulsion particles in the void volume and secondly,
the absorbance at about 2.4 x Vo due to the bovine serum albumin
present in the substrate emulsion. Therefore this technique was
suitable for investigating the interaction between the substrate
emulsion and apolipoprotein A-I.
When cholesterol oieate substrate emulsion was mixed with
apolipoprotein A-I and the sample subjected to gel filtration on
Sepharose CL-4B, the results obtained were identical to the two graphs
obtained in Figs. 3.10a and b. Therefore no interaction between the





























Fig. 3.10. Interacti^5°f apolipoprotein A-I with cholesterol oleate
substrate emulsion. I-labellecL apolipoprotein A-I (approximately
0.4 pCi.pl in 50 mM potassium phosphate buffer pH 7.4) was prepared
as described in the methods section. Unlabelled apolipoprotein A-I
(1 mgml ) was in 20 mM Tris-HCl buffer pH 7.4 at 4°C. Cholesterol
olgate substrate emulsion contained 0.6 mg cholesterol oleate and
10 cpm per ml (see methods section) and the unlabelled emulsion was
prepared identically except no radiolabel was included. The Sepharose
CL-4B column (2.5 x 50 cm) was equilibrated and eluted with 20 mM
Tris-HCl buffer pH 7.4 at
t-Wc]
4°C.
[x-»c] oleate substrate emulsion was applied to column.a) 1 ml cholesterol
125
b) 1 ml I-labelled apoJ^goprotein A-I solution (0.5 ml unlabelled
apolipoprotein A-I, 25 pi -labelled apolipoprotein A-I in a total
volume of 1 ml) was applied to column.
Fraction No.
Fig. 3.10 contd.
c) 0.5 ml unlaljjglled apolipoprotein A-1 was mixed with 0.5 ml
cholesterol Q.- C Joleate substrate emulsion and 5 pi egg yolk
lecithin (50 yg) and sonicated on a Rapidis 150, power 7 for 40s
(4 x 10s) at 4 C, before application to column.
125
d) As c) except I-labelled apolipoprotein and unlabelled cholesterol
oleate substrate emulsion were used.
14 .
C was determined m 500 yj.9gamples of the fractions by liquid
scintillation counting and ~ I was determined in 50 yl samples of
the fractions in a Wilj y~counter.
□ 14C- • 125I- a A0, , 1, ' A280-
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HDL and an important component of all lipoproteins is phospholipid
which, due to its amphipathic nature, is essential for the stability
and maintenance of all the lipoproteins (Lux, Hirz et al. (1972)).
There have been extensive investigations into the association of
apolipoproteins A-I and A-II with phospholipid complexes (Swaney
(1980), Swaney and Chang (1980)). Therefore it was possible that
phospholipid may be necessary for the formation of apolipoprotein A-I:
cholesterol ester complexes. A further experiment was performed in
which the cholesterol oleate substrate emulsion was sonicated with
apolipoprotein A-I in the presence of egg yolk lecithin. Figs. 3.10 c
and d show that the addition of phospholipid had an effect on the
r 14 n
dissociation of the emulsion particles as there was cholesterol 1- C
oleate present throughout the column fractions with a major peak at
2.3 x Vo. This effect was found to be dependent upon the ratios of
phospholipid to apolipoprotein A-I and cholesterol oleate. In this
experiment 50 yg phospholipid was mixed with 500 yg apolipoprotein A-I
and 300 yg cholesterol oleate. When the phospholipid content was
raised to 200 yg the effect of the dissociation was much reduced and
with 400 yg phospholipid the effect was abolished completely. At these
high phospholipid concentrations, the phospholipid may preferentially
form micelles. Figs. 3.10c and d also show that the effect of
sonication with phospholipid appeared to be primarily on the emulsion
particles. That is, they were dispersed into apolipoprotein A-I/
cholesterol oleate/phospholipid complexes of smaller size. The
apolipoprotein A-I was not introduced into the larger emulsion particles,
but there was some broadening of the apolipoprotein A-I peak, possibly
indicating a larger spread of particle size. Sonication without
phospholipid, gave only a small degree of dissociation of the emulsion
particles.
These experiments showed that scnication in the presence of
phospholipid resulted in the association of the cholesterol oleate
contained in the substrate emulsion with apolipoprotein A-I. It was
known that CEH preparations from bovine adrenocortical cytosol,
similar to the ammonium sulphate preparation, were rich in phospholipids
(Wallat and Kunau (1976)). Therefore it was possible that apolipoprotein
A-I could interact with the cholesterol oleate substrate emulsion in the
presence of the phospholipid contained in the CEH preparation. It was
possible that the complexes formed as a result, contain cholesterol
oleate in a central core or some other situation where it was not
available to the CEH.
It has been shown recently that apolipoproteins A-I and A-II
inhibit hepatic triglyceride lipase from human post-heparin plasma
(Kubo, Matsuzawa et al. (1981)). Earlier work had shown that whole
serum and purified HDL inhibited this enzyme when added to the assay
(Kubo, Matsuzawa et al. (1980)). The concentrations of apolipoproteins
A-I and A-II required to inhibit the enzyme activity were similar to
those found in this study for inhibition of CEH activity. Concentrations
of up to 240 yg ml ^ of A-l/A-II protein were added to the assay to
give 50% inhibition of hepatic triglyceride lipase. This compares
with the CEH inhibition in this case, where 100 yg and 50 yg of
of apolipoprotein A-I were required in the CEH assay (0.4 ml total
volume) to give 50% inhibition of the enzyme in the basal and activated
states respectively (Fig. 3.9). However Kubo, Matsuzawa et al. (1981)
did not give any indication of the possible mechanism of this inhibition.
The finding that first HDL, and then purified apolipoprotein A-I
inhibit CEH was similar to the situation with hepatic triglyceride
lipase and like that system the mechanism of the inhibition is unclear.
Preliminary work has shown that apolipoprotein A-I does not contain
72.
any phosphoprotein phosphatase activity and does not stimulate endogenous
phosphoprotein phosphatases in the CEH preparation. The apolipoprotein
A-I may interact with the cholesterol oleate substrate emulsion in the
presence of phospholipid contained in the CEH sample, and so block
access of the CEH to the ester function of the substrate.
3.6 SUMMARY
1. Sodium cholate has been found to effectively solubilise CEH activity
in ammonium sulphate precipitates prepared from bovine adrenocortical
cytosol.
2. The cholate treatment inhibits the enzyme on long term exposure but
glycerol can protect the enzyme from this inhibition.
3. However, cholate was not compatible with the use of ion-exchange
techniques for the purification of the enzyme. Chromatography of CEH
in cholate buffers leads to inactivation of the enzyme.
4. Human HDL and purified apolipoprotein A-I were not effective at
solubilising the enzyme activity in ammonium sulphate precipitates.
5. Both hHDL and apolipoprotein A-I inhibited the activity of CEH.
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Two major biochemical separation techniques had not been attempted
previously with adrenocortical cytosolic CEH. These were hydrophobic
interaction chromatography and affinity chromatography.
Although proteins had been separated previously on lipophilic ion-
exchange resins (Weiss and Bilcher (1970)) it is generally accepted that
hydrophobic chromatography arose out of affinity chromatography when
it was discovered that the alkyl spacer arms, used to link the ligand
to the gel, could cause adsorption of the enzyme on their own (Er-el,
Zaidenzaig and Shaltiel (1972)). This phenomenon was further studied
(Yon (1972)) and found to be useful in the separation of proteins by
their intrinsic differences in hydropnobicity (Yon (1974), Hjerten,
Rosengren and Pahlman (1974), Shaltiel (1974), reviewed Hjerten (1973),
Yon (1978)). There are now a great variety of different ligands that
can be used for this purpose including alkyl, aminoalkyl and aryl
derivatives of agarose which offer a wide range of hydrophobic and
mixed hydrophobic/ionic affinities (Yon (1972), Yon (1974), Hjerten,
Rosengren and Pahlman (1974)). Alteration of the chemical linkage
between the ligand and the gel matrix (reviewed Yon (1978)), and of
the gel matrix itself (Imamura and Horiuti (1979)) can alter the ability
of the media to separate proteins by their intrinsic hydrophobic and
hydrophobic/ionic differences.
The natural substrates for CEH in adrenal cortex are the long chain
fatty acid esters of cholesterol (Beckett and Boyd (1975), Vahouny,
Hodges and Treadwell (1979)). These compounds are almost totally
insoluble in water and thus are hydrophobic, and so it is probable that
the CEH enzyme molecule has an hydrophobic cleft at the active site,
for the substrate molecule. The enzyme has also been shown to hydrolyse
norcholesteryl oleate and pregnenol oleate (Beckett (1975)) and may also
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catalyse the hydrolysis of triacylglycerols (Gorban and Boyd (1977),
Pittman and Steinberg (1977)), hence it was possible that the fatty
acid moiety was responsible for the binding of substrate to the active
site of the enzyme. For these reasons it was thought that CEH would
be an ideal enzyme to use in studies of protein separation by
hydrophobic chromatography techniques. The aim of the first part of
this work was to investigate the use of hydrophobic interaction
chromatography in the purification of CEH from bovine adrenocortical
cytosol.
CEH had been successfully solubilised from bovine adrenal cortex
cytosol using cholate (see Section 3), and it was decided to use this
preparation as the enzyme source for subsequent experiments. Although
it was originally expected that hydrophobic chromatography would be
useful in the purification of the most hydrophobic proteins, such as
membrane proteins, it has been found that the detergents used to
solubilise these proteins can interfere with the enzyme-ligand
interactions (Yon (1978)). However, there -were many examples of the
successful use of hydrophobic chromatography in the purification of
detergent solubilised proteins (Carson and Konigsberg (1981) , reviewed
Hjerten (1978)). Furthermore the purification of hepatic microsomal
cytochrome P-450 had been reported using cholate solubilisation
followed by hydrophobic chromatography on aminooctyl-Sepharose
(Masuda-Mikawa, Fujii-Kuriyama et al. (1979)) or octyl-Sepharose
(Beaune, Dansette et al. (1-979)) columns, equilibrated in cholate-
containing buffers.
Affinity chromatography was another potentially powerful technique
for the purification of proteins, that had not been used previously
with CEH from adrenocortical cytosol. The basic principle in affinity
chromatography is to separate proteins from complex mixtures by
their binding to a ligand that is biospecific for a particular protein
(Cuatrecasas (1970), reviewed Lowe (1977)). The ligand is usually
covalently attached to a suitable gel matrix such as agarose or
polyacrylamide (Cuatrecasas (1970)), although other supports such as
glass (Weetal and Filbert (1974)) and plastic (Kondorosi, Nagy and
Denes (1977)) have been used. This technique has been useful in the
purification of enzymes with nucleotide (or nucleotide derived)
cofactors, but as over 30% of all known enzymes can recognise the AMP
moiety, the problem for each specific protein has been the precise
structure of the nucleotide derivative used as the ligand (Lowe (1977))
Much work has been carried out using amino-acids, nucleic acids and
sugars, and their respective derivatives, as ligands (reviewed
Wilcheck and Jakoby (1974)). Lectins are also used widely (Sieber
(1977)) and there are numerous applications of affinity chromatography
using immunological procedures (Kondorosi, Nagy and Denes (1977),
Weintraub (1970), Gospodarowicz (1972)).
With CEH there was only one known biospecific ligand, the substrate
with which to develop a true affinity column. The aim of the second
part of this work was to investigate the use of affinity chromatography
in the purification of CEH from bovine adrenocortical cytosol using
cholesteryl ester as a biospecific ligand.
4.2 HYDROPHOBIC INTERACTION CHROMATOGRAPHY
Shaltiel hydrophobic chromatography kits (Er-el, Zaidenzaig and
Shaltiel (1972)) were obtained from Miles Laboratories Ltd. These kits
contained a series of 1 ml columns of agarose gel that had various
lengths of either alkyl or ur-aminoalkyl chains covalently bound.
4.2.1 Application of enzyme
The columns were equilibrated with 300 mM potassium phosphate
buffer pH 7.4 containing 1 mM EDTA, 0.1 mM DTT, 10% (v/v) glycerol and
0.1% (w/v) cholate. 200 yl of cholate solubilised enzyme (see Section
3.3.4) in the same buffer was applied to the column and washed through
with 2 ml of the column buffer. Aliquots of the eluant were assayed
for CEH activity and the percentage of activity eluted was plotted
against the chain length. It had been found that with most proteins,
as the ligand chain length increased, in general the amount of protein
bound increased (Shaltiel (1974)). Fig. 4.1 shows that this pattern
was only found with the cj-aminoalkyl columns, whereas with the alkyl-
agarose series the percentage activity eluted decreased, as expected,
to hexyl-agarose and then increased with octyl- and decyl-agaroses.
The reason for this was not known as no comparative study on the
hydrolysis of different fatty acid esters of cholesterol by cytosolic
adrenocortical CEH had been reported, except indirect studies by
Beckett and Boyd (1975) and Vahouny, Hodges and Treadwell (1979) in which
the differential hydrolysis of cholesterol esters of rat adrenal lipid
droplets and cholesterol esters of rat adrenal cells was measured before
and after subjecting the animal to hormonal stimulus such as ether
stress (Beckett and Boyd (1975)) or challenging adrenal cells with
dibutyryl cAMP (Vahouny, Hodges and Treadwell (1979)). The in vitro
assay of CEH involves presenting the cholesterol ester substrate to
the enzyme in a ethanolic emulsion. The technical difficulties in
presenting esters of cholesterol with different fatty acid moieties such
as stearate, palmitate, oleate and linoleate that have different chain
lengths and degrees of saturation, to CEH under identical substrate
emulsion conditions have prevented direct studies. Therefore it was
not possible to speculate on the physiological significance, if any,
of this observation.
A control column, with no ligand attached was included in each kit,
and Fig. 4.1 shows that 87% of the CEH was eluted from the control column
Chain length (n)
Fig. 4.1. Shaltiel hydrophobic chromatography test kits. 200 yl
cholate solubilised enzyme (4.8 mgml in 300 mM potassium phosphate
buffer pH 7.4 containing 1 mM EDTA, 0.1 mM DTT, 10% (v/v) glycerol
and 0.1% (w/v) cholate was applied to the columns, previously
equilibrated with the sample buffer. The sample was washed through
with 2 ml of the same buffer and the eluant assayed for CEH activity.
A further 200 yl sample of cholate solubilised enzyme was diluted with
2 ml buffer and assayed to give the control (100%) activity.
The percentage of the control activity eluted was plotted against
alkyl or w-aminoalky1 chain length (n).
a) Alkyl agarose columns;
b) uj-aminoalkyl columns.
included in the alkyl agarose kit whereas only 56% was eluted from the
apparently identical column included in the aj-aminoalkyl kit. Although
this was difficult to explain these figures were compatable with the
pattern obtained for each series and so it was not considered a major
problem. Whereas the alkyl-agarose columns contain purely hydrophobic
ligands the oj-aminoaklyl agarose series has a mixed function ligand
containing both hydrophobic and ionic elements (Hjerten (1973)).
This may introduce an additional, unwanted interaction between the
matrix and the ionic detergent. Furthermore it was known that
interactions between hydrophobic gels and detergents tend to interfere
with the protein-adsorbant interactions (Yon (1978), Hjerten (1978)).
However the extent of these ionic interactions should be relatively
minor in the buffer system used, where the pH and relatively high
ionic strength would reduce these forces. In both the alkyl series
and aminoalkyl series, the ligand with 6 carbons in the chain proved
to be the most effective at binding CEH and so these columns were
chosen for further experiments on the elution of the bound activity
from the gel. w-Aminohexyl agarose was chosen in preference to the
aminooctyl and aminodecyl derivatives as the binding forces should be
the minimum required for complete retension of the enzyme.
4.2.2 Elution of CEH activity from hydrophobic columns
If hydrophobic chromatography was to be useful in the purification
of CEH, it must yield an enzyme preparation of increased specific
activity and also allow substantial recovery of the enzyme activity.
This was investigated using the hexyl agarose and uj-aminohexyl agarose
columns.
The columns were washed extensively with 1 M sodium chloride
followed by treatment with ethanol, butanol, ethanol and distilled water
(see Octyl Sepharose CL-4B, Phenyl Sepharose CL-4B, Pharmacia Fine
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Chemicals, AB, Upsalla, Sweden (1976)) to remove all bound protein,
and were then reequilibrated in the column buffer. A sample of 200 yl
cholate solubilised enzyme was applied and washed through with 2 ml
column buffer as before. Various buffer systems were then applied to
the columns and the percentage of activity found in the successive
eluants was determined.
Table 4.1 shows that cv-aminohexyl agarose again bound almost all
the CEH in the sample, but in this experiment the hexyl agarose also
bound some 99% of the activity compared to only 76% bound in the first
experiment (Fig. 4.1). However the results show that in general the
enzyme was less tightly bound to the hexyl agarose column, as was
expected. Despite this it was still tightly bound on both columns and
none of the buffer systems investigated eluted more than 2.4% of the
applied CEH activity. Although the protein content of each eluant was
not measured in this experiment and thus the specific activity of the
enzyme after each elution was not known, the overall recovery of the
enzyme activity was sufficiently low that the use of hydrophobic
chromatography under these conditions would be of little value in a
CEH purification procedure. It was known that some proteins could
bind almost irreversibly to hydrophobic ligands (Shaltiel (1974)) and
this technique had been used for the non-covalent immobilisation of
enzymes, in some cases, in their active state (Hofstee (1973)).
In these experiments a sample of cholate solubilised enzyme in
relatively high ionic strength was applied to the columns and the CEH
activity was found to be almost entirely bound in some cases. However
all the elution conditions studied including lowering ionic strength,
increasing detergent, changing the ions from those that are effective
at increasing hydrophobic interactions (potassium and phosphate) to those
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salting-out and chaotropic effects, and increasing pH were all ineffective
in eluting the enzyme activity. In some cases with more hydrophobic
proteins, several bed volumes of elution buffer may be required to
elute the protein, especially if a gradient is used (Simmonds and Yon
(1976a&b)). However, in this case, the elution conditions were batch-
wise, and each batch of buffer was four bed volumes giving a total
elution volume in this experiment equivalent to 24 bed volumes.
Therefore it was likely that if any CEH activity could be eluted by
these conditions, it would be possible to detect this from this
experiment.
With a technique such as hydrophobic chromatography there are
many different methods that can be used in both the application of the
protein preparation and also for the elution of the bound enzyme
(see Hjerten (1973), Shaltiel (1974), Yon (1978)). For example,
there are cases of application of the protein in low ionic strength
buffer and elution with increasing ionic strength (Hjerten (1973)),
although this may only be useful with the mixed hydrophobic/ionic
columns such as the u-aminoalkyl agaroses. There are many different
methods for elution of the enzyme including changes in temperature and
polarity of the eluant (Hjerten (1973), Shaltiel (1974)) in addition
to those utilised here. Therefore after a study such as this it was
not possible to state that hydrophobic interaction chromatography
cannot, under any circumstances, be of value in the purification of
CEH from bovine adrenocortical cytosol, as there are too many variables
which could, theoretically, influence the performance of the system.
It was possible that the ligands investigated here were too short,
but as the binding of the enzyme to the column was not a problem,
it seems unlikely that longer alkyl chains would be of any benefit.
However using the cholate solubilised enzyme and the most commonly used
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and, theoretically, the most appropriate methods with a range of both
alkyl and oraminoalkyl agarose columns it was found that hydrophobic
chromatography was of no benefit in the purification of this enzyme.
For this reason it was decided not to pursue the investigation of this
technique and to omit such a step from subsequent purifications of CEH
from bovine adrenocortical cytosol.
A.3 AFFINITY CHROMATOGRAPHY
Affinity chromatography had not been used in any previous purification
of CEH from adrenocortical cytosol. The main reason for this was that
the only known biospecific ligands for the enzyme were the substrates,
the cholesteryl esters of long chain fatty acids. There are three main
problems associated with the use of these compounds in the preparation
of a conventional affinity column:
1) These substrates are insoluble in water and so the coupling
reactions would need to be carried out in an organic solvent in which
cholesteryl esters are soluble and the gel matrix is stable (Cuatrecasas
(1970)). Another approach might be to synthesise a more water-soluble
derivative of the cholesterol ester, similar to the derivatives of
steroids used in the preparation of affinity columns for steroid
metabolising enzymes (Nicolas (1974), Benson, Surada et al. (1974)).
2) As these ligands are the substrates for the enzyme there is a
possibility that the column may be hydrolysed by the enzyme as it is
applied, although this should be substantially reduced by performing
the experiment at low temperature. This possibility does raise an
interesting feature of such a column, where the enzyme could be
applied and bound to the column at low temperature and then eluted
from the column simply by a rise in temperature. However this would
be a rather expensive method to use if it were possible. Therefore it
might be more useful to block the ester bond to prevent the hydrolysis
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of the affinity column ligand. It would not be sufficient to use a
cholesteryl ether of a long chain fatty alcohol as it was found that
cholesterolole yl ether was a poor inhibitor of the enzyme activity
(Gorban (1980)) and so presumably the enzyme has low affinity for such
compounds. Such a ligand with low biospecificity for CEH would operate
simply as a hydrophobic interaction column.
3) Finally, cholesterol esters are fairly unreactive compounds with no
reactive side groups other than the carbonyl of the ester bond.
Therefore the molecule would require to be activated at some position,
for coupling to the gel matrix. Beckett (1975) found that the enzyme
had low specificity towards the cholesterol side-chain moiety and so
it might be possible to use a derivative with a reactive group on
the cholesterol side-chain for this purpose. This would leave the
rest of the molecule relatively free and flexible for binding to the
CEH enzyme molecule.
However it was also possible to circumvent all these problems and
indeed utilise one of them to make a simple and quick affinity column.
It had been noted that it may be possible to non-covalently coat the
surface of glass beads with a substance, particularly if it was "highly
insoluble in water" (Cuatrecasas and Anfinsen (1971)). Although glass
beads had been used quite widely as a support for affinity chromatography
they have generally been porous, controlled-pore glass (CPG) beads with
the ligand covalently bound (Weetal and Filbert (1974), Sieber (1977)).
However there was a report where a ligand, in this case immunoglobulin,
was coated non-covalently onto the surface of non-porous glass or
plastic beads (Kondorosi, Nagy and Denes (1977)). Therefore it was
decided to investigate the use of non-porous glass beads in the
preparation of an affinity column for CEH.
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4.3.1 The affinity chromatography column
Cholesterol oleate is a solid, water insoluble lipid at room
temperature (m.p. 42-44°C). It is also the substrate used in most of
the studies of cytosolic CEH, partly because it is the predominant
unsaturated fatty acid ester of cholesterol found in the adrenal lipid
droplets and partly because of the relative stability of this ester
compared to esters of other long chain unsaturated fatty acids (Trzeciak
and Boyd (1973), Beckett and Boyd (1975), Naghshineh, Treadwell et al.
(1974), Wallat and Kunau (1976), Pittman and Steinberg (1977)).
For these reasons cholesterol oleate was chosen as the ligand for the
preparation of an affinity column.
Cholesterol oleate (0.5 g) was dissolved in diethyl ether (50 ml)
and mixed with glass beads (3-4 mm diameter) which had previously been
thoroughly cleaned by heating in chromic acid (65°C) for 1 h followed
by extensive washing with distilled water and drying in a hot oven
(90°C) for 2 h. The ether was evaporated under a light vacuum in a
rotary evaporator (Blichi Rotavapor-R) at room temperature, in a
1 litre round bottomed flask. At this stage the beads adhered to the
wall of the flask and had an oily appearance. The flask was then
removed from the rotary evaporator and shaken vigorously to dislodge
the beads and this resulted in the coating of the beads having a white,
semi-opaque and dry appearance. The beads were now able to move
relatively freely over each other and did not adhere to the walls of
the flask to any great extent. After the beads were dried under
vacuum to remove the remaining diethyl ether, they were added to buffer.
The thin coating of cholesterol oleate was found to be stable in
aqueous buffer and did not float off from the surface of the beads.
The beads were carefully poured into a glass column (2.5 x 25 cm)
containing some buffer, taking care to eliminate air bubbles trapped
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in the system. The flow rate through the column was high and so all
experiments were performed with a peristaltic pump to control the flow
rate. Buffer (3 bed volumes) was slowly pumped through the column to
remove loosely bound cholesterol oleate or any of the coating dislodged
by the mechanical process of pouring the column. The affinity column
was then ready for use in the following experiments.
4.3.2 Application of the CEH enzyme sample
For the initial experiments it was decided to use the ammonium
sulphate (0-40%) precipitate prepared from bovine adrenocortical cytosol
as the enzyme source as it was possible that the cholate contained in
the cholate solubilised enzyme preparation would disrupt and probably
solubilise the cholesterol oleate coating on the beads. It was found
that applying the enzyme in simple buffers containing no glycerol at
either low ionic strength (20 mM potassium phosphate buffer pH 7.4) or
high ionic strength (20 mM potassium phosphate buffer pH 7.4 containing
0.3 M potassium chloride or 0.3 M potassium phosphate buffer pH 7.4)
did not result in the CEH activity binding to the column. The elution
profiles were identical to the one shown in Fig. 4.2a with a large peak
of activity coeluting with the unadsorbed protein peak. Application of
high ionic strength buffers after enzyme application in low ionic
strength and vice versa, and inclusion of 1% (w/v) cholate in these
elution buffers did not elute any activity, confirming that no CEH
had been bound.
The buffer system was changed to Tris-HCl and the pH of the
application buffer raised. Figs. 4.2a and b show that when the enzyme
was applied in 50 mM Tris-HCl buffer pH 7.4 at 4°C the enzyme activity
coeluted with the unadsorbed protein peak, but when the enzyme was
applied in 50 mM Tris-HCl buffer pH 8.4 at 4°C, very little activity





































Fig. 4.2. Affinity chromatography on cholesterol oleate-coated glass
beads. The cholesterol oleate coated-glass bead column (55 ml volume)
was prepared and equilibrated with the appropriate buffer as described
in the text. A1 ml sample of an ammonium sulphate (0-40%) precipitate
(19 mgml ^), prepared from bovine adrenocortical cytosol was dialysed
against the appropriate buffer and applied to the column (10 ml. h ^)
and elution continued with the same buffer. Fractions of 4 ml were
collected and CEH activity determined as described in the methods section.
a) Application of enzyme in 50 mM Tris-HCl buffer pH 7.4 at 4°C.
b) Application of enzyme in 50 mM Tris-HCl buffer pH 8.4 at 4°C.
At fraction 17, 10 mM Tris-HCl buffer pH 7.4 at 4°C containing 1 mM
EDTA, 0.1 mM DTT, 10% (v/v) glycerol and 0.25% (w/v) cholate was applied (EB)
O, CEH activity; A, A^.
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this experiment in order to obtain higher pH's, but this buffer is
affected by temperature (Bates and Bower (1956)). This means that the
pH in the CEH assay incubations may be altered as the pH in the Tris-HCl
buffers will fall as the temperature rises from 4°C to 37°C (the assay
temperature). Therefore Tris-HCl buffer with pH 7.4 or 8.4 at 4°C
will decrease to approximately pH 6.5 and 7.5 at 37°C, respectively.
However these changes will, themselves, be buffered by the 100 mM
r 14 ~i
potassium phosphate buffer pH 7.4 in the cholesterol 1- C oleate
substrate emulsion, which was added to the assays of the column fractions
in equal amounts (200 yl column fraction plus 200 yl substrate emulsion).
However to check this further, a series of Tris-HCl buffers at a range
of pH's from 7.2-9.3 at 4°C were prepared and a concentrated ammonium
sulphate (0-40%) precipitate from bovine adrenocortical cytosol was
diluted 50 fold by each of these buffers. 200 yl aliquots of each of
r 14 ithe diluted enzyme solutions had 200 yl cholesterol 1- C oleate
substrate emulsion added (as in Fig. 4.2) and the CEH activity measured.
Fig. 4.3 shows that in 50 mM Tris-HCl buffer pH 8.4 the enzyme
was only 65% as active as in the same buffer at pH 7.4. Therefore,
although this buffer did lead to reduced CEH activity when assayed,
the results show that pH inhibition cannot explain the total lack of
activity eluting with the unadsorbed protein in Fig. 4.2b.
4.3.3 Elution of the bound CEH activity
Figs. 4.2a and b showed that CEH was bound to the column at pH 8.4
but not at pH 7.4. Therefore there was a possibility of eluting the
bound enzyme by reducing the pH to 7.4. Fig. 4.2b shows that when
10 mM Tris-HCl buffer pH 7.4 at 4°C containing 1 mM EDTA, 0.1 mM DTT, 10% (v/vi
glycerol and 0.25% (w/v) cholate was applied to the column, the enzyme
activity was eluted in possibly two peaks. No protein could be
detected in these fractions, by ^gQ, or when selected fractions were
Fig. 4.3. CEH activity in Tris-HCl buffer systems at various pH's.
A series of Tris-HCl buffer systems were prepared with various pH's
at 4°C, as shown. An ammonium sulphate (0-40%) precipitate
(50 mgml ■*") prepared from bovine adrenocortical cytosol was diluted
to 1 mgml ^ by each of the buffers at each pH. 200 yl of each
r 141diluted enzyme solution had 200 yl cholesterol 1- C oleate substrate
emulsion added and CEH activity was assayed as described in the
methods section. Each point is the mean of triplicate assays.
• , 10 mM Tris-HCl;O , 50 mM Tris-HCl; ▲ , 10 mM Tris-HCl containing
1 mM EDTA, 0.1 mM DTT, 10% (v/v) glycerol and 0.25% (w/v) cholate.
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assayed for protein by the method of Lowry, Rosebrough_et al. (1951).
A further experiment was performed to study the relative contributions
of reduced pH and cholate on the elution of the CEH activity.
A cholesterol oleate affinity column was prepared as before and 2 ml
ammonium sulphate (0-40%) precipitate (19.2 mgml ^) was applied in
50 mM Tris-HCl buffer pH 8.4 at 4°C, and a series of buffers were applied
successively to elute the enzyme activity.
Fig. 4.4 shows that application of twice as much protein had
resulted in overloading of the column and some CEH activity eluting
just after the unadsorbed protein peak, suggesting some retardation.
In subsequent experiments it was found that application of more than
20 mg ammonium sulphate (0-40%) precipitate protein resulted in overloading,
but no retardation of the overloaded activity was observed. The results
shown in Fig. 4.4 also show that reduction of the pH to 7.4 was
sufficient to elute some bound activity, but that inclusion of 0.25%
(w/v) cholate in the buffer eluted a further batch of enzyme activity.
In all subsequent experiments the bound activity was eluted by application
of 10 mM Tris-HCl buffer pH 7.4 at 4°C containing 1 mM EDTA, 0.1 mM DTT,
10% (v/v) glycerol and 0.25% (w/v) cholate.
4.3.4 The purified CEH enzyme
The exact nature of the interactions involved in the binding of the
enzyme to this column were not known, and as elution was possible by
methods such as changes in pH and inclusion of detergent in the buffer
it may not be valid to regard this as true affinity chromatography.
However, there are many examples of non-biospecific methods being
used for elution of bound proteins from affinity columns (Cuatrecasas
and Anf ins en (1971)) .
When the affinity chromatography experiment was repeated several








































Fig. 4.4. Effect of pH and cholate on the elution of bound CEH from
the cholesterol oleate affinity column. A cholesterol oleate affinity
column (2.5 x 25 cm) was prepared as described in the text. 2 ml of an
ammonium sulphate (0-40%) precipitate (19.2 mgml ^) was applied in
50 mM Tris-HCl buffer pH 8.4 at 4°C and the column washed with 100 ml
of this buffer. Two column volumes of the following buffers were
applied as shown:
I - 10 mM Tris-HCl buffer pH 7.4 at 4°C;
II - 10 mM Tris-HCl buffer pH 7.4 at 4°C containing 0.05% (w/v) cholate;
III - 10 mM Tris-HCl buffer pH 7.4 at 4°C containing 0.25% (w/v) cholate.
O , CEH activity; ▲ , A 8Q.
86.
Unfortunately, all attempts to further study the purified CEH enzyme
were unsuccessful. When the eluted enzyme activity was pooled and
reassayed the activity was lost. Occasionally some activity did remain
although much reduced, and was totally lost after storage overnight at
either 4°C, -20°C or -70°C. If the pooled activity was immediately
dialysed against buffers containing 50% (v/v) glycerol and 1 mM DTT
to remove the cholate and stabilise the activity, there was no activity
remaining in the dialysed preparation. Furthermore, no protein was
detected in the fractions containing CEH when measured by A 0 or by
ZoU
the method of Lowry, Rosebrough et_ _al. (1951). When the pooled CEH
activity was dialysed against volatile buffer, concentrated by
lyophilisation and analysed by SDS/PAGE as described in the methods
section, no protein was detected on the gels. At the time when these
experiments were performed the results caused a certain amount of
confusion, and a suitable explanation for them was difficult to produce.
The elution profile shown in Fig. 4.2b was observed on 9 or 10 occasions
in repeat experiments and there was no evidence for any problems with
the CEH assay system as controls, in which buffer containing no enzyme
was applied to the column, followed by elution buffers, did not result
in any detectable enzyme activity. However the eluted CEH activity was
impossible to maintain and, furthermore, no protein could be detected
on polyacrylamide gels corresponding to the pooled CEH activity.
The only possible explanation that would fit this data was that
the CEH enzyme in bovine adrenocortical cytosol was present at
extremely low concentration. As the enzyme activity was easy to
measure in the cytosol, the enzyme must have a high specific activity
in the pure state. In the affinity chromatography experiments the
activity was able to be measured initially in the eluted fractions as
they were assayed within 1 h of elution, but because the amount of
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enzyme protein was extremely small the activity was soon lost. The activity
may be lost due to the enzyme adhering to the glass walls of the test
tubes, especially as the enzyme is hydrophobic, but the high cholate:
protein ratio will also be inhibitory (see Section 3.2). This could also
explain why no protein was observed on polyacrylamide gels, as the
staining methods would not detect protein below 2-3 yg. The possibility
that this was the explanation for these results was not fully
appreciated at the time. However it was known that the affinity columns
were of low capacity, as only 20 mg of protein could be applied without
leakage of the CEH activity with the unbound protein. An attempt was
made to increase the capacity of the column by using smaller beads.
About 1 kg of glass beads (2-3 mm) were washed and prepared as described
in Section 4.3.1 but it was not possible to coat these beads with
cholesterol oleate. The coating was unstable and floated off the
beads in aqueous buffers. The beads were lightly etched by rolling
in a ball mill overnight, but again this procedure did not improve the
stability of the coating and no successful results were obtained with
these beads.
As it was not possible to maintain the purified CEH activity,
or detect the protein in the pooled enzyme peak and as a column of
greater capacity was not available this technique was not pursued
further at that time, although it was attempted later (see Section 5.5.2).
4.4 SUMMARY
1. Hydrophobic interaction chromatography was investigated in the
purification of CEH from bovine adrenocortical cytosol using Shaltiel
test kits and cholate solubilised enzyme. With these columns and
the conditions used it was found that the aminoalkyl derivatives of
agarose bound the enzyme better than the corresponding alkyl derivatives.
2. Aminohexyl- and hexyl-derivatives were chosen for further studies
but it was not possible to elute substantial quantities of the bound
CEH from these columns.
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3. The potential for hydrophobic interaction chromatography in the
purification of CEH from adrenocortical cytosol was discussed.
4. A cholesterol oleate affinity chromatography column using glass beads
as a support was developed.
5. CEH from bovine adrenocortical cytosol bound to the cholesterol
oleate-coated glass beads at pH 8.4.
6. It was possible to elute CEH activity from the beads by reducing
the pH and including cholate in the elution buffer.
7. The eluted activity was unstable and no further investigation was
possible.
8. A possible reason for the instability of the eluted CEH activity
was discussed.
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Triacylglycerol lipase in adipose tissue cytosol, the enzyme responsible
for the cleavage of the first fatty-acid residue from triacylglycerols
was found to be activated by adrenalin (Vaughan, Berger and Steinberg
(1964)), and so was termed hormone-sensitive lipase (HSL). The activation
was later discovered to be via a phosphorylation catalysed by cAMP-
dependent protein kinase (Huttunen, Steinberg and Mayer (1970)).
Following the discovery that CEH in adrenal cortex cytosol was also
activated (Trzeciak and Boyd (1973)) via a cAMP-dependent phosphorylation
(Trzeciak and Boyd (1974)), an activatable CEH activity was found in
adipose tissue cytosol (Pittman and Khoo (1974), Pittman, Khoo and
Steinberg (1975)). Subsequently an activatable triacylglycerol lipase
was found in rat adrenal cytosol (Gorban and Boyd (1977) , Pittman and
Steinberg (1977)). In attempted purifications of either HSL from
adipose tissue cytosol or CEH from adrenal cytosol, the two activities
cofractionated (Pittman, Khoo and Steinberg (1975), Steinberg (1976),
Pittman and Steinberg (1977), Gorban (1980)). A major problem that
prevented the purification of HSL from adipose tissue, was the
lipoprotein nature of the enzyme in the cytosol (Huttunen, Aquino and
Steinberg (1970)) and a similar situation was found with the CEH in
bovine adrenocortical cytosol (Beckett (1975), Wallat and Kunau (1976),
Gorban (1980)). There had been much investigation and speculation on
the possibility that these two enzyme activities were contained on the
same enzyme protein (Pittman, Khoo and Steinberg (1975) , Pittman and
Steinberg (1977), Gorban and Boyd (1977), Gorban (1980), Yeaman, Cook
and Lee (1980)).
Recently, in other laboratories , some success was obtained with
the purification of HSL from rat and chicken adipose tissue. In both
cases the cytosolic enzyme was solubilised by non-ionic detergent and
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then subjected to ion-exchange chromatography. With chicken adipose
tissue, Triton X-100 was used to solubilise the enzyme followed by
hydroxylapatite, DEAE-cellulose and TEAE-cellulose chromatography in
buffers containing Triton X-100, to give over 300-fold purification
of the enzyme with 20% recovery (Berglund, Khoo and Steinberg (1979),
Berglund, Khoo et_ al_. (1980)) . However with rat adipose tissue a
purification for the HSL was reported, claiming a 2000-fold increase
in specific activity from the tissue homogenate (Belfrage, Fredrikson
_et al_. (1980), Nilsson, Stralfors £t_ a_l. (1980) ) . This represented a
large increase in the purity of the enzyme compared to previous work.
However the details of the purification procedure were not reported
until later (Fredrikson, Stalfors e_t a_l. (1981a)) . In this purification
scheme a pH 5.2 precipitate prepared from the cytosol was solubilised
by non-ionic detergent followed by two unusual ion-exchange chromatography
steps referred to as gradient sievorptive chromatography (Kirkegaard
(1976)) and finally chromatography on "triacylglycerol-containing gel".
The initial stages of this purification up to, and including,
the solubilisation by non-ionic detergent were similar to those used
in other studies on HSL (Belfrage, Jergil et_ al_. (1977), Berglund, Khoo
and Steinberg (1979)) and also to the methods used in this study on
CEH from bovine adrenocortical cytosol. However the gradient
sievorptive chromatography procedure was a departure from the conventional
ion-exchange chromatography that had been used previously with HSL in
adipose tissue (Belfrage, Jergil et_ al_. (1977) , Berglund, Khoo and
Steinberg (1979)) and also in this study with CEH from bovine
adrenocortical cytosol. Furthermore, the final chromatography step on
"triacylglycerol-containing gel" was the first reported use of an
affinity technique for either HSL or CEH and was of particular interest
due to the similarity to the affinity technique presented in this thesis.
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Due to the similarities between HSL from adipose tissue and CEH
from adrenal cortex, the novel techniques used, and the success of
that purification, it was decided to investigate the use of some of
these techniques in the purification of CEH from bovine adrenal cortex
cytosol. It was hoped that this would not only provide a preparation of
CEH of greater purity than obtained previously, but that it would also
lead to a clearer understanding of the relationship between the HSL of
adipose tissue and the CEH of adrenal cortex.
All procedures were carried out at 4°C unless otherwise stated.
5.2 INITIAL STAGES OF THE PURIFICATION
The first two stages of the purification were the same as those
used in the previous purification schemes in this study (Sections 3
and 4). Adrenocortical tissue cytosol was prepared from about 30-40
bovine adrenal glands as described in the methods section. An ammonium
sulphate (0-40%) precipitate was prepared essentially as described in
Section 3.2. The collected precipitate was resuspended in 20 mM
Tris-HCl buffer pH 7.4 at 4°C containing 1 mM EDTA and 0.2 mM DTT in a
total volume of 10 ml, and dialysed overnight at 4°C against 4.5 1 of
this buffer.
5.3 S0LUBILISATI0N OF ENZYME BY ^ E
Previous work in this study (see Section 3.4) had shown that the
ionic detergent cholate, although effective at solubilising the CEH
activity in the ammonium sulphate precipitate, interfered in ion-
exchange chromatography procedures. The next two stages in the
purification scheme were essentially ion-exchange techniques and so it
was not possible to use cholate at these stages. Although it was
possible to solubilise the enzyme with cholate and then exchange this
detergent for a non-ionic detergent on hydroxylapatite, that process
would involve a further and unnecessary chromatographic step.
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Berol 058 (Berol Kemi AB,Stenungsund, Sweden) was the detergent used by
Fredrikson, Stralfors _et_ aJ. (1981a) in their procedure that resulted in
a 2000-fold purification of HSL from rat adipose tissue. Although no
direct evidence was given for the effectiveness of the solubilisation,
this detergent was similar to Nonipol TD12 which had been shown to
solubilise HSL in rat adipose tissue, as the solubilised enzyme eluted
after the void volume on Sephadex G-200 superfine (Belfrage, Jergil
et al_. (1977)) . Berol 058 is a polyoxyethylene monoether, designated
C13E12 according to the general formula CnH2r+i(OC^C^)X0H, abbreviated
to (Tanford and Reynolds (1976)). It is a heterogeneous detergent
containing (<1.5%) , Ci2E]_2 ^ C14E12 and C16E12
and has an average molecular weight of 730 and a CMC of approximately
35 yM (20°C). It was decided to use this detergent to solubilise the
CEH activity and so avoid the detergent exchange procedure necessary
if cholate was used to solubilise the enzyme. However as the ^23^12
detergent inhibits the enzyme activity, all enzyme samples must be
*■
appropriately diluted to non-inhibitory (approximately 0.001%) detergent
concentrations. To the dialysed ammonium sulphate precipitate (10 ml),
*
2.86 g sucrose, 83.6 mg sodium chloride, 4.5 mg EDTA and 0.5 mg DTT
were added to give final concentrations in the detergent-enzyme mixture
of 13% (w/v) sucrose, 65 mM sodium chloride, 1 mM EDTA and 0.2 mM DTT.
The enzyme solution was added in portions to 12 ml of 12% (w/v) C^3E12
detergent in 30 mM Tris-HCl buffer pH 7.97 at 4°C. The detergent-enzyme
solution was sonicated on a Rapidis 150 at power rating 7 for 2 min
(8 x 15s) with the temperature maintained below 8°C. The solubilised
enzyme was immediately applied to the first gradient sievorptive
chromatography column.
5.4 GRADIENT SIEVORPTIVE CHROMATOGRAPHY
For maximal effect, fractionation procedures for cellular extracts
should be as rapid and gentle as possible to minimise the loss of
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biological activity. Sievorptive chromatography (Kirkegaard and Agee
(1973)), the name given to systems that combine molecular sieve (gel
filtration) and adsorption chromatography can be of great assistance
in this task. There are three techniques available that use this
combination. Ion filtration chromatography (Kirkegaard, Johnson and
Bock (1972)), a process optimised for the separation of macromolecules
of similar physical properties, intervent dilution chromatography
(Kirkegaard and Agee (1973)) which utilises a solvent boundary to
separate strongly interacting macromolecules, and gradient sievorptive
chromatography (Kirkegaard (1973)). The theory and application of all
three techniques is described in detail by Kirkegaard (1976).
The following is a brief account of the principles and practice of
gradient sievorptive chromatography.
During ion-exchange chromatography, proteins are fractionated by
the inherent differences in their surface:charge distributions.
Conventionally this has been achieved by applying the protein mixture
at a pH at which most of the proteins present have a high net charge
and will bind to a column matrix of opposite charge. The proteins are
fractionated by application of a gradient, most commonly, of ionic
strength. However if the pH is, say too high, in the case of cationic
exchangers, the proteins will not be adsorbed and will be eluted and
filtered according to the properties of the particular gel matrix.
Between these two extremes of pH there will be a gradient of net
charge on any protein and at some point this will result in the protein
being fractionated by the combination of both processes (Fig. 5.1).
In gradient sievorptive chromatography the conditions of pH and ionic
strength are chosen exactly for the particular protein of interest so
that it is in this narrow range of net charge whereas other proteins









Fig. 5.1. The effect of pH on the net charge on a protein and its
fractionation by a cation-exchange gel. At low pH the protein has a
high net charge and will bind to the cation-exchange gel. At high pH
the protein has low net charge and so the gel filtration properties
of the gel predominate. Between these extremes there is a narrow
band of pH where the net charge on the protein is such that neither
property of the gel predominates and the protein is fractionated by both.
(Taken from Kirkegaard (1976)).
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In practice, with the gels employed, the sieving properties are
utilised to manipulate the behaviour of small molecules and the adsorptive
properties are used to resolve the large molecules. Gradients of
ionic strength are used to optimise the basic technique, and focus the
protein of interest. The focusing effect of gradient sievorptive
chromatography is summarised in Fig. 5.2.
Whereas normal ion-exchange is a passive process, this technique
also has molecules projected forward by exclusion transport (see
Fig. 5.2) and so has some characteristics of isoelectric focusing or
density gradient centrifugation. Finally the buffer system must have
the same charge as the gel and in the procedures described subsequently,
QAE-Sephadex A-25 was used in conjunction with Tris-HCl buffers.
5.4.1 QAE-Sephadex A-25 I
The gradient sievorptive chromatography technique was applied
utilising QAE-Sephadex A-25 as the ion-exchange gel. In this case a
gradient was not applied to the column before the sample but was formed
on the column by the sieving effects of the gel matrix on the ions in
the buffers.
A QAE-Sephadex A-25 column (3.2 x 60 cm) was equilibrated with
10 volumes 0.1 M Tris-HCl pH 7.97 at 4°C (EB1), followed by 10 volumes
40 mM Tris-HCl buffer pH 7.97 at 4°C containing 15 mM sodium chloride
(EB2) and 2 volumes 40 mM Tris-HCl buffer pH 7.97 at 4°C containing
15 mM sodium chloride, 0.2 mM EDTA, 0.2 mM DTT, 20% (v/v) glycerol and
0.2% (w/v) C;l3E-]_2 (EB3). The solubilised enzyme (about 22 ml, 5% bed
volume) was applied to the column followed by 35 ml of EB3 with the
sodium chloride raised to 65 mM and containing 5% (w/v) sucrose.
Elution was continued with EB3 with 65 mM sodium chloride (EB3/65)
until all the unbound protein was eluted, and then a 65-1000 mM sodium






Fig. 5.2. Focusing properties of a sieving range gradient. Frames
A-D show steps in the development of a sievorptive column utilising
a gradient. The left-hand side of the figure represents the input
of the column and the right-hand side the output. Frame A shows the
gradient that is applied to the gel column before the addition of sample.
The gradient is such that the applied macromolecule binds to the gel
at the front of the gradient, but has no interaction with the resin
at the back of the gradient. Frame B shows that the situation after
a sample has been added to the column. In this illustration,
the macromolecule travels twice as fast as the sample solvent;
hence the macromolecular peak is twice as broad as the sample volume.
It is further assumed that aside from the macromolecule, the sample
has the same composition as the end point of the gradient. Frame C
shows the situation after a volume of eluent equivalent to the sample
volume has been added to the column. The leading edge of the
macromolecule peak has reached the point in the gradient where
adsorptive forces are beginning to slow the macromolecular migration
rate to that of the gradient. Frames D and E, respectively, show the
situation after three and four sample volumes of the eluent have been
added to the column. After concentration the sample peak moves along
the column at the same rate as the gradient migrates. The position
along the gradient where the concentrated peak and the gradient move
at the same rate depends upon the adsorptive properties of the
macromolecule and of the gel.
(Taken from Kirkegaard (1973)).
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CEH activity was eluted at 35-40 mM sodium chloride (Fig. 5.3).
The active fractions were pooled as indicated and concentrated 10-fold
by pressure ultrafiltration using an Amicon Diaflo PM 30 membrane.
The sodium chloride concentration was kept at between 50 mM and 75 mM
to prevent enzyme aggregation and adsorption to the membrane.
The detergent was also concentrated during this procedure (Fredrikson,
Stralfors et al. (1981a)).
5.4.2 QAE-Sephadex A-25 II
A column (2 x 96 cm) of QAE-Sephadex A-25 was equilibrated with
10 volumes EB1 followed by 10 volumes EB2 and 2 volumes of EB3 containing
17.5 mM sodium chloride. A 50 ml gradient of 17.5-50 mM sodium
chloride in EB3 was applied to the column. The concentrated sample
from the first QAE-Sephadex A-25 column was dialysed against EB3
containing 50 mM sodium chloride (EB3/50) and immediately applied to
the column after the gradient. The column was eluted with EB3/50
and finally EB3 containing 100 mM sodium chloride was applied to the
column to elute the bound protein.
CEH activity eluted at about 30-40 mM sodium chloride (Fig. 5.4).
The active fractions were pooled as indicated and designated the CEH^
preparation.
5.5 AFFINITY CHROMATOGRAPHY
The greatest increase in specific activity (almost 14-fold) during
the purification of HSL from rat adipose tissue reported by Fredrikson,
Stralfors et al.(1981a) occurred at the final chromatography step on
triacylglycerol-containing gel. This was obviously some form of
affinity chromatography step, and so attempts were made to further
purify the CEH^ Preparation by an affinity chromatography method.
Two different approaches were tried, one based upon the procedure
described by Fredrikson, Stralfors e_t_ aJ. (1981a) and one based upon the








Fig. 5.3. Gradient sievorptive chromatography: QAE-Sephadex A-25 I.
A QAE-Sephadex A-25 column (3.2 x 60 cm) was equilibrated as described
in the text. The solubilised enzyme sample (22 ml) was applied,
followed by 35 ml EB3/65 containing 5% (w/v) sucrose, and eluted
with EB3/65. A 65-1000 mM sodium chloride gradient in EB3 was then
applied. The column flow rate was 50 ml.h . Glycerol containing
25 mM potassium dihydrogen phosphate and 0.2 mM DTT was added
continuously to the column eluant at a rate of 27 ml.h ^ to reduce the
pH and raise the glycerol to 50% (v/v) and hence stabilise the
eluted enzyme activity. Fractions of 12.8 ml were collected.
^13^12 -"-Habits CEH activity (see Section 5.3) and so samples were
diluted to reduce the detergent concentration for assay: 5 pi fraction
had 95 pi 0.02% (w/v) bovine serum albumin in 20 mM potassium phosphate
T 14 1buffer added, followed by 100 pi cholesterol II- C I oleate substrate
emulsion, and the assay completed as described in the methods section.
O, CEH activity; ▲ , A Q ; — Sodium chloride concentration;A o(J
1——t , Fractions pooled.
Fig. 5.4. Gradient sievorptive chromatography: QAE-Sephadex A-25 II.
A QAE-Sephadex A-25 column (2 x 96 cm) was equilibrated as described
in the text. The pooled and dialysed enzyme sample was applied to the
column immediately after a 17.5~50 mM sodium chloride gradient (50 ml
total volume) in EB3. Elution was continued with EB3/50. The adsorbed
proteins were eluted with 100 mM sodium chloride in EB3. The column
flow rate was 30 ml.h ^ and acid glycerol was continuously added to
the eluant at a rate of 17.5 ml.h ^. Fractions of 9.5 ml were collected
and assayed as described in the legend to Fig. 5.3.
O
, CEH activity; a, A^g , Sodium chloride concentration;
I——<, Fractions pooled.
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5.5.1 Affinity chromatography on cholesterol oleate-containing
Ultrogel AcA34
The triacylglycerol-containing gel used in the purification of
HSL from rat adipose tissue was pre-1977 Ultrogel AcA34 (LKB, Stockholm,
Sweden). It was discovered that batches of this gel produced before
1977 contained approximately 0.3 mg of soyabean oil triacylglycerol per
millilitre of wet gel. This was a consequence of the manufacturing
procedure, but this procedure was changed by the manufacturers during
1977 and batches of the gel after that date cannot be used for this
purpose. No pre-1977 Ultrogel AcA34 was available for this study,
however this was not a major problem because a cholesterol ester affinity
column was required, as the relationship between HSL and CEH was not
fully understood.
To introduce cholesterol ester into the Ultrogel AcA34 a
modification of the method suggested by Fredrikson, Stralfors et_ al.
(1981b) was used. The main problem in this procedure was the
insolubility of cholesterol ester in aqueous solutions. However,
Ultrogel AcA34 is a molecular sieve (gel permeation) type of gel
containing 4% agarose and 3% polyacrylamide and is similar to Sephacryl
S-200,which is relatively stable in a number of organic solvents
(Gel Filtration Booklet, Pharmacia Fine Chemicals). Cholesterol oleate
was the cholesterol ester chosen for the ligand, as it is the predominant
ester in adrenal lipid droplets and is more stable than other cholesteryl
esters of long chain unsaturated fatty acids and has been used as the
substrate in most of the studies on cytosolic CEH (Trzeciak and Boyd
(1974), Beckett and Boyd (1977), Naghshineh, Treadwell et al. (1974),
Wallat and Kunau (1976), Pittman and Steinberg (1977)).
Cholesterol oleate (10 g per 100 ml of gel) was suspended in 75%
(v/v) ethanol containing 0.1% (w/v) sodium azide, and heated to 45°C.
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This was added to Ultrogel AcA34, that had previously been washed in
water followed by 75% (v/v) ethanol containing 0.1% (w/v) sodium azide.
The mixture was stirred for 2 h at 45°C (cholesterol oleate
m.p. v42~44°C) and then transferred to a warm room (30°C) and stirred
slowly overnight. The gel was then poured into 10 volumes of 1 M
sodium chloride and washed extensively to remove the large quantities
of excess lipid. The gel was then ready for use.
The detergent inhibits the adsorption process of HSL on the
triacylglycerol-containing gel, consequently the column was equilibrated
in CgEg detergent (Fredrikson, Stralfors et al.(1981a)). The reason for
the different behaviour of the two detergents was not known, although
the difference in critical micellar concentration was suggested as a
possible explanation. The critical micellar concentration of CgEg is
10 mM (Fredrikson, Stralfors et_ al_. (1981a)) which is 100-fold higher
than C^gE^ (Helenius, McCaslin e_t aT. (1979)). It is unusual for
a non-ionic detergent to have such a high critical micellar concentration
and it is similar to the critical micellar concentrations for
ionic detergents, including sodium cholate (13-15 mM) (Helenius,
McCaslin e_t al_. (1979)) . Therefore as CgE^ was not commercially
available, and as much of the previous work in this study investigated
the effect of cholate on the enzyme, it was decided to use cholate as
the detergent in the affinity column.
A column (3.5 x 50 cm) of cholesterol oleate-containing gel was
washed with 10 volumes of 1 M sodium chloride followed by 2 volumes of
5 mM potassium phosphate buffer pH 7.4 containing 30% (v/v) glycerol,
0.2 mM DTT, 0.15 M sodium chloride and 0.2% (w/v) C^gE.^ an<^ finally
equilibrated in 4 volumes of the same buffer with 0.1% (w/v) cholate
replacing the ^ sample of CEH^ preparation (2 mg) was dialysed
against the column buffer, applied to the column and eluted with the
same buffer. The results are shown on Fig. 5.5.
Fraction No.
Fig. 5.5. Affinity chromatography on cholesterol oleate-containing
Ultrogel AcA34. A cholesterol oleate-containing Ultrogel AcA3.4
column (3.5 x 50 cm) was equilibrated as described in the text and
10 ml concentrated CEH^ preparation (2 mg), previously dialysed
against the column buffer, was applied and eluted with the same buffer.
The fractions were assayed as described in the legend to Table 5.1.
O, CEH activity; ▲ , A28Q.
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The protein was just detectable by ^gQ measurements and the CEH
activities measured were extremely low, representing a maximum of only
20 cpm above background (67 cpm). When the peak fraction was assayed
for specific activity there was a 4-fold decrease compared to the CEH^
preparation (see Table 5.1). The coelution of the activity and the
protein shows that the affinity column did not work under these
conditions. The reasons for this failure were not certain but it may
be that the incorporation of cholesterol oleate into the gel was not
successful. However the mechanism involved in the adsorption of HSL to
the triacylglycerol-containing gel was not clear. Although affinity
interaction was involved, non-specific hydrophobic and polar interactions
were probably also part of the mechanism because although triacylglycerol
was essential for adsorption, the eluted activity was only 50% HSL
protein (Fredrikson, Stralfors £t_ al_. (1981a)) . Therefore it was also
possible that cholate could interfere with some of these interactions
and so prevent any purification. It was probable that the low activity
was due to the cholate induced deactivation observed in Section 3.4.
5.5.2 Affinity chromatography on cholesterol oleate-coated glass beads
Glass beads (3-4 mm) were washed, and coated with cholesterol
oleate as described in Section 4.3.1. The beads were packed in a
column (1.5 x 60 cm) and equilibrated with 50 mM Tris-HCl buffer pH 8.4
at 4°C containing 0.2 mM DTT, 20% (v/v) glycerol and 0.02% (w/v) cholate.
A sample of enzyme after the first QAE-Sephadex chromatography step was
concentrated and dialysed for 3 h against the column buffer, applied to
the column and eluted with this buffer. The results are shown in
Fig. 5.6.
This column was not successful as the enzyme activity was not
retarded, and eluted with the unadsorbed protein. This result was not
entirely surprising as circumstances dictated that the column be run in
300"
Fig. 5.6. Affinity chromatography on cholesterol oleate-coated glass
beads. A sample (14 ml) of concentrated enzyme from the first QAE-
Sephadex chromatography step was dialysed against 50 mM Tris-HCl
buffer pH 8.4 at 4°C containing 0.2 mM DTT, 20% (v/v) glycerol and
0.02% (w/v) cholate. The dialysed sample was applied to a column
(1.5 x 60 cm) of cholesterol oleate-coated glass beads (see Section 4.3.1)
equilibrated and eluted with the sample buffer. The flow rate was
10 ml.h ^ and acid glycerol was added to the fractions at a rate of
5.4 ml.h . Fractions of 2.5 ml were collected and assayed for CEH
activity as described in the legend to Fig. 5.3.
O, CEH activity; A, A^.
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a different set of conditions to those found to be successful in
Section 4.3. This was because the enzyme was unstable and inactivated
if the detergent was removed and so the column had to be run in
detergent. As relatively high detergent was known to inhibit the
binding to this column (see Section 4.3.3)it was decided to use this
column in a similar way to the cholesterol oleate-containing gel.
In the purification of HSL from rat adipose tissue the enzyme did not
bind completely to the affinity gel but was retarded and eluted after
the main protein peak, and so a long column was used (Fredrikson,
Stralfors et_ al_. (1981a)). Therefore it was hoped that it might be
possible to use the glass bead column in a similar way (i.e. simply a
different support for the ligand) and so the column was equilibrated
in a low concentration of cholate plus glycerol and DTT to protect the
enzyme. However the results show that the affinity column did not
operate in this way and no retardation of the CEH was seen.
5.6 THE OVERALL PURIFICATION
A representative purification is summarised in Table 5.1.
The ammonium sulphate (0-40%) precipitate was again shown to be an
effective early batch-wise step. The enzyme activity in the
solubilised ammonium sulphate precipitate could not be measured
accurately due to the high detergent concentration. Both the gradient
sievorptive chromatography steps on QAE-Sephadex A-25 were successful
and gave substantial increases in specific activity. However the
affinity chromatography step on cholesterol-oleate containing Ultrogel
AcA34 was not successful, resulting in no purification (Fig. 5.5) and
substantial deactivation of the enzyme.
The procedure, up to the CEH^ Preparation, gave a recovery from
19-38% with a purification of 122-162 fold (range of 4 purifications).










































Table 5.1. Summary of purification procedure. The enzyme was purified
from bovine adrenocortical cytosol,prepared from about 30 adrenals as
described in the methods section. The CEH activity was measured after
dilution of the samples to non-inhibitory detergent concentrations (see
Section 5.3): 5 yl enzyme preparation had 195 yl 0.02% (w/v) BSA in
20 mM potassium phosphate buffer pH 7.4 added,followed by 200 yl
r 141cholesterol 11- C oleate substrate emulsion,and was assayed as described
in the methods section. Protein was measured by the method of Bradford
(1976) with the appropriate calibration curves for samples with and
without detergent. |^N.B. The affinity chromatography step was known to
have a low capacity (Fredrikson, Stralfors et al. (1981a)) and so only half
CEH^ preparation was chromatographed. Due to this problem and enzyme
inactivation - recovery was not calculated, j Enzyme activity units are
nmol oleic acid produced.min
■]
100.
oleic acid produced.min ^.mg protein \ Samples from various stages of
the purification were subjected to SDS/PAGE and the gel stained for
protein. The results in Fig. 5.7 show that there was a substantial
loss of protein during the purification and that there were at least 8
protein bands observed in the CEH preparation. Virtually all the
v^Z
variation in the recovery, and purification factor stated above occurred
at the second QAE-Sephadex chromatography step as the resolution on
this column was not as consistent as with the first QAE-Sephadex step.
This inconsistency also resulted in the protein profile on SDS/PAGE
varying slightly from one preparation to another.
The CEHq2 preparation was over twice as pure as the enzyme obtained
by Beckett and Boyd (1977), and with the failure of both affinity
chromatography steps to produce a purer enzyme preparation, the CEH^
preparation was used in further studies described in Section 6.
5.7 SUMMARY
1. CEH was purified 150-fold with approximately 25% recovery from bovine
adrenocortical cytosol.
2. A non-ionic detergent, WaS utiiise<i to solubilise the enzyme
from an ammonium sulphate (0-40%) precipitate. This detergent inhibits
the enzyme activity and so the enzyme must be diluted to non-inhibitory
detergent concentrations before it can be assayed.
3. Gradient sievorptive chromatography on QAE-Sephadex A-25 was
effective in fractionating and purifying the solubilised enzyme.
4. Attempts at affinity chromatography to further purify the enzyme after
gradient sievorptive chromatography were not successful.
A B S C D E
Fig. 5.7. SDS/PAGE of samples from stages in the purification procedure
Samples from various stages of the purification were subjected to
SDS/PAGE on a 7.5% gel, and stained for protein, as described in the
methods section. The approximate amount of protein is given below:
A, Tissue cytosol (180 yg); B, Ammonium sulphate (0-40%) precipitate
(160 yg); C, QAE-Sephadex A-25 I (50 yg); D, QAE-Sephadex A-25 II
(CEHq2) (20 yg>; E, QAE-Sephadex A-25 II (CEHQ2) (20 yg);
S, Standards (B-galactosidase (125 000), phosphorylase a (92 000),
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Despite the failure of the affinity chromatography procedures to
produce highly purified CEH enzyme, the CEH „ preparation represented a
great improvement on previous purifications of CEH from bovine
adrenocortical cytosol (Beckett and Boyd (1977)). Furthermore, although
the CEHq2 Preparation was not pure and contained several proteins
(see Fig. 5.7) it might be possible to use this as the CEH source for
studies on the postulated control system (see Fig. 1.3) provided that
it was free from the other components of the control system such as
phosphoprotein phosphatase and cAMP-dependent protein kinase.
Similarly, this preparation could be useful in the identification of
the CEH enzyme protein in bovine adrenocortical cytosol. This was
necessary for Krebs' criteria for phosphorylated enzymes to be fulfilled,
and for final proof of a physiologically important phosphorylation of
CEH in adrenal cortex. It would also be useful in the elucidation of
the relationship between CEH in adrenocortical cytosol and the HSL of
adipose tissue cytosol.
Although the CEH^ PraParation contained several proteins, labelling
studies could assist in the identification of the enzyme protein.
Studies on partially purified CEH from adrenal cortex following
incubation with 32pY_ p ATP have shown an increase in CEH activity with
32
concomitant labelling of the protein fraction by P (Trzeciak and
Boyd (1974), Wallat and Kunau (1976), Beckett and Boyd (1977)).
In one of these studies a subunit of Mr 41 000 was estimated for a
32
P-labelled protein exhibiting esterase activity (Beckett and Boyd
(1977)). It had been found previously that incubation of partially
p,]purified HSL from rat adipose tissue with I y pl ATP resulted in
32
incorporation of P radioactivity into the protein fraction with a
parallel increase in enzyme activity (Huttunen, Aquino and Steinberg
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(1970), Huttunen, Steinberg and Mayer (1970)). Recently it has been
reported that purified HSL from chicken adipose tissue was phosphorylated
32twith y
32 .
ATP, with P incorporation into a protein with Mr 42 000
on SDS/PAGE (Berglund, Khoo et al.(1980)). Phosphorylation with
T 32 1 .
y- P ATP, of HSL purified from rat adipose tissue had indicated a
molecular weight of 86 000 (Belfrage, Jergil et_ £l_.(1977)) or 84 000
(Khoo, Berglund et aM. (1980) , Fredrikson, Stralfors et al. (1981a))
32
for this enzyme. Therefore labelling the CEH enzyme with P using
ATP could assist in the identification of the enzyme protein.
Civen, Brown and Morin (1977) found that the ACTH- or cAMP-
induced increase in corticoid production by isolated rat adrenal cells
was blocked by minute amounts of chlorpyrifos oxone, an organophosphate
insecticide, known to be an inhibitor of plasma and erythrocyte
acetylcholine esterase (Civen, Lifrak and Brown (1977)). The insecticide
did not affect cAMP production or affect corticoid synthesis when
pregnenolone was added to the adrenal cells in vitro (Civen, Lifrak and
Brown (1977)). Chloropyrifos oxone was found to inhibit adrenal
cytosolic CEH and triacylglycerol lipase (Pittman and Steinberg (1977)).
It was also found that di-isopropylfluorophosphate (DFP) inhibited rat
adipose tissue HSL (Belfrage, Jergil et_ al_. (1977)) and phenylmethyl-
sulphonylfluoride (PMSF) inhibited HSL in chicken adipose tissue
(Berglund, Khoo and Steinberg (1979)) and CEH in bovine adrenal cortex
(Yeaman, Cook and Lee (1980)). Furthermore, incubation of purified HSL
14
from chicken adipose tissue with C-labelled PMSF resulted m the
labelling of a protein with Mr 42 000 on SDS/PAGE (Berglund, Khoo and
Steinberg (1979)). Therefore incubation of CEH with radioactively
labelled inhibitors such as these, may also assist in the identification
of the enzyme protein.
103.
As the elucidation of the control system regulating CEH activity
in adrenocortical cytosol was a long term aim of this project, some
experiments were performed to evaluate the potential of the CEH^
preparation in the study of this control system. Further experiments
were performed to investigate, identify and characterise, with respect
to molecular weight, the CEH enzyme protein in bovine adrenocortical
T 32 1
cytosol using the CEH^ preparation and labelling with ly- PJ ATP
and jj., 3-3h| DFP.
6.2 ENZYME ACTIVITIES IN THE CEH^ PREPARATION - THE PARTIALLY
PURIFIED CEH
The activities of the three main enzymes in the postulated CEH
control system in bovine adrenocortical cytosol were determined in the
CEH^ preparation.
6.2.1 The basal CEH activity
The basal CEH activity in the CEH^ PraParati°n> measured after
dilution (1 in 80) to reduce the detergent concentration, was found to
vary considerably when apparently identical preparations were studied
over a 9 month period. The average activity was 51 - 20 (S.D.) nmol
oleic acid produced.min \mg protein There were two reasons for the
variation observed. Firstly the figures reflect a variation in basal
CEH activity in the cytosol, observed during this project. During the
winter months (November-February) the basal CEH activity in the cytosol
was found to be twice as high as that observed in summer (April-June).
The average CEH activities in the CEH^ Preparation during these periods
+ + -1 -1
were 70 - 16 (S.D.) and 37-7 (S.D.) nmol.min . mg , respectively.
A detailed study of the possible cause of this seasonal variation in
cytosolic CEH activity was not carried out during this project.
Therefore statistical analysis was not possible and so the phenomenon
remains simply an observation at the present time. The physiological
104.
significance of such variation could only be speculated, but it was
possible that, in response to long-term cold stress during winter,
the circulating ACTH concentration was greater resulting in a trophic
effect such as induction of CEH enzyme protein, rather than an effect
on the phosphorylation state of the enzyme.
The second reason for the variation in the basal CEH activity in
the CEHq2 Preparation was due to the inconsistency of the second
QAE-Sephadex A-25 chromatography step. This gave not only a variation
in the specific activity of the enzyme, but also a variation
in the purification factor and protein profile observed by SDS/PAGE
(see Section 5.6).
However, the specific activity was considerably higher than that
reported in the purification of Beckett and Boyd (1977), where a 57-fold
purified enzyme had a specific activity of 800 pmol.min \mg \ but it
was less than the specific activity of 300 nmol.min . mg ^ claimed by
Naghshineh, Treadwell et_ al_.(1978) for their enzyme preparation.
Both of these studies used substrate dissolved in acetone and thin-layer
r 141 r 14 ~i
chromatography to assay the release of 4- C cholesterol from 4- C
cholesterol oleate, and hence the activities cannot be compared directly
to the specific activity observed in this study.
6.2.3 Phosphoprotein phosphatase activity
The CEHq2 preparation was concentrated by pressure ultrafiltration
(see Section 5.4.1) and dialysed against 10 mM potassium phosphate
buffer pH 7.4 containing 30% (v/v) glycerol, 0.2 mM DTT and 0.2%
32
Phosphoprotein phosphatase activity was determined using P-labelled
phosphohistone as substrate. An increased amount of radiolabel appearing
in the TCA-supernatant with a concomitant decrease in the radiolabel
in the protein pellet indicated phosphoprotein phosphatase activity.
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Table 6.1 shows that none of the incubations resulted in an
32
increase in P released from the protein, and the slight differences
were not significant (p>0.1). The results for the protein pellet are
more variable due to procedural errors that occur during the washing.
However the differences observed were not significant (p>0.1).
These results show that there was no phosphoprotein phosphatase
activity in the CEH^ Preparation. The CEH^ preparation was diluted
to the same degree as for the CEH activity assays (1 in 80) and so
phosphoprotein phosphatase activity was not observed at detergent
concentrations at which the CEH was not inhibited. The concentrations
2+ 2+
of Mg and Mn chosen were known to stimulate phosphoprotein
phosphatase activity in bovine adrenal cortex (Beckett and Boyd (1977),
see Fig. 7.4 this thesis), but they had no effect in this experiment.
6.2.3 Protein kinase activity
The protein kinase activity in the concentrated CEH^ preparation
T 32 "1
was determined using y- P ATP and histone as described m the methods
32
section. Increased P incorporation into the protein pellet indicated
protein kinase activity.
Table 6.2 shows that, in certain cases, the CEH^ preparation
32 f 32 "1
stimulated the incorporation of P from y- P ATP into the TCA
precipitated protein compared to the control assays without CEH^
preparation. Of the three protein kinase activities assayed, cAMP- dependent,
cAMP-independent and Ca -dependent, only the first two activities were
detected, although even those activities were low. There was variation
in the different control incubations and thus the significance of the
2+
result obtained in the Ca -dependent protein kinase assay (8.1 pmol)
was difficult to estimate. This figure was less than that obtained for
2+
the CEHq2 preparation alone, hence the presence of Ca appeared to



























Table 6.1. Phosphoprotein phosphatase activity in the CEH „ preparation.
32 . -1 -1
50 pi P-labelled phosphohistone (1 mgml , 4 pCi.ml ) prepared as
described in the methods section, was incubated for 30 min at 37°C with
the additions stated above in a total volume of 400 pi. The phosphoprotein
phosphatase activity was determined as described in the methods section.
CEH^ preparation (0.4 mgml in 10 mM potassium phosphate buffer pH 7.4
containing 30% (v/v) glycerol, 0.2 mM DTT and 0.2% was diluted
2+2+ ...
1 m 80 in the assay. Mg and Mn were the chloride salts in distilled
water. The results are expressed as means - S.E.M. of triplicate assays.
32 32








Assay buffer + CEHq2 preparation 14.6
+
1.5





+ CEH^ preparation + 19.8 + 1.0
Assay buffer + 2.0 mM Ca^+ 4.4 + 0.7
Assay buffer
2.0 mM Ca
+ CEH^ preparation + 8.1 + 1.1
Table 6.2. Protein kinase activities in the CEH „ preparation.
T 32 1 -1The incubations contained 0.1 mM Y~ P ATP (352 cpm.pmol ) prepared
as described in the methods section. The assay buffer contained
2-glycerophosphate (50 mM), calf thymus histone (240 yg) , sodium fluoride
(20 mM), theophylline (2 mM), magnesium acetate (3.5 mM) and EGTA
(0.3 mM), adjusted to pH 6.0. The figures indicate the final concentrations
in the assay. CEH^ preparation was as described in the legend to
2+
Table 6.1 and was diluted 1 in 40 in these assays. cAMP and Ca
(calcium chloride) were in 20 mM Tris-HCl buffer pH 7.4 at 37°C and
all incubations were made up to 100 yl with this buffer (Buffer).
Incubation was for 10 min at 30°C and ^P incorporated into histone was
determined as described in the methods section. Results are expressed
as means - S.E.M. of triplicate assays.
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a small, but significant stimulation of P incorporation into histone
by the CEH^ Preparation without cAMP (p<0.02) and with cAMP (p<0.05).
Taking an average control value of 6.6 pmol (7.5 and 5.7) from these
figures the specific activities of cAMP-independent and cAMP-dependent
32 -1
protein kinases' were 27 and 16 pmol P incorporated.min .mg CEH^
protein \ respectively. This was low in comparison to the specific
activity of GEH in the CEH^ preparation (see Section 6.2.1).
However it must be noted that the dilution was only 40-fold in this
experiment, consequently detergent inhibition may be reflected in
these activities.
6.2.4 Modulation of CEH activity
The previous experiments had shown that there was residual cAMP-
dependent and independent protein kinase activities, but no phosphoprotein
phosphatase activity in the CEH^ preparation when measured against
commonly used substrates. However as it was the postulated control
system for CEH that was under investigation, a more specific assay for
protein kinase and phosphoprotein phosphatase activities would be to use
the CEH^ preparation as the substrate. As it was known that this
enzyme preparation contained many proteins (see Section 5.6) it was
thought that the preparation was not sufficiently pure to give results
32
for either assay if P incorporation and release were used m the
kinase and phosphatase assays. Therefore it was decided to investigate
the modulation of CEH activity in the CEH^ preparation, to determine
if there was a specific phosphoprotein phosphatase for CEH or if the
cAMP-dependent protein kinase activity observed previously could
2+
activate CEH. The CEH^ preparation was preincubated with Mg ,
2+ 2+ 2+
Mg /ATP or Mg /ATP plus cAMP, cGMP or Ca before the addition of
[l-14C] ocholesterol I" c oleate substrate emulsion and assay of the CEH activity.
107.
The experiment was performed as described in the legend to
Fig. 6.1 because it was discovered that preincubation of small amounts
of CEHq2 protein at 40-fold dilution and 37°C led to inactivation of
the enzyme. This did not occur during normal CEH assays due to the
presence of the substrate which protects the enzyme. The presence of
0.02% bovine serum albumin (see legend to Fig. 5.3) may also prevent
inactivation but this was omitted from the preincubations due to other
effects, such as binding,that it may exert. A concentrated CEH^
preparation was not used as the concentration procedure often led to
substantial losses of CEH activity.
2+
Fig. 6.1 shows that preincubation of CEH^ preparation with Mg
did not significantly alter the CEH activity. Similarly preincubation
o «, o , o ,
of the CEH^ preparation with Mg /ATP or Mg /ATP plus cGMP or Ca
did not significantly affect the CEH activity. However, preincubation
2+
with Mg /ATP in the presence of cAMP led to a significant increase
in the specific activity of CEH in the CEH^ preparation (p<0.005).
Inclusion of exogenous cAMP-dependent protein kinase (bovine heart)
2+
with the cAMP and Mg /ATP led to a further significant increase in
the specific activity of CEH. These results show that there was no
specific phosphoprotein phosphatase in the CEH „ preparation capable
of deactivating CEH under conditions known to stimulate the deactivation
of CEH in crude preparations (Trzeciak and Boyd (1974) , Wallat and
2+
Kunau (1976), Beckett and Boyd (1977)). Preincubation with Mg /ATP
showed that there was no modulation of CEH activity by cAMP-independent
2+
protein kinase and that additions of cGMP and Ca did not alter this.
However, the residual cAMP-dependent protein kinase, previously observed
in the CEH^ preparation, was able to activate CEH, giving a 32%
increase in specific activity. Addition of exogenous cAMP-dependent




















































Fig. 6.1. Modulation of CEH activity in the CEH £ preparation.
The CEHq2 Preparation was dialysed against 20 mM Tris-HCl buffer pH 7.4
at 4°C containing 0.2 mM DTT, 50% (v/v) glycerol and 0.1% (w/v)
C"13E12' 1 ml samples of the preparation (0.036 mgml 2) were preincubated
• o . . • . 2+
for 10 mm at 37 C without any additions, with 10 mM Mg , 10 mM
ATP/Mg2+, 10 mM ATP/Mg2+ with either 2 mM Ca2+, 25 yM cGMP, 20 yM cAMP
or 20 yM cAMP/cAMP-dependent protein kinase (20 yg), all in 20 mM
Tris-HCl buffer pH 7.4 at 37°C, in a total volume of 2.1 ml. 10_ yl
samples from each incubation were assayed for CEH activity after
dilution with 0.02% bovine serum albumin in 20 mM potassium phosphate
buffer pH 7.4 (see Section 5.3). The results are means - S.E.M. of
triplicate assays.
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Again detergent inhibition may have played a role in the results
observed. It was noted previously that the experiment was performed
in a particular manner to avoid detergent-induced inactivation of the
CEH activity. However it was not known if the detergent inhibited
phosphoprotein phosphatase or protein kinase activities. In this
experiment the detergent concentration in the preincubate was just
under 0.05% which was 50 times higher than the non-inhibitory concentration
for CEH activity. Despite this the results were in good agreement with
those obtained in Sections 6.2.2 and 6.2.3, in which the detergent
concentration was more dilute. Therefore the results suggested that
the detergent does not have a serious effect on the activity of cAMP-
dependent protein kinase.
Overall the results indicated that at least one further purification
step must be included to remove the residual cAMP-dependent protein
kinase activity before this preparation would be suitable for detailed
studies on the postulated control mechanism. It would also be necessary
to investigate the levels of heat-stable inhibitors in this preparation
after the protein kinase had been removed, as these were not determined
in this study. However, detergent inhibition of CEH and possibly of
the other activities suggested that this purification procedure may not
yield a suitable CEH enzyme preparation for the study of a complex
system, with several different interacting components, such as the
postulated control system (Fig. 1.3).
6.2.5 Triacylglycerol hydrolase (lipase) activity
It was not possible to measure the triacylglycerol hydrolase
activity in the CEH^ Preparation due to detergent inhibition coupled
to the inherent lower activity of this enzyme in adrenal cortex.
Gorban (1980) found that CEH activity was 1.5-3.5 fold greater than
the triacylglycerol hydrolase activity in both rat adrenal cytosol and
109.
bovine adrenocortical cytosol. This was in agreement with previous
work which showed the activity of CEH in rat adrenal cytosol was some
2.5-3.0 fold higher (Gorban and Boyd (1977)) or 2.0 fold higher
(Pittman and Steinberg (1977)) than the triacylglycerol lipase.
When fractions from the first QAE-Sephadex A-25 chromatography
step were assayed for triacylglycerol lipase activity using the same
dilution as for the CEH assay, there was a small peak of activity
coeluting with the CEH peak. The activity was four fold lower than the
CEH activity. When fractions from the second QAE-Sephadex A-25
chromatography step were assayed for triacylglycerol lipase activity
using a 1 in 80 dilution which was twice the dilution used in the CEH
assay, no activity was detected. The CEH _ preparation was also
r 14 ~i
assayed at an 80-fold dilution using glycerol tri- 1- C oleate
substrate emulsion with a 3-fold greater specific radioactivity for 1 h
at 37°C, but this did not overcome the detergent inhibition. It was
not practical to dilute the enzyme further as the amount of enzyme
protein in the assay was already extremely low (<1 yg). The peak
fraction for CEH activity at the second QAE-Sephadex A-25 step was
only 2.5-4.5 times the background count (60-70 cpm) after dilution.
Therefore due to the dual problems of detergent inhibition and inherent
lower activity the triacylglycerol lipase activity in the CEH „
• r 141
preparation was unable to be measured with glycerol tri- 1- C oleate
substrate emulsion.
Workers investigating the HSL of adipose tissue do not always use
, f 14 1
glycerol tri-II- C oleate as the substrate for the enzyme. One reason
for this is that the HSL enzyme also has diacylglycerol lipase activity
and therefore further hydrolysis of the substrate can occur after the
cleavage of the first fatty acid (Khoo and Steinberg (1974), Khoo,
Steinberg et al. (1978), Steinberg (1976)). There is also a highly
110.
active monoacylglycerol lipase in adipose tissue cytosol (Tornqvist
and Belfrage (1976), Berglund, Khoo et_ al ,(1980)). This can therefore
add to the activity observed by hydrolysis of monooleoylglycerol
produced by the action of HSL.
In the purification of HSL from chicken adipose tissue using
Triton X-100 solubilisation, the activity of HSL was assayed towards
diacylglycerol, as the enzyme was 20 times more active against that
substrate than the trioleoylglycerolsubstrate (Berglund, Khoo et al.
(1980)). Similarly, in the purification of HSL from rat adipose
tissue using solubiiisati°n> H^L activity was assayed using
(Fredrikson, Stralfors et_ a_l.(1981a), Tornqvist, Bjorgel et_ al_. (1978)).
The enzyme was 10 times more active against this monoether analogue of
diacylglycerol than with triacylglycerol, and hydrolysis did not
provide a substrate for the monoacylglycerol lipase.
The activities of both CEH and triacylglycerol lipase (HSL) are
3-fold higher in adipose tissue than adrenal cortex (Gorban and Boyd
(1977)). Therefore in the purification of HSL from rat adipose tissue,
it was possible to detect HSL activity in the purified preparation
using trioleoylglycerol substrate, despite ^3^2 inhibition (Fredrikson,
Stralfors e_t al_, (1981a)) . However the activities of diacylglycerol
lipase and monoacylglycerol lipase in adrenocortical cytosol, and
their relationships to the CEH in the tissue have not been studied.
6.2.6 Inhibition of CEH activity by di-isopropylfluorophosphate (DFP)
CEH and HSL have been shown to be inactivated by agents that are
known to covalently bind to essential or active-site serine residues
(see Sigman and Mooser (1975)). Both CEH and triacylglycerol lipase
__8 —g
activities were inhibited by chlorpyrifos oxone in the 10 -10 M
range in rat adrenal (Pittman and Steinberg (1977)) and bovine adrenal
a synthetic substrate,
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cortex (Gorban (1980)). The CEH activity may be more sensitive to the
inhibition than the triacylglycerol lipase activity in rat adrenal
(Pittman and Steinberg (1977)). Phenyl methyl sulphonylfluoride (PMSF)
in the micromolar range had been shown to inhibit HSL in chicken
adipose tissue (Berglund, Khoo and Steinberg (1979)) and CEH in bovine
adrenal cortex (Yeaman, Cook and Lee (1980)). In bovine adrenal cortex
the CEH activity was more sensitive to PMSF treatment than the
triacylglycerol lipase activity (Yeaman, Cook and Lee (1980)). It had
been reported that DFP at 50 yM could inhibit partially purified HSL
from rat adipose tissue by 50% (Belfrage, Jergil et al.(1977)).
It was decided to examine the inhibition of CEH in the CEH^
preparation by a single dose of DFP. More recent work had reported a
50% inhibition of both HSL and CEH in rat adipose tissue at a DFP
concentration of 10 yM (Fredrikson, Stralfors et_ _al_. (1981a)), consequently
a concentration of twice this was used. A 1 ml sample of CEH^
preparation was incubated with 20 yM DFP (25 yl in propyleneglycol)
for 30 min at 4°C. After incubation the sample was extensively
dialysed and the CEH activity measured and compared to a control sample
(1 ml CEHq2 preparation + 25 yl propylene glycol), that was subjected
to the same procedure without DFP.
Table 6.3 shows that 20 yM DFP inhibited the CEH activity in the
CEH^ preparation by 90%. This was in agreement with the previous work
using other agents, where it was found that chlorpyrifos oxone at 1 yM
inhibited rat adrenal CEH by 98% (Pittman and Steinberg (1977)) and
bovine adrenocortical CEH by 92% (Gorban (1980)). Similarly, PMSF at
10 yM inhibited bovine adrenocortical CEH by 80% (Yeaman, Cook and Lee
(1980)). The site or sites at which these reagents interact with CEH
or HSL are not known, although it was found that some stimulation of
chlorpyrifos oxone-inhibited CEH was possible by incubation for 10 min
CEH Activity
Sample (nmol oleic acid produced.min ,mg protein )
Control 43.4 - 5.1
20 yM DFP-treatment 4.2 - 1.1
Table 6.3. Inhibition of CEH activity by DFP. A sample of 1 ml
CEH^ preparation in 20 mM Tris-HCl buffer pH 7.4 at 4°C containing
0.2 mM DTT, 0.2 mM EDTA, 15 mM NaCl, 50% (v/v) glycerol and 0.1% C^E^
was incubated for 30 min at 4°C with 25 yl I 1,3-JH I DFP (in popylene[I,3-3H]
glycol, final DFP concentration 20 yM, 125 yCi). A control sample
of 1 ml CEH^ Preparation was incubated with 25 yl propylene glycol.
After incubation both samples were extensively dialysed against the
above buffer at 4°C. Samples were diluted 80 fold for the assay of
CEH activity as described in the legend to Table 5.1. Results are
expressed as means - S.E.M. of triplicate assays.
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2+
with ATP/Mg and cAMP (Gorban (1980)). Furthermore both cAMP-activated
2+
and Mg -deactivated CEH from bovine adrenal cortex were inhibited to the
same extent by chlorpyrifos oxone (Gorban (1980)) suggesting that the
phosphophorylation site was not a site of action for these inhibitors.
6.3 LABELLING OF THE CEH^ PREPARATION I - [y-32P ] ATP
It was found that incubation of bovine adrenocortical cytosol with
f 32 1 32 ...
y- P ATP led to P-labelling of the protein fraction with a
concomitant 122% increase in CEH activity (Trzeciak and Boyd (1974)).
Chromatography of the phosphorylated protein on Sephadex G-200 revealed
32
that the P radioactivity peak was associated with CEH activity.
32 2+
Incubation of the P-labelled protein with 5 mM Mg resulted in the
32
loss of P-labelled phosphate from the phosphorylated protein with a
concomitant decrease in CEH activity. These results were supported by
32 T 32 "I
Wallat and Kunau (1976) where P radioactivity from y- P ATP was
incorporated into the protein fraction of bovine adrenocortical cytosol.
32 ...
The protein-bound P radioactivity essentially copurified with the CEH
activity during ammonium sulphate precipitation or acid precipitation
followed by gel permeation chromatography.
32
Beckett and Boyd (1977) described a purification of P-phosphorylated
32
CEH, m which a P-labelled ammonium sulphate precipitate prepared from
the cytosol was subjected to chromatography on Sephadex G-200 and
Sepharose 4B. This procedure separated the phosphorylated CEH protein
from some other phosphorylated proteins. The molecular weight of the
purified CEH preparation was estimated at 173 000 by gel permeation
chromatography. Electrophoresis of the phosphorylated enzyme on native
gels gave two proteins, but only the one of higher electrophoretic
32
mobility was labelled with P and an esterase activity stain (1-napthol
propionate as substrate). SDS/PAGE of the same sample showed two main
proteins in close proximity with the radioactivity associated more with
the band of greater mobility, with an estimated molecular weight of 41 000.
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Therefore there was good evidence that the activation of CEH by
cAMP required the transfer of the terminal phosphate from ATP to the
enzyme protein. This could be used to label the enzyme protein when
r 321
y- P ATP was used in the activation reaction. However the study by
Beckett and Boyd (1977) was the only one where the identification of the
CEH enzyme protein was attempted. The CEH preparation in this study was
only 57-fold purified with a specific activity of 0.8 nmol oleic acid
produced.min \mg protein ^ and a major assumption was made in the
comparison of native and SDS polyacrylamidegels of the purified material.
The CEHq2 preparation, purified 150-fold with a specific activity of
approximately 50 nmol oleic acid produced.min ''".mg protein ^ was now
available. Furthermore, modern slab gel techniques provide greater
resolution and sensitivity than could be achieved with disc gel
32
electrophoresis. Therefore it was decided to reinvestigate P-
r 32 "i ....
labelling of CEH using y- P ATP as a technique for the identification
of the CEH enzyme protein.
32
6.3.1 Analysis of P-labelled proteins by autoradiography
Samples of concentrated CEH^ preparation (specific activity =
70 nmol oleic acid produced.min \mg protein ^ and 122-fold purified)
f 32 1 2+
were incubated with y- P ATP, Mg and cAMP with or without added
exogenous cAMP-dependent protein kinase (type II, bovine heart),
as described in the methods section. The reaction was terminated by
the addition of ice-cold 25% (w/v) TCA and the precipitated protein
washed with ice-cold 5% (w/v) TCA and acetone. The protein pellets were
dried by vacuum desiccation and subjected to SDS/PAGE as described in
the methods section. The dried gel was autoradiographed without an
intensifying screen as described in the methods section.
The gel, stained for protein, and the corresponding autoradiograph
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Legend to Fig. 6.2. P-labellmg of CEH^ preparation with j y- PJ ATP;
Autoradiography. The CEH^ preparation was concentrated by pressure
ultrafiltration as described in Section 5.4.1 and dialysed against 20 mM
Tris-HCl buffer pH 7.0 at 37°C containing 0.2 mM DTT. Samples of this
preparation (100 pg protein) were incubated for 30 min at 37°C with
0.3 mM^y-^pJ ATP (50 pCi, 400 cpm.pmol ^), 5 mM magnesium chloride
and 50 pM cAMP in 50 mM Tris-HCl buffer pH 7.4 at 37°C. The reaction
was terminated by the addition of ice-cold 25% (w/v) TCA and the
samples prepared for SDS/PAGE on a 6-12% exponential gradient gel as
described in the methods section. The dried gel, stained for protein
was subjected to autoradiography as described in the methods section.
Slots 1, 2 and 3, protein stain; slots a, b and c, autoradiograph.
ATP;
ATP and exogenous cAMP-
dependent protein kinase (20 pg, type II bovine heart);
r 321 .Slots 3,c - y- P ATP plus exogenous cAMP-dependent protein kinase
(as above).
The arrows indicate the position on the gel of molecular weight
standards.
Slots l,a - CEH £ preparation plus





there were about 8 major proteins in the CEH 2 Preparation including one
with Mr 80 000 and at least another 8 lesser proteins observed when the
gel was stained for protein (Fig .6.2, 1&2). However autoradiography of
the gel showed that only one major band of radioactivity, corresponding
to a protein with Mr 82 000-84 000, was observed when the CEH^
f 32 1 2+
preparation was incubated with y- P ATP, Mg and cAMP (Fig. 6.2a).
This was due to phosphorylation by endogenous protein kinase. When
exogenous cAMP-dependent protein kinase was added to the incubation,
a further 5 phosphorylated bands were observed (Fig. 6.2b), but four of
these were due to contaminating proteins in the cAMP-dependent protein
kinase preparation that were phosphorylated, including the regulatory
subunit (Fig. 6.2c). However an additional CEH^ Protein with
Mr 105 000 was phosphorylated while the phosphorylation of the protein
with Mr 82 000-84 000 was enhanced.
It was shown in Table 6.2 that there was residual cAMP-independent
protein kinase activity and cAMP-dependent protein kinase activity in
the CEHq2 Preparation. However only the cAMP-dependent protein kinase
activated CEH in the CEH^ preparation and the activation was enhanced
by the addition of exogenous cAMP-dependent protein kinase (Fig. 6.1).
In the experiment performed here, it was shown that only one major
protein with Mr 82 000-84 000 was phosphorylated when the CEH
T 32 "1
preparation was incubated with y- P ATP in the presence of cAMP.
The addition of exogenous cAMP-dependent protein kinase enhanced the
phosphorylation of this protein and a further protein with Mr 105 000
was also phosphorylated. Although a control incubation without cAMP
was not included in this experiment it was possible that the protein
with Mr 82 000-84 000 represented the CEH enzyme protein.
32 . .
6.3.2 Analysis of the P-labelled proteins by gel slicing
[>P]
Samples of concentrated CEH^ preparation were incubated with
2+
ATP, Mg and cAMP with and without added exogenous cAMP-dependent
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32
protein kinase as described m the previous experiment. The P-labelled
proteins were prepared for and subjected to SDS/PAGE as described in the
methods section. In this case the dried gel was cut into 1 mm slices
32
using a sharp scalpel and the P incorporation estimated as described
in the methods section.
The inconsistency between different CEH^ PreParati°ns was observed
in this experiment, as six proteins were phosphorylated in this preparation
without exogenous cAMP-dependent protein kinase (Fig. 6.3A) compared to
only one in the previous CEH^ preparation (Fig. 6.2a). The phosphorylated
proteins had Mr 82 000, 75 000, 73 000, 54 000, 33 000 and 15 000.
Addition of cAMP-dependent protein kinase slightly stimulated the
phosphorylation of the protein with Mr 82 000, and possibly stimulated
the phosphorylation of the protein with Mr 15 000, with respect to the
others (Fig. 6.3b). The addition of cAMP-dependent protein kinase also
resulted in the rather broad peak at 54 000 splitting into 2-3 large
peaks with Mr 56 000, 54 000 and 42 000. However these peaks were due
to phosphorylated proteins, such as the regulatory subunit, in the cAMP-
dependent protein kinase preparation (Fig. 6.3C). Although not so
conclusive as the previous experiment, this experiment supports the
hypothesis that the phosphorylated protein with Mr 82 000-84 000 may be
the CEH enzyme protein.
6.3.3 The time-course of the phosphorylation pattern
The time course for the activation of CEH has been well documented.
Wallat and Kunau (1976) showed that the activation reached a maximum by
15-20 min and was 50% complete by 5 min. Beckett and Boyd (1977) showed
that the activation and phosphorylation closely paralleled each other
during the first 5 min, but the activation had reached a maximum in
10-15 min whereas the phosphorylation still showed a slight rise.
However this experiment used partially purified CEH and so other proteins
were also phosphorylated.
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Fig. 6.3 contd.
32
P-labelling of CEH^ preparation with [Y-32P] ATP;
Gel slicing. A CEH^ preparation was concentrated and dialysed against
10 mM Tris-HCl buffer pH 7.0 at 37°C containing 1 mM DTT. Samples of
P2p] ATP100 yg protein were incubated for 30 min at 37 C with 0.2 mM
(50 yCi, 930 cpm.pmol ^), 3 mM magnesium chloride and 30 yM cAMP in
50 mM Tris-HCl buffer pH 7.4 at 37°C. The reaction was terminated by the
addition of ice-cold 25% (w/v) TCA and the samples prepared for
SDS/PAGE on a 6-12% exponential gradient gel as described in the
methods section. The slots on the dried gel were cut into 1 mm slices
32
P incorporation estimated as described in the methods section.and
A - CEH
Q2 preparation plus






ATP and exogenous cAMP-dependent
frotein kinase (20 yg, type II bovine heart);Y_32pJatP plus exo enous cAMP-dependent protein kinase (as above).
The arrows indicate the position on the gel of molecular weight standards.
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It had been shown in this study that incubation of the CEH^
2+
preparation with cAMP, ATP and Mg for 10 mm resulted in a 32%
increase in CEH activity without exogenous cAMP-dependent protein kinase
and a 55% increase in the enzyme activity with exogenous cAMP-dependent
protein kinase. Evidence from the previous two experiments suggests
that the CEH activity may be associated with a protein with Mr 82 000-
84 000. Therefore it was decided to investigate the time-course of the
dependent protein kinase (650 units). The reaction was initiated by
the addition of the labelled ATP. Samples were withdrawn from the
incubation after 1, 2, 5, 10, 15, 20, 30 and 60 min and immediately
added to an equal volume of ice-cold 25% (w/v) TCA. The samples were
analysed by SDS/PAGE and autoradiography (with intensifying screen)
as described in the methods section.
Fig. 6.4 shows that complete phosphorylation had been achieved
after 10 min incubation. In this experiment, using another CEH^
preparation and the catalytic subunit of cAMP-dependent protein kinase,
the phosphorylation pattern was more complex than observed in previous
experiments, with at least 12 phosphorylated proteins. However after
an incubation period of 1 min, only 2 proteins were phosphorylated,
with Mr 88 000 and 36 000. The lower molecular weight protein may be
the catalytic subunit of cAMP-dependent protein kinase, which is now
known to be autophosphorylated although its molecular weight is usually
quoted at about 39 000-42 000 (Flockhart and Corbin (1982)). By 5 min
several other proteins were phosphorylated including one with Mr 84 000.
As with the other proteins, full phosphorylation of this protein was
achieved after 10-15 min.
A sample of
Mg2+, 30 mM DTT,
ion was incubated with 10 mM
subunit of cAMP-
"TIK\E
Legend to Fig. 6.4. Time-course of the phosphorylation pattern in the
CEH^ preparation. A CEH^ Preparation was concentrated by ultrafiltration
and dialysed against 10 mM Tris-HCl buffer pH 7.0 at 37°C containing
0.5 mM DTT. A sample of 8 ml of the preparation (600 yg protein) was
incubated at 30°C with 10 mM magnesium chloride, 30 mM DTT, 0.12 mM
! 32 1 . -1
J^y- PJ ATP (400 yCi, 630 cpm.pmol ) and the catalytic subunit of
cAMP-dependent protein kinase (650 units). The incubation was initiated
by the addition of the ATP and samples of 1.2 ml were extracted at
1, 2, 5, 10, 15, 20, 30 and 60 min after initiation and immediately
added to an equal volume of ice-cold 25% (w/v) TCA. The samples were
subjected to SDS/PAGE on a 6-12% exponential gradient gel and
autoradiography as described in the methods section.
a, protein stain; b, autoradiography.
The arrows indicate the position on the gel of molecular weight standards.
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These results are in agreement with the results obtained in the
previous studies showing parallel activation of CEH and phosphorylation
of the protein fraction (Beckett and Boyd (1977), Naghshineh, Treadwell
at al_. (1978) , Gorban (1980)). However, in these previous studies,
the phosphorylation was measured by TCA precipitation of the protein
32
fraction and determination of the total P incorporation. Here, the
phosphorylation was measured in a qualitative manner in order to study
the phosphorylation of individual proteins. As in the previous experiment,
the results shown in Fig. 6.4 were consistent with the hypothesis that
the protein with Mr 82 000-84 000 was the CEH enzyme protein. The identity
of the protein with Mr 88 000, which was phosphorylated very rapidly
was not known, and had not been observed in the previous experiments.
Further proteins with Mr's approximately 160 000, 110 000, 100 000,
70 000, 64 000, 61 000, 51 000, 45 000, 39 000, 28 000, 25 000 and 15 000
were also phosphorylated in this experiment. Some of these corresponded
to those found in the previous experiment.
32
Overall, labelling the protein m the CEH „ preparation with P
r 321
using y- P ATP was partly successful in the identification of the
CEH enzyme protein. The variation in the phosphorylation pattern observed
with different CEH^ preparations made identification more difficult.
There was evidence, however, to suggest that CEH in bovine adrenocortical
cytosol may be associated with a protein with Mr 82 000-84 000.
This phosphorylated protein was found in all the cAMP-dependent
phosphorylation experiments (using 5 different Q2 enzyme preparations)
despite the variation observed in the phosphorylated protein pattern,
and with one CEH^ preparation this was the only protein phosphorylated
(Fig. 6.2). Furthermore the phosphorylation of this protein was enhanced
by the addition of exogenous cAMP-dependent protein kinase (Figs. 6.2
and 6.3) , was markedly phosphorylated within 5 min and fully
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phosphorylated by 10-15 min after the initiation of the reaction
(Fig. 6.4). However, this protein was not a major component of the
CEH^ preparation as was observed when the gels were stained for protein,
although there was a relatively major protein with slightly higher
electrophoretic mobility (Figs. 5.7 & 6.2). This protein was not
always as prominent in other CEH^ preparations (Fig. 6.4).
6.4 LABELLING OF THE CEHq2 PREPARATION II - [I,3~3H]DFP
32
The results obtained from the P-labellmg experiments had suggested
a possible molecular weight for the CEH enzyme protein in bovine
adrenocortical cytosol. However the evidence was not conclusive and so
an attempt was made to label the CEH enzyme protein in the CEH „
r 31
preparation, more specifically, with 1,3- H DFP. This chemical had
been shown to inhibit the CEH activity in this preparation (Table 6.3).
3
6.4.1 Analysis of the H-labelled proteins by autoradiography
A sample of concentrated CEH^ preparation was incubated with
75 pM 1,3~3H DFP (0.5 mCi, 6 Ci.mmol ^) for 30 min at 37°C.
The incubation was terminated by the addition of an equal volume of
ice-cold 25% (w/v) TCA and the sample prepared for and subjected to
SDS/PAGE followed by fluorography-autoradiography as described in the
methods section.
Fig. 6.5 shows that 3-4 proteins were labelled by the [i,3-3h] DFP,
and that the major labelled protein had Mr 84 000. There was also a
diffuse area of labelling with peaks corresponding to proteins with
Mr 54 000 and 50 000, and possibly a third area of labelling moving
just behind the dye-front corresponding to a protein with Mr 20 000.
However the most densely-labelled band was due to the protein with
Mr 84 000 and this corresponded with the molecular weight postulated
from the results obtained in the phosphorylation experiments. There
was also a diffuse area of labelling at an approximate Mr of 50 000 in
20 000
Fig. 6.5. Labelling of the CEH^ preparation with j^l,3~^HJ DFP;
Fluorography. A CEH preparation was concentrated by ultrafiltration
o
and dialysed against 10 mM Tris-HCl buffer pH 7.0 at 37 C containing
0.5 mM DTT. A sample of the preparation (150 pg protein) was incubated
for 30 min at 37°C with 75 pM J\,3-^hJ DFP (500 pCi, 6 Ci.mmol ^).
The incubation was terminated by the addition of ice-cold 25% (w/v)
TCA and the sample subjected to SDS/PAGE on a 7.5% gel and fluorography
as described in the methods section.
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some phosphorylation experiments (Fig . 6.3A&B), but probably this was
due to the regulatory subunit of type II cAMP-dependent protein kinase
(Fig. 6.3C) and was not prominent in all phosphorylation experiments
(Figs. 6.2 & 6.4). Similarly there was labelling of low molecular weight
proteins in some phosphorylation experiments with one prominent protein
with Mr 15 000, but phosphorylation of a protein with Mr 20 000 was not
observed. Therefore, the protein with Mr 84 000 was the most likely
candidate as the CEH enzyme protein.
3 . . .
6.4.2 Analysis of the H-labelled proteins by gel slicing
The ^1,3-"^hJdFP labelling experiment was carried out as described
in Section 6.4.1 except that before the gel was dried the appropriate
3
track was excised from the gel and sectioned into 1 mm slices. The H
incorporation was determined by liquid scintillation counting after NCS
solubilisation of the gel slices (see methods section).
Fig. 6.6 shows that the results were almost identical to those
obtained from the autoradiograph, and that 4 proteins were labelled
with Mr 84 000, 54 000, 50 000 and 20 000. In this experiment the
proteins with similar electrophoretic mobilities were the most highly
labelled, again in a rather wide band. However the protein with
Mr 84 000 was again highly labelled with the low molecular weight
protein labelled least.
labelling experiments was that CEH activity in bovine adrenocortical
cytosol was associated with a protein of molecular weight about 84 000
It was possible that this was only a subunit of a holoenzyme, although
as it was both labelled by DFP and phosphorylated it was probable that
it contained catalytic and regulatory properties.
6.5 SUMMARY
The overall conclusion from both
Fig. 6.6. Labelling of the CEH^ preparation with ^1,3-^HjDFP; Gel
slicing. The experiment was performed as described in the legend to
Fig. 6.5 except that before the gel was dried, this slot was cut from
3 . .
the gel and sectioned into 1 mm slices. H incorporation was determined
by liquid scintillation counting after solubilisation of the protein in
the excised slices by NCS tissue solubiliser as described in the methods
section. The arrows indicate the position on the gel of molecular
weight standards.
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2. This preparation also contained residual cAMP-independent and cAMP-
dependent protein kinase activities, but was free from phosphoprotein
phosphatase activity.
3. It was possible to activate CEH in this preparation by incubation
2+ 2+
with ATP/Mg and cAMP, but incubation with Mg alone did not alter
the activity.
r 32 "i4. Studies using y- P I ATP to label the CEH enzyme protein suggested
that the activity was associated with a protein with Mr 82 000-84 000.
5. Labelling the CEH^ PreParati°n with [i > 3-3h] DFP was found to
inhibit the enzyme activity, and supported the suggestion that the CEH
activity was associated with a protein with Mr 84 000.
SECTION 7
INVESTIGATION OF THE EFFECT OF A PHOSPHOPROTEIN PHOSPHATASE
PURIFIED FROM BOVINE ADRENOCORTICAL CYTOSOL ON THE ACTIVITY
OF PARTIALLY PURIFIED CHOLESTEROL ESTER HYDROLASE FROM
BOVINE ADRENOCORTICAL CYTOSOL
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7.2 Purification of the multifunctional phosphoprotein
phosphatase from bovine adrenocortical cytosol
7.3 Studies on the multifunctional phosphoprotein
phosphatase with Mr 35 000, purified from bovine
adrenocortical cytosol
7.3.1 Endogenous phosphoprotein phosphatase activity in
the partially purified CEH preparation
7.3.2 The effect of purified multifunctional phosphoprotein
phosphatase on CEH activity and "P-labelled
phospho-CEH
7.3.3 Further studies on the effect of the multifunctional
phosphoprotein phosphatase on CEH activity
7.4 Purification of a low molecular weight phosphoprotein




CEH in the adrenal cortex cytosol is phosphorylated and activated
by cAMP-dependent protein kinase (Trzeciak and Boyd (1974), Wallat and
2+
Kunau (1976)). Incubation of the activated enzyme with millimolar Mg
resulted in a time-dependent dephosphorylation and deactivation
(Trzeciak and Boyd (1974)). It was also shown that incubation of the
activated enzyme with bovine liver alkaline phosphatase resulted in a
time-dependent deactivation of the enzyme (Beckett and Boyd (1977)).
Whereas, there had been much work investigating protein kinases
(reviewed Flockhart and Corbin (1982)) and their phosphorylation
processes including those in the adrenal cortex, there had been
relatively little work investigating the dephosphorylation processes
involving phosphoprotein phosphatases (see Krebs and Beavo (1979),
Glass and Krebs (1980), Hardie (1981), Cohen (1982)). However the
role of phosphoprotein phosphatases in the regulation and control of
metabolic pathways is now being actively investigated (see Fischer
and Brautigan (1982)).
It had been shown that adrenal cortex contained an alkaline
phosphatase activity (Li (1979)) and at least three distinct phosphoprotein
phosphatases (Merlevede and Riley (1966), Ullman and Perlman (1975),
Li (1979)). However the role of these phosphoprotein phosphatases in
the regulation of cytosolic CEH activity had not been studied.
Therefore, it was decided to purify a major phosphoprotein phosphatase
from bovine adrenocortical cytosol and to study its effects on the
activity of partially purified CEH from bovine adrenocortical cytosol.
It had been known for some time that phosphoprotein phosphatases
purified from a wide range of tissues demonstrated a variety of
molecular weights ranging from very high (200 000-300 000) to low
(30 000-35 000). Subsequent studies resulted in the hypothesis that
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the low molecular weight forms were catalytically active subunits
derived from the high molecular weight forms (Brandt, Capulong and Lee
(1975), Kobayashi and Kato (1977)). This catalytic subunit of about
Mr 35 000 could be released from the high molecular weight forms by a
variety of rather harsh treatments including 80% ethanol at room
temperature (Brandt, Killilea and Lee (1974)), urea (Killilea, Mellgren
al_. (1979)), freeze-thawing with 2-mercaptoethanol (Kato and Sato
(1974)), limited proteolysis with trypsin (Killilea, Mellgren et al.
2+
(1979)) or Ca -dependent protease (Mellgren, Aylward et al. (1979))
and storage at 4°C for 1-2 days (Khandelwal, Vandenheede and Krebs
(1976)). However it has also been found that an Mr 260 000
phosphoprotein phosphatase could be progressively dissociated by
increasing salt concentration (Khandelwal, Zinman and Ng (1980)).
The catalytic subunit has a low specificity and was relatively unaffected
by a variety of metabolic effectors, and has been termed the multi¬
functional phosphoprotein phosphatase (Krebs and Beavo (1979)).
At the time when the following experiments were performed the
phosphoprotein phosphatase-free CEH^ preparation (see Section 6.2.2)
was not available and so the cholate solubilised enzyme was used
(see Section 3.3.4). This preparation exhibited phosphoprotein
phosphatase activity in the presence of divalent cations. The endogenous
phosphoprotein phosphatases would interfere in experiments with a
purified phosphoprotein phosphatase and consequently it was decided to
purify the multifunctional phosphoprotein phosphatase and investigate
its effect on CEH activity. As this enzyme had no specific requirements
for divalent cations and a low specificity it was hoped that this
would eliminate interference by the endogenous phosphoprotein
phosphatases present in the CEH preparation.
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7.2 PURIFICATION OF THE MULTIFUNCTIONAL PHOSPHOPROTEIN PHOSPHATASE
FROM BOVINE ADRENOCORTICAL CYTOSOL
A low molecular weight (Mr 35 000) phosphoprotein phosphatase of
the multifunctional phosphoprotein phosphatase type had been purified
from bovine adrenal cortex (Li (1979)). This enzyme was found to have
low substrate specificity and was active against phosphorylase a,
phosphohistone, phosphocasein and also exhibited alkaline phosphatase
activity when assayed with p-nitrophenyl phosphate. Divalent cations
2+ 2+
were not required with the phosphoprotein substrates, but Mg , Mn
2+
or Co and also a sulphydryl compound were required for the alkaline
phosphatase activity. However the role of the phosphoprotein phosphatase
in the deactivation of CEH in the adrenal cortex was not investigated
or discussed. Therefore it was decided to purify this enzyme from
bovine adrenocortical cytosol and to investigate the effects of the
purified phosphoprotein phosphatase on partially purified CEH from
bovine adrenocortical cytosol.
The phosphoprotein phosphatase was purified essentially as described
by Li (1979) with certain modifications. The enzyme source was the
105 000 x g supernatant from bovine adrenal cortex, whereas Li (1979)
had used a 15 000 x g supernatant. Throughout the purification the
32
enzyme was monitored using p-nitrophenyl phosphate and P-labelled
phosphohistone (prepared as described in the methods section) as substrates
for the alkaline phosphatase and phosphoprotein phosphatase activities
respectively, using the procedures detailed in the methods section.
All purification steps were carried out at 4°C unless stated otherwise.
Step 1 - Tissue cytosol
The 105 000 x g supernatant was prepared from the cortex of about
40-50 bovine adrenal glands as described in the methods section.
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Step 2 - Ammonium sulphate fractionation
Solid ammonium sulphate was added to the cytosol, slowly and with
stirring, up to 55% saturation in the final mixture. The precipitate
was collected by centrifugation and was resuspended in 20 mM Tris-HCl
buffer pH 7.4 at 4°C containing 10 mM 2-mercaptoethanol, 5 mM magnesium
p
chloride, 1 mM EDTA and 50 mM potassium chloride (buffer A ) and
dialysed overnight against the same buffer.
Step 3 - Ethanol precipitation
The ammonium sulphate fraction had 5 volumes 95% (v/v) ethanol
added to it at room temperature. The mixture was immediately centrifuged
at 10 000 x g for 10 min at 20°C and the enzyme was extracted from the
p
pellet by four successive washes with 100 ml buffer A . The pellet was
gently homogenised with the buffer to ensure maximum recovery, and all
extractions were carried out at 10°C. The combined extracts were
filtered through Whatman No. 1, concentrated by precipitation with
p
ammonium sulphate to 70% saturation and dialysed against buffer A
overnight.
Step 4 - DEAE-cellulose chromatography
The concentrated and dialysed fraction from the previous step was
loaded onto a DEAE-cellulose column (2.5 x 40 cm) equilibrated with
p
buffer A . The enzyme was eluted with a linear gradient of potassium
chloride (0.05-0.45 M) (Fig. 7.1a). The p-nitrophenyl phosphatase
activity eluted in two peaks at 0.25 M and 0.35 M potassium chloride,
whereas the phosphohistone phosphatase activity eluted in a broad peak
associated with the second p-nitrophenyl phosphatase peak. At this
stage, both peaks of activity were pooled as indicated in Fig. 7.1a,
concentrated by precipitation with ammonium sulphate to 70% saturation
P


























Legend to Fig. 7.1. Purification of the multifunctional phosphoprotein
phosphatase from bovine adrenocortical cytosol.
a) DEAE-cellulose - The column (2.5 x 40 cm) was equilibrated in buffer
P ... . .
A (see text) and eluted with a linear gradient of potassium chloride
p
(0.05-0.45 M) in buffer A in a total volume of 500 ml. The flow rate
was 80 ml.h ^ and fractions of 8.2 ml were collected.
b) DEAE-Sephadex A-50 - The column (2.1 x 23 cm) was equilibrated in
P . .
buffer A and eluted with a linear gradient of potassium chloride
p
(0.1-0.45 M) in buffer A in a total volume of 600 ml. The column was
operated under a pressure of 25 cm H^O and fractions of 8.2 ml were
collected.
c) Sephadex G-100 - The column (2 x 96 cm) was equilibrated and eluted
p
with buffer C (see text) under a pressure of 70 cm H^O, and fractions
of 5.8 ml were collected.
32
P-labelled phosphohistone phosphatase and p—nitrophenyl phosphatase
activity were measured as described in the methods section.
32
O , p-Nitrophenyl phosphatase; ▲ , A^SO' • P-phosphohistone
phosphatase; , Potassium chloride concentration;
l 1 , Fractions pooled.
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Step 5 - DEAE-Sephadex A-50 chromatography
The dialysed enzyme solution was applied to a DEAE-Sephadex A-50
P
column (2.1 x 23 cm) equilibrated with buffer A . The enzyme was eluted
with a linear gradient of potassium chloride (0.1-0.45 M). The p-
nitrophenyl phosphatase activity was eluted in a peak at 0.27 M potassium
chloride with a large shoulder at about 0.33 M potassium chloride
(Fig. 7.1b). As in the previous step, the phosphohistone phosphatase
activity eluted as a broad peak associated mainly with the second
p-nitrophenyl phosphatase peak. The fractions indicated were pooled,
concentrated by pressure ultrafiltration (Amicon YM10 membrane) to about
10 ml and dialysed against 20 mM Tris-HCl buffer pH 7.4 at 4°C
p
containing 10 mM 2-mercaptoethanol and 50% (v/v) glycerol (buffer B ).
This resulted in a further concentration of the enzyme sample which
was necessary for the next step.
Step 6 - Sephadex G-100 chromatography
The concentrated sample was subjected to gel filtration chromatography
on a Sephadex G-100 column (2 x 96 cm) equilibrated with 20 mM Tris-HCl
buffer pH 7.4 at 4°C containing 10 mM 2-mercaptoethanol, 10% (v/v)
P
glycerol and 0.1 M potassium chloride (buffer C ). The p-nitrophenyl
phosphatase activity eluted in two peaks (II and III) as shown in
Fig. 7.1c. The phosphohistone phosphatase activity also eluted in two
peaks (I and III) with the second peak coeluting with the second
p-nitrophenyl phosphatase peak. Peak I was associated with the major
protein peak and was not investigated further, but peaks II and III
were pooled as indicated.
A summary of a typical purification is shown in Table 7.1.
Peak III represented the greater purification of the enzyme and SDS/PAGE
of samples from each stage of the procedure show a substantial




















































































Fig. 7.2. SDS/PAGE of samples from each stage of the purification of
the phosphoprotein phosphatase with Mr 35 000. Samples of approximately
100 pg protein were subjected to SDS/PAGE on a 10% gel and stained
for protein as described in the methods section.
The arrows indicate the position on the gel of molecular weight standards.
1, Tissue cytosol; 2, Ammonium sulphate fraction; 3, Ethanol precipitate;
4, DEAE-cellulose; 5, DEAE-Sephadex A-50; 6, Sephadex G-100 (peak III).
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Peak III contains a major protein with approximate Mr 35 000 with a few
minor contaminants in the Mr 25 000-40 000 range. Analytical gels
obtained from other identical purifications always showed a major
protein component in the Mr 30 000-35 000 range with some minor
contaminants. There are several different molecular weights reported
for purified low molecular weight phosphoprotein phosphatases from
various tissues although nearly all are in the Mr 30 000-35 000 range
(Khandelwal, Vandenheede and Krebs (1976), Khandelwal, Zinman and Ng
(1980), Li and Chan (1981), Imazu, Imaoka et_ al_, (1981)) . Peak II had
a higher protein concentration and much lower specific activity and
this was reflected in a more complex pattern on SDS/PAGE. The specific
activity of the Mr 35 000 enzyme was 1055 nmol p-nitrophenol
. -1 . -1 32 . -1 . -1
produced.mm .mg protein and 392 pmol P produced .mm .mg protein ,
representing a purification of 109-fold and 22-fold when measured
32
against p-nitrophenyl phosphate and P-phosphohistone, respectively.
In the purification reported by Li (1979) a final hydrophobic
chromatography step using Phenyl-Sepharose 4B was included after the
G-100 step. This resulted in an increase in the specific activity of
the enzyme when assayed for phosphorylase phosphatase activity but a
decrease in specific activity when assayed against p-nitrophenyl
phosphate. On two occasions during the purification described here,
a further Octyl-Sepharose 4B step was included, but this did not
result in an increase in the specific activity when assayed against
either substrate and consequently this step was not included routinely.
7.3 STUDIES ON THE MULTIFUNCTIONAL PHOSPHOPROTEIN PHOSPHATASE WITH
Mr 35 000 PURIFIED FROM BOVINE ADRENOCORTICAL CYT0S0L
The purified phosphoprotein phosphatase used was the peak III
enzyme from the Sephadex G-100 step (Fig. 7.1c). This preparation was
concentrated 10—fold by pressure ultrafiltration (Amicon YM10 membrane),
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dialysed against 20 mM Tris-HCl buffer pH 7.4 at 4°C containing 10% (v/v)
P o
glycerol (buffer D ) and stored at -20 C in this buffer. The enzyme
was active when assayed using p-nitrophenyl phosphate as substrate in
2+
the presence of Mg and 2-mercaptoethanol (see Table 7.1). However
32
the activity of the enzyme using P-labelled phosphohistone as substrate
was not dependent upon divalent cations and was dependent upon the
amount of enzyme protein (Fig. 7.3). This difference in divalent
cation sensitivity of the two activities was similar to that found by
Li (1979).
The source of CEH enzyme used in the following experiments was the
cholate solubilised enzyme (see Section 3.3.4), following dialysis
against 20 mM Tris-HCl buffer pH 7.4 at 4°C containing 10% (v/v) glycerol,
The enzyme was less stable in this buffer upon storage and the
subsequent freeze-thawing, and so was stored at -20°C in small batches
for no longer than 1 week. This preparation contained endogenous
phosphatase activity and so some preliminary experiments were performed
to determine the extent of this activity.
7.3.1 Endogenous phosphoprotein phosphatase activity in the partially
purified CEH preparation
Samples of the dialysed cholate solubilised enzyme (CEH preparation)
2+ 2+
were incubated with Mg or Mn , at various concentrations, for 15 mm
at 37°C. Cholesterol I l-^C I oleate substrate emulsion was then added
and the CEH activity determined as described in the methods section.
2+
Fig. 7.4 shows that with Mg there was no deactivation below a
concentration of 1 mM, but above this concentration there was an almost
2+ . 2+
linear deactivation with increasing Mg concentration, with 30 mM Mg
2+
giving 50% deactivation. However, Mn stimulated the deactivation of
CEH at concentrations between one and two orders of magnitude lower
2+ 2+
than that for Mg . At concentrations of up to 0.1 mM Mn , virtually
2+










Fig. 7.3. Activity of the Mr 35 000 phosphoprotein phosphatase
purified from bovine adrenocortical cytosol when assayed against
32
P-labelled phosphohistone. Phosphoprotein phosphatase
-1 p 32
(0.1 mgml in buffer D ) was incubated with P-labelled
phosphohistone for 30 min at 37°C. The phosphoprotein phosphatase
activity was measured as described in the methods section.
Points are means - S.E.M. of triplicate assays.
32 32
O, P in TCA supernatant; • , P in TCA precipitated pellet.
0.2 0.4 0.6 0.8 1.0 MnClJ mM
2+ 2+
Fig. 7.4. Endogenous Mg /Mn -stimulated phosphoprotein phosphatase
activity in the partially-purified CEH preparation. The CEH
preparation was the dialysed cholate solubilised enzyme (1 mgml
in 20 mM Tris-HCl buffer pH 7.4 at 4°C containing 10% (v/v) glycerol.
Samples (150 yl) of this preparation were preincubated for 15 min at
37°C with various concentrations of magnesium or manganese chloride
(both in 50 mM Tris-HCl buffer pH 7.4 at 37°C) . Cholesterol
oleate substrate emulsion was then added and CEH activity measured
as described in the methods section.
O
, Mn2+; • , Mg2+.
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A second preliminary experiment was performed to compare the
activity of partially purified multifunctional phosphoprotein phosphatase
2+ 2+
with the activity of the Mg /Mn -stimulated endogenous phosphoprotein
2+
phosphatases, at low Mg concentrations. The multifunctional
phosphoprotein phosphatase was purified to the stage where the low
molecular weight (Mr 35 000) catalytic subunit is released from the
holoenzyme, the ethanol precipitate (Step 3). The CEH preparation was
incubated with various amounts of Step 3 phosphoprotein phosphatase in
P P o
buffer A , or with buffer A alone, for 15 min at 37 C. Cholesterol
oleate substrate was then added and CEH activity measured as
P
before. Buffer A contains 5 mM magnesium chloride and thus this
2+
experiment showed the effect of low concentrations of Mg (0.5-2.0 mM)
on CEH activity, in the presence or absence of partially purified
phosphoprotein phosphatase.
2+
Fig. 7.5 shows that in this experiment, Mg up to a final
concentration of 2 mM did not affect the activity of CEH. However
the partially purified phosphoprotein phosphatase deactivated the CEH
2+
despite the low concentration of Mg , and gave 89% deactivation at the
highest concentration used. The amount of partially purified
phosphoprotein phosphatase added to the incubations increased in
2+
parallel with the Mg and so this experiment could not give any
indication of the ion requirements of the low molecular weight
phosphoprotein phosphatase at this stage of the purification.
The two preliminary experiments indicated that the endogenous
phosphoprotein phosphatases in the CEH preparation were not stimulated
2+ 2+
at concentrations of Mg and Mn below about 2 mM and 0.1 mM,
respectively. However, the partially purified multifunctional
2+
phosphoprotein phosphatase deactivated CEH at concentrations of Mg
2+
well below the Mg concentration required to activate the endogenous
phosphoprotein phosphatases.
Fig. 7.5. The effect of partially—purified multifunctional phosphoprotein
. . 2+
phosphatase on CEH activity at low Mg concentrations. The phosphoprotein
P
phosphatase was the step 3 (ethanol precipitate) fraction in buffer A ,
from the purification procedure summarised in Table 7.1. The CEH
preparation was the cholate solubilised enzyme dialysed against
20 mM Tris-HCl buffer pH 7.4 at 4°C containing 10% (v/v) glycerol.
100 pi samples of CEH preparation (1 mgml were incubated for
15 min at 37°C with various amounts (25, 50, 75 and 100 pi) of buffer
P P
A , or step 3 phosphoprotein phosphatase m buffer A . Cholesterol
r 14 i1- C oleate substrate emulsion was then added and CEH activity
. • • •
measured as described m the methods section. Points are means -
S.E.M. of triplicate assays.
P . P
O, Buffer A ; •, step 3 phosphoprotein phosphatase in buffer A .
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7.3.2 The effect of purified multifunctional phosphoprotein phosphatase
32
on CEH activity and P-labelled phospho-CEH
All subsequent experiments were carried out using the purified
phosphoprotein phosphatase (Mr 35 000) obtained from Step 6 (peak III).
The CEH preparation was activated before incubation with the phosphoprotein
2+
phosphatase. A sample of CEH preparation was incubated with cAMP, Mg
and ATP for 10 min at 37°C, desalted on a Sephadex G-25 column and
incubated with the phosphoprotein phosphatase, in the presence or absence
of 0.1 mM Mn^+, for 15 min at 37°C. Cholesterol I i-"c I oleate substrate[i-14c]
emulsion was then added and CEH activity measured as described in the
r 321methods section. A parallel experiment was performed m which y- P ATP
replaced ATP in the activation step. After desalting and incubation
with phosphoprotein phosphatase as above, the phosphoprotein phosphatase
activity was assayed as described in the methods section.
Table 7.2 shows that the purified phosphoprotein phosphatase contained
no CEH activity and that the activation of CEH by endogenous cAMP-
dependent protein kinase resulted in a 63% increase in the CEH activity.
2+ . .
Incubation with 0.1 mM Mn resulted m a reduction m the CEH activity
32
and an increase in P released from the protein pellet, however these
differences were not significant (p>0.1). This was as predicted from
2+
the preliminary experiments where this concentration of Mn did not
stimulate endogenase phosphoprotein phosphatases (Fig. 7.4). Addition
2+
of the phosphoprotein phosphatase, in the absence of Mn , had contrasting
effects in the parallel experiments. The phosphoprotein phosphatase
32
caused a 65% increase in the P released into the TCA supernatant and
32
a corresponding 46% decrease in the P content of the protein fraction.
However the phosphoprotein phosphatase had no significant effect upon
2+
the activity of CEH. Addition of 0.1 mM Mn to the incubations with








































Table 7.2. Effect of multifunctional phosphoprotein phosphatase on CEH
32 . -1
activity and P-labelled phosphoCEH. The CEH preparation (1 mgml )
was incubated for 10 min at 37°C with 5 mM magnesium chloride, 20 yM
r 321cAMP and 5 mM ATP or 0.2 mM I y- P ATP. The samples were desalted on
p
a Sephadex G-25 column equilibrated in buffer D . The desalted samples
were incubated for 15 min at 37°C with or without purified phosphoprotein
p
phosphatase (10 yg in buffer D ) in the presence or absence of 0.1 mM
2+
Mn . The phosphoprotein phosphatase and CEH activities were measured
» +
as described m the methods section. Results are expressed as means -
S.E.M. of triplicate assays.
Sample Phosphoprotein Phosphatase
Activity




results. The activity of the purified phosphoprotein phosphatase towards
32
the P-labelled proteins m the CEH preparation was dependent upon the
amount of phosphoprotein phosphatase enzyme (Fig. 7.6). The specific
activity of the phosphoprotein phosphatase when measured against this
32 -1 -1
substrate was 19 pmol P released.mm .mg enzyme
These results indicated that the multifunctional phosphoprotein
phosphatase was of low specificity and divalent cation-independent
32
when assayed against various P-labelled proteins m the CEH preparation.
However this enzyme appeared to be unable to deactivate the CEH enzyme.
7.3.3 Further studies on the effect of the multifunctional phosphoproteiri
phosphatase on CEH activity
The effect of a higher concentration of Mn and the effect of Mg
on the activity of the phosphoprotein phosphatase, when measured towards
CEH activity, was investigated. Samples of CEH preparation were
incubated with the phosphoprotein phosphatase for 15 min at 37°C in the
2+ 2+
presence or absence of various concentrations of Mn or Mg . Controls
2+2+ .
with Mg and Mn alone were also included. After incubation, cholesterol
[l-14c] o leate substrate emulsion was added and the CEH activity determined.
Table 7.3 shows that the phosphoprotein phosphatase alone did not
2+
deactivate CEH. Mg at 1 mM and 10 mM deactivated the enzyme by 15%
and 76% respectively. Addition of the phosphoprotein phosphatase did
2+
not significantly alter these results (p>0.05). Mn at 1 mM was
sufficient to reduce the CEH activity to zero and addition of
2+
phosphoprotein phosphatase had no effect. However at 0.1 mM, Mn alone
resulted in 96% deactivation of CEH. This was far greater than
experienced with previous CEH preparations and suggests this preparation,
although prepared identically, contained a more active endogenous
2+
phosphoprotein phosphatase. The deactivation with Mg alone was also
greater than observed previously (Fig. 7.4). Furthermore, the deactivation
Fig. 7.6. Activity of the multifunctional phosphoprotein phosphatase
32
against P-labelled proteins m the CEH preparation. The experiment
was performed as described in the legend to Fig. 7.3 except that the
32
phosphoprotein phosphatase substrate was the P-labelled CEH
preparation prepared as described in the legend to Table 7.2.
Points are means - S.E.M. of triplicate assays.
32 32O, P in TCA supernatant; •, P in TCA precipitate.
Additions to CEH Preparation
2+ 2+
Phosphoprotem Mn Hg
Phosphatase (yg) (mM) (mM)
CEH Activity




- 0.1 - 49
+
32
7 0.1 - 1162
+
87
- 1.0 - 0
7 1.0 - 0
- - 1.0 1076
+
30
7 - 1.0 1278
+
90
- - 10.0 306
+
45




Table 7.3. The effect of Mn and Mg on the activity of the
multifunctional phosphoprotein phosphatase when assayed against
CEH activity. Dialysed cholate solubilised CEH preparation
-IP o
(0.43 mgml in buffer D ) was incubated for 15 min at 37 C with
the additions indicated above. The phosphoprotein phosphatase
-1 p 2+ 2+
(35 ygml ) was in buffer D and Mn and Mg were added as the
chloride salts in distilled water. After incubation cholesterol
r H i1- C oleate substrate emulsion was added and CEH activity
assayed as described in the methods section. Results are expressed
as means - S.E.M. of triplicate assays.
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2+ ...
by 0.1 mM Mil was inhibited by the addition of the purified phosphoprotein
phosphatase. This suggested that the phosphoprotein phosphatase was
2+
chelating the Mn at this low concentration and thus preventing the
2+
Mn from stimulating the endogenous phosphoprotein phosphatases.
2+
A similar effect was observed with 1 mM Mg
The results have shown that the multifunctional phosphoprotein
phosphatase alone was not able to deactivate CEH. When concentrations
2+ 2+
of Mn or Mg that stimulate endogenous phosphoprotein phosphatases
are included in the incubations, no increased deactivation was observed
upon the addition of the multifunctional phosphoprotein phosphatase.
The alkaline phosphatase activity of the Mr 35 000 enzyme required
a thiol such as 2-mercaptoethanol or DTT for full activity (Li (1979)).
Consequently, an experiment was performed in which the CEH preparation
2+
was incubated with the phosphoprotein phosphatase and 1 mM or 5 mM Mg
2+
m the presence or absence of 1 mM DTT. Table 7.4 shows that 1 mM Mg caused
a 10% reduction in CEH activity and this was not significantly altered by
the addition-of DTT or DTT plus phosphoprotein phosphatase (p>0.1).
2+ . .
With 5 mM Mg , the CEH activity was reduced by 54% and the addition of
DTT or DTT plus phosphoprotein phosphatase tended to inhibit the activity
of the endogenous phosphoprotein phosphatases. The reason for the
latter result was unknown, but the results show that the activity of
the phosphoprotein phosphatase towards CEH activity was not stimulated
by a thiol.
10
It had been shown that the metal ion-dependent form of the Mr 35 000
enzyme could be converted by pyrophosphoryl compounds (e.g. ATP or PP_^)
to a metal ion-dependent form which, subsequently, could be reactivated
by incubation with Co^+ or Mn^+ but not with Mg^+ (Li (1979)). It was
possible that the phosphoprotein phosphatase was converted to this form
of the enzyme during the purification procedure, particularly during
Additions to CEH Preparation CEH Activity
2+ . -1
Mg DTT Phosphoprotem (pmol oleic acid produced.min .
(mM) (mM) Phosphatase (yg) ^ . -1.r
mg protein )
- - 1458 - 36
1.0 - " 1322 - 88
1.0 1.0 - 1251 - 34
1.0 1.0 7 1318 - 30
5.0 - - 671 - 33
5.0 1.0 - 883 - 24
5.0 1.0 7 1063 - 7
Table 7.4. Effect of DTT on the activity of the multifunctional
phosphoprotein phosphatase when assayed against CEH activity.
2+
The CEH preparation, phosphoprotein phosphatase and Mg were all
as described in the legend to Table 7.3. DTT was in 20 mM Tris-HCl
buffer pH 7.4 at 37°C. The experiment was performed as described
• "J*
in the legend to Table 7.3. Results are expressed as means - S.E.M.
of triplicate assays.
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the preparation of cytosol when pyrophosphoryl compounds would be present.
After this stage, however, there were several dialysis steps that would
remove pyrophosphoryl compounds from the preparation. Furthermore the
. . 32
activity of the enzyme, when assayed against P-labelled phosphohistone
would be low and this was not observed (see Table 7.1 and Fig. 7.3).
Despite this evidence, as there was a possibility of the enzyme existing
in a less active form, samples of the phosphoprotein phosphatase were
incubated for 20 min at 4°C with 0.1 mM Mn^+ and 0.01 mM Co^+.
The studies by Li (1979) had shown that half maximal activation of the
2+
pyrophosphate-mactivated enzyme could be achieved with 80 yM Mn or
2+
5 yM Co . The preincubated phosphoprotein phosphatase/ion mixtures were
then assayed for activity towards CEH activity as in the previous
experiments. In the controls, the CEH preparation was incubated with
2+2+ .
40 yM Mn and 4 yM Co alone. This was the concentration of the ions
in the CEH/phosphoprotein phosphatase incubations.
Table 7.5 shows that incubation of the CEH preparation with 40 yM
2+
Mn had no significant effect on CEH activity, but when the CEH
2+
preparation was incubated with the phosphoprotein phosphatase/Mn
mixture there was a 31% increase in the CEH activity, which was
significant (p<0.02). Similarly, incubation of the CEH preparation
2+ . .
with Co resulted in a slight but not significant increase m CEH
activity (p>0.1) but there was a 47% increase in CEH activity when the
2+
CEH preparation was incubated with the phosphoprotein phosphatase/Co
mixture (p<0.001).
The mechanisms involved in these increases in CEH activity were
2+
unknown. The phosphoprotein phosphatase/Mn result was different to
any obtained in previous experiments. Table 7.3 showed that, at low
2+
concentrations, all the Mn was chelated by the phosphoprotein
phosphatase and so a significant increase in activity was difficult
Additions to CEH Preparation
2+ 2+
Mn Co Phosphoprotem2+ Phosphoprotein2+
Phosphatase/Mn Phosphatase/Co






40 1119 - 14
(7,40) 1406 - 62
1222 - 95
(7,4) 1572 - 12
2+ 2+
Table 7.5. The effect of preincubation with Co and Mn on the
activity of the multifunctional phosphoprotein phosphatase when
assayed against CEH activity. Samples of the purified phosphoprotein
2+ 2+
phosphatase were preincubated with 0.1 mM Mn or 0.01 mM Co for
20 min at 4°C. Mn^+ and Co^+ were the chloride salts in distilled
water. The preincubated phosphoprotein phosphatase/ion mixtures,
and controls of ions alone,were incubated with CEH preparation and
the experiment completed as described in the legend to Table 7.3.
Results are expressed as means - S.E.M. of triplicate assays.
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2+
to explain. No work on the effect of Co on the activity of CEH had
2+
been reported, but it appeared that Co alone may stimulate CEH activity.
2+
How preincubation of Co with phosphoprotein phosphatase could stimulate
this activation was not known.
Another ion that may be involved in metabolic regulation such as
2+
this is Ca . In the study of the 35 000 Mr phosphoprotein phosphatase
2+
from bovine adrenal cortex by Li (1979) , Ca was found to have no effect
on the activity of the enzyme towards phosphohistone and phosphocasein.
In equimolar concentrations it could protect the enzyme from inactivation
by pyrophosphoryl compounds, but could not reactivate the inactivated
form, nor could it serve as an activator for the alkaline phosphatase
.2+
activity. However it was possible that Ca could have an affect on the
activity of the enzyme towards CEH, consequently various concentrations
2+
of Ca were incubated with the CEH preparation in the presence and
2+
absence of phosphoprotein phosphatase. Intracellular Ca concentration
_8 —7
in the cytosol of most mammalian cells is about 10 -10 M, rising to
-"6
about 10 M in 'stimulated cells' (Cheung (1980)). Therefore a series
2+
of Ca concentrations m this range and up to 1 mM was chosen for
this experiment.
2+ -5 . .
Fig. 7.7 shows that Ca up to 10 M had no effect on CEH activity,
2+
but at higher concentrations Ca inhibited CEH. This may be a direct
effect on the CEH enzyme or it may be due to a stimulation of endogenous
phosphoprotein phosphatases. Inclusion of phosphoprotein phosphatase
-5 2+
had no effect up to 10 M Ca , and at higher concentrations it partly
2+
mhibited the Ca -induced reduction, but not significantly.
The results in this section strongly suggest that the multifunctional

















































Fig. 7.7. Effect of Ca on the activity of CEH and the multifunctional
phosphoprotein phosphatase. The CEH preparation and the purified
phosphoprotein phosphatase were as described in the legend to Table 7.3.
2+
Ca was the chloride salt m distilled water. The CEH preparation was
2 "t* 2+
incubated for 15 min at 37 C with either Ca or Ca plus
2+
phosphoprotein phosphatase (10 pg) at the Ca concentrations
r 141indicated. Cholesterol 1- C oleate substrate emulsion was then
added and CEH activity measured as described in the methods section.
Points are means - S.E.M. of triplicate assays.
2+ 2+
——
, Control CEH activity (no additions); O, Ca ; • , Ca plus
phosphoprotein phosphatase.
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7.4 PURIFICATION OF A LOW MOLECULAR WEIGHT PHOSPHOPROTEIN PHOSPHATASE
USING DEACTIVATION OF CEH AS THE ASSAY
It was possible that during the purification of the enzyme, using
32
p-nxtrophenyl phosphate and P-labelled phosphohistone as substrates
to monitor the phosphatase activity, a fraction active against CEH was
discarded. This appeared possible as the results shown in Fig. 7.5
indicate that there was a phosphoprotein phosphatase activity in the
ethanol precipitate that was active against CEH in the presence of low
2+
concentrations of Mg . Therefore the purification was repeated using
CEH deactivation as the assay and pooling the fractions that deactivate
CEH.
The CEH preparation used as the substrate in this assay procedure
P
was the cholate solubilised enzyme after dialysis into buffer D .
2+
Therefore, this preparation contained Mg -stimulated endogenous
P
phosphoprotein phosphatases (Fig. 7.4). The main buffer (buffer A )
used in the phosphoprotein phosphatase purification contained 5 mM
2+
Mg and 1 mM EDTA, thus in an assay incubation with equal volumes of
2+
CEH preparation and column fraction the Mg concentration may be 2 mM.
This may stimulate the endogenous phosphoprotein phosphatases in the
CEH preparation sufficiently to mask any additional deactivation due to
the phosphoprotein phosphatase activity in the column fractions.
2+ P
Therefore the Mg concentration in buffer A was reduced to 2 mM and
2+ . .
EDTA was omitted. The final Mg concentration in the assay incubations
was now 1 mM, which should reduce activation of endogenous phosphoprotein
phosphatases in the CEH preparation to a minimum,and still activate the
phosphoprotein phosphatase present in the ethanol precipitate if this
was required (Fig. 7.5).
The purification was performed as described in Section 7.2 with the
buffer modifications mentioned, except that the column fractions were
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assayed for p-nitrophenyl phosphatase activity and CEH deactivating
activity (see Fig. 7.8).
Fig. 7.8a shows that p-nitrophenyl phosphatase activity eluted
from DEAE-cellulose in 3 peaks, at 0.25 M and 0.35 M potassium chloride
as observed previously (Fig. 7.1a), and a further peak that was not
adsorbed but was eluted just after the main protein peak. This result
had been observed previously, but in this case it was unusually large.
The main peak of CEH deactivating activity was not adsorbed and eluted
between the main protein peak and the unadsorbed p-nitrophenyl-
phosphatase peak. This peak was pooled as indicated in Fig. 7.8a.
A smaller CEH deactivating peak was eluted at 0.28 M potassium chloride,
but this was not pooled in this purification. This was because the second
peak was associated with fractions that had been pooled during the
previous purifications (see Fig. 7.1a). In the later fractions from
this column the CEH activity was also affected by the high salt
concentration.
The pooled material from the DEAE-cellulose step was then applied
(without dialysis) to the DEAE-Sephadex A-50 column equilibrated with
P
the modified buffer A . The column was developed with a linear gradient
p
of potassium chloride (0.05-0.45 M) in modified buffer A . Fig. 7.8b
shows that the p-nitrophenyl phosphatase activity eluted in a broad
peak between the peaks of unadsorbed and adsorbed protein, and was
partly eluted as the gradient was applied. This suggested that the
activity was not fully adsorbed but merely retarded by the gel. No CEH
deactivating activity was detected in the fractions eluted from this
column. It was possible that the phosphoprotein phosphatase was too
dilute when eluted from the column to be detected in this particular
assay. The fractions indicated in Fig. 7.8b were pooled using the
p-nitrophenyl phosphatase activity as a guide, because the CEH deactivating
%ReductionofC ntr lEHActivity
Legend to Fig. 7.8. Purification of a low molecular weight phosphoprotein
phosphatase using deactivation of CEH as an assay.
a) DEAE-cellulose - The column (2.5 x 35 cm) was equilibrated with
P
modified buffer A (see text) and eluted with a linear gradient of
potassium chloride (0.05-0.45 M) in a total volume of 500 ml. The flow
rate was 90 ml.h ^ and fractions of 8.2 ml were collected.
b) DEAE-Sephadex A-50 - The column (2.1 x 25 cm) was equilibrated in
. . P
modified buffer A and eluted with a linear gradient of potassium
chloride (0.05-0.45 M) in a total volume of 600 ml. The column operated
under a pressure of 25 cm 1^0 and fractions of 8.2 ml were collected.
c) Sephadex G-100 - The column (2 x 95 cm) was equilibrated and
P
eluted with buffer C under a pressure of 70 cm H^O and fractions of
5.8 ml were collected.
p-Nitrophenol phosphatase activity was measured as described in the
methods section. CEH deactivating activity was measured by incubating
100 pi column fraction for 10 min at 37°C with 100 pi CEH preparation
P -1
(cholate solubilised enzyme dialysed into buffer D , 1.54 mgml ).
r 141200 pi cholesterol 1- C oleate substrate emulsion was then added
and CEH activity determined as described in the methods section.
a, CEH deactivating activity; • , p-Nitrophenyl phosphatase;
a
, A ; , Potassium chloride concentration; | 1 , Pooled fractions.
ZoU
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activity was associated with this in the DEAE-cellulose step. This
material was concentrated by pressure ultrafiltration (Amicon YM10
membrane ) to about 15 ml and dialysed against 20 mM Tris-HCl buffer
pH 7.4 at 4°C containing 10 mM 2-mercaptoethanol and 50% glycerol,
which resulted in a further concentration to about 6 ml.
The concentrated material was applied to the Sephadex G-100 column
p
equilibrated and eluted with buffer C . Fig. 7.8c shows that no CEH
deactivating activity was detected in the fractions from this column.
A large proportion of the protein applied was eluted in the void volume
but there were 2 peaks of protein that were retarded and the
p-nitrophenyl phosphatase activity was associated with the second of
these. The fractions indicated were pooled and concentrated by
pressure ultrafiltration (Amicon YM10 membrane) but no CEH deactivating
activity was detected in the concentrated sample. SDS/PAGE of the
sample showed a major protein with Mr 20 000, a further protein with
Mr 15 000 and minor components with Mr 35 000 and 18 000 (Fig. 7.9).
There were no reports in the literature of a phosphatase with a
molecular weight as low as 20 000 or 18 000, although Severson and
Sloan (1980) reported a phosphoprotein phosphatase with Mr 28 000,
obtained from rat adipose tissue, that was capable of deactivating HSL
in the presence of divalent cations. It was possible that the alkaline
phosphatase activity (684 pmol p-nitrophenol produced.min ^.mg protein ^)
32
was due to the contaminating 35 000 Mr protein. As no P-labelled
phosphohistone was available at that time, it was not known if this
preparation exhibited phosphoprotein phosphatase activity. However as
the aim of this purification, to purify a CEH deactivating activity,






Fig. 7.9. SDS/PAGE of the low molecular weight phosphoprotein
phosphatase, purified as described in Section 7.4. A sample
(25 pg protein) of the concentrated, pooled fractions from the
Sephadex G-100 chromatography step was subjected to SDS/PAGE
on a 10% gel and stained for protein as described in the methods
section.
The arrows indicate the position on the gel of molecular weight
standards.
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The reason for the loss of activity between the DEAE-cellulose and
DEAE-Sephadex A-50 steps was not known although overnight storage at 4°C
may be responsible (Khandelwal, Vandenheede and Krebs (1976)). It was
possible that there was proteolysis by a contaminating protease.
Proteolysis was known to be a method for the production of low molecular
weight phosphoprotein phosphatases from the high molecular weight forms
(Vandenheede, Yang and Merlevede (1981)). However the 35 000 Mr
protein was known to be resistant to proteolysis (Mellgren, Aylward
et_ al_. (1979) ), suggesting that the 20 000 and 15 000 Mr proteins were
not likely to arise by proteolysis of the 35 000 Mr protein.
The results from all the experiments suggest that the 35 000 Mr
multifunctional phosphoprotein phosphatase was not responsible for the
deactivation of CEH. The 35 000 Mr subunit may require another subunit,
present in the physiological (high molecular weight) form of the
phosphoprotein phosphatase, to gain access to and dephosphorylate an
enzyme of a lipoprotein nature, such as CEH. The amounts of
phosphopholipid or cholate that remained associated with CEH in the
dialysed cholate solubilised enzyme preparation were not known.
However the results in Section 7.4 showed that the CEH deactivating
activity present in the ethanol precipitate was lost during the
subsequent purification steps.
7.5 SUMMARY
1. The low molecular weight (Mr 35 000) multifunctional phosphoprotein
phosphatase was purified from bovine adrenocortical cytosol.
2. This phosphoprotein phosphatase was active when assayed against
32 32 .
P-labelled phosphohistone, P-labelled phosphoCEH preparation and
p-nitrophenyl phosphate. Divalent cations were not required for the
2+
phosphoprotein phosphatase activity but Mg and a thiol were required
for the alkaline phosphatase activity.
138.
3. The 35 000 Mr phosphoprotein phosphatase did not deactivate CEH.
4. Addition of Mg^+, Mn^+, Co^+, Ca^+ or DTT did not stimulate the
phosphoprotein phosphatase to deactivate CEH.
5. During preparation of the 35 000 Mr phosphoprotein phosphatase the
ability to deactivate CEH was lost at a stage after ethanol precipitation.
6. Possible explanations for these observations were discussed.
Page No.
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Cholesterol is the sole precursor for steroidogenesis and is stored
in the adrenal cortex in lipid droplets mainly in the form of long chain
fatty acid esters (Moses, Davis et_ al_. (1969)) . It had been shown that
administration of ACTH to hypophysectomised rats caused a depletion in
the cholesterol ester concentration of the adrenals with a concomitant
increase in the corticosteroid output (Davis and Garren (1966)). Later
it was shown that the activity of CEH could be enhanced by ACTH
administration to intact (Behrman and Greep (1972)) or hypophysectomised
(Shima, Mitsunaga and Nakao (1972)) rats, or by increasing the concentration
of corticotropin in the blood by ether anaesthesia stress (Trzeciak and
Boyd (1973)). It was later established that ACTH caused an increase in
intracellular cAMP which led to the phosphorylation and activation of
cytosolic CEH with subsequent hydrolysis of cholesterol esters in the
lipid droplets and an increase in corticosteroid output (see Boyd and
Gorban (1980)).
It has been shown that ACTH secretion, in all animal species
investigated, exhibits a diurnal variation and that the glucocorticoid
output from the adrenals reflects the variation in ACTH secretion
(Boissin, Nauguier-Soule and Assenmacher (1976)). In a nocturnal animal
such as the rat, ACTH secretion rises during the light, resting phase to
a maximum at the onset of the dark, waking phase, before falling back to
a minimum at the onset of the light phase (Retiene, Zimmerman et al.
(1968)). The serum corticosterone concentration correlates with this,
displaying a similar variation through the light-dark cycle (Retiene,
Zimmerman et al.(1968), Ixart, Szafarczyk et ^1.(1977)). It had also
been shown that adrenal total cholesterol esters undergo a diurnal
variation, with the level falling from the middle of the light phase to
a minimum in the middle of the dark phase before rising to a maximum in
the middle of the light phase (Young and Walker (1978)).
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Despite the known involvement of CEH between ACTH stimulation and
glucocorticoid output (see Figs. 1.1 and 1.3), little work had been
carried out to investigate the variation of CEH activity during a 12 h
light-12 h dark period. Previous work had shown that the activity of
3-hydroxy-3-methylglutary1 coenzyme A reductase, the enzyme that
regulates cholesterol biosynthesis, varies diurnally in the adrenal
gland (Balasubramaniam, Goldstein and Brown (1977)). However, Pederson
and Brownie (1979) measured CEH activity in rat adrenals at two time
points, 10 h apart, but found no difference in the enzyme activity.
The experiments described in this section were performed to
investigate the activity of adrenal cytosolic CEH throughout a 24 h
period in rats adapted to a 12 h light-12 h dark cycle, to discover if
there was a diurnal variation in the enzyme activity. The serum
corticosterone concentration was also measured in these experiments.
The effects of acute administration of ACTH and corticoid treatment were
investigated to assess the role of ACTH in the production and maintenance
of any enzyme variation.
8.2 DIURNAL VARIATION IN CYTOSOLIC CEH ACTIVITY IN THE RAT ADRENAL
Adrenal cytosolic CEH activity over a 24 h period was measured in
rats. The animals were kept in a 12 h dark-12 h light cycle and groups
were killed at intervals of 6 h as described in the methods section.
The adrenals were collected, tissue cytosol prepared and CEH activity
measured as described in the methods section. Trunk blood was also
collected for serum corticosterone measurements as described in the
methods section.
The results in Fig. 8.1 showed that rat adrenal CEH exhibited a
diurnal variation in activity with the peak occurring during the dark
phase. The serum corticosterone concentration showed a similar variation,














































Fig. 8.1. Diurnal variation in rat adrenal cytosolic CEH activity and
serum corticosterone concentration. Rats adapted to a 12 h light- 12 h
dark cycle (as indicated) were killed at 6 h intervals. Blood was
collected for serum corticosterone assays (•) and tissue cytosol was
prepared from the adrenals for CEH activity measurements (O).
Details of the experiment are given in the methods section. For CEH
activity the points are means - S.E.M. for 18 assays. For serum
. . .4*
corticosterone the points are mean values obtained from 6 rats - S.E.M.
77m , Dark phase.
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the values obtained during the dark phase and the values obtained during
the light phase were highly significant (p<0.001) for both CEH activity
and serum corticosterone. However there was no significant difference
between the two measurements made during the dark phase at 10.00 h and
16.00 h for the CEH activity or serum corticosterone.
In a series of four experiments this rhythmic variation was
observed on each occasion (Table 8.1). For the CEH activity figures
all the differences between the values obtained during the dark phase
and the values obtained during the light phase were highly significant
(p<0.001, except for experiment 3 10.00 h-04.00 h, p<0.05). In all but
one instance the values obtained during the light phase were lower than
those during the dark phase. The exception to this was the figure
obtained at 22.00 h in experiment 2. This was exceptionally high, and
considerably higher than any other activity obtained during these
experiments. The reason for this was not known but it was possible
that this group of animals were stressed in some way, prior to killing.
However, the serum corticosterone concentrations for this experiment do
not support this theory, as the value obtained at 22.00 h was very much
lower than the values obtained during the dark phase and not significantly
different to the value obtained at 04.00 h during the light phase.
As all the values obtained in this experiment were higher than in the
other three experiments, it was possible that substrate variation was
responsible for the differences observed in this experiment.
Despite this one opposing figure, the results show a clear diurnal
variation for CEH activity, with the enzyme significantly more active in
the dark phase. On two occasions (experiments 1 and 4) there was no
significant difference between the two values for CEH activity obtained
during the dark phase. In the other two experiments the enzyme activity
was higher in the early part of the dark phase in one experiment and
A. CEH Activity (pmol oleic acid produced .min ^.mg protein -1)
Expt No. of Time (h)
rats
04.00 10.00 16.00 22 .00
1 24 604 - 4 668 - 3 664 - 3 499 ± 4
2 24 896 - 2 986 - 10 1055 - 9 1229 i 5
3 24 525 -6 542 - 4 574 - 5 518 i 5
4 12 569 - 3 652-5 641 - 12 542 i 6
r/////////// /I
B. Serum Corticosterone (pg/100 ml)
Expt No. of Time (h)
rats
04.00 10.00 16.00 22 00
1 24 8.0 - 1.5 47.3 - 4.3 53.1 - 6.4 7.1 - 4.6
2 24 16.4 - 6.2 68.1 - 10.1 53.3 - 3.0 16.7 - 5.0
3 24 56.1 - 2.2 87.5 - 2.5 82.1 - 9.5 29.7 i 5.8
4 12 7.7 - 2.4 20.3 - 5.7 15.6 - 3.6 16.4 - 4.2
Ezzzzzzzzzzzza
Table 8.1. Diurnal variation in rat adrenal cytosolic CEH activity
and serum corticosterone concentration. The experiment was performed
and the results expressed as described in the legend to Fig. 8.1.
YZZZ1 indicates results obtained during dark phase.
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higher in the later part of the dark phase in the other. Apart from the
one exception discussed previously, the enzyme activity was higher in
the late part of the light phase, prior to the onset of the dark phase.
Overall these results suggest that the enzyme activity was at a minimum
in the early part of the light phase rising during the later part of the
light phase to a maximum in the dark phase.
The serum corticosterone followed a similar pattern of variation,
with the concentrations obtained during the dark phase significantly
higher compared with those obtained during the light phase, for the
first three experiments (p<0.001, except experiment 3 16.00 h-04.00 h
p<0.05). Due to the unusually low corticosterone concentrations during
the dark phase in experiment 4, the differences between the concentrations
in the dark and light phases were not statistically significant.
As was generally found with the CEH activity, there was no significant
difference between the levels of corticosterone measured during the
dark phase for each experiment. The results suggested that the
concentration of corticosterone in the blood was at a minimum in the
early part of the light phase, rising to a peak concentration throughout
the middle of the dark phase.
It was known that ACTH exhibited a diurnal variation in rats
(Ixart, Szafarczyk _et_ a_l (1977)). From a minimum at the beginning of
the light phase, it rose throughout this phase to a maximum at the
onset of the dark phase and slowly fell throughout this phase back to a
minimum at the beginning of the light phase. The results obtained here
(see Fig. 8.1) show that CEH activity and serum corticosterone concentration
reflect this variation in ACTH secretion. The CEH activity rose,
in response to the increasing ACTH concentration, from a minimum at the
beginning of the light phase to a maximum at the onset of the dark phase.
Although the ACTH concentration falls during the dark phase there will
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still be a concentration great enough to maintain CEH activity at a high
level through much of the dark phase. The slight lack of correlation
may be due to the spare ACTH receptors (Mcllhinney and Schulster (1975))
with only 3% occupancy required for full steroidogenesis (Buckley and
Ramachandran (1981)), and also excess cAMP is produced in stimulated
cells (Podesta, Milani et_ al_. (1979a)) . However, as the ACTH concentration
reaches a minimum at the onset of the light phase, the CEH activity also
falls to a minimum at the beginning of the light phase. The serum
corticosterone concentration reflects this variation in CEH activity
and a similar pattern was observed. However there was not a sufficient
number of data points in this experiment to indicate whether the
corticosterone concentration lags slightly behind the CEH activity.
8.3 THE EFFECT OF CORTICOID ADMINISTRATION ON THE DIURNAL VARIATION OF
CYTOSOLIC CEH ACTIVITY IN RAT ADRENAL
In Addison's disease, in which Cortisol secretion is decreased and
the plasma steroid levels are depressed, the concentration of ACTH
circulating is found to be elevated (Liddle, Island and Meador (1962)).
Furthermore, acute administration of Cortisol produces a rapid decline
in plasma ACTH concentration in man (Besser, Cullen et al. (1971)).
It was concluded that the secretion of ACTH was under negative feedback
regulation by the level of circulating corticoid (see James (1975)).
This phenomenon is now used widely to suppress pituitary ACTH production,
both in medicine (before surgery) and in biochemical research (see
James (1975), McEwan (1979)). In this study two corticoid derivatives,
prednisolone and dexamethasone, were used in an attempt to suppress
pituitary ACTH secretion.
8.3.1 Prednisolone
Prednisolone (1-dehydrocortisol) has the structure shown in Fig. 8.2.
It is similar to the main corticoid produced by rats, corticosterone,











Fig. 8.2. Structure of prednisolone, dexamethazone and corticosterone.
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Rats, adapted to a 12 h light-12 h dark cycle, received subcutaneous
injections of 500 yg prednisolone in propylene glycol (200 yl) at 72 h
and 24 h before sacrifice. Control animals received 200 yl of propylene
glycol alone. The rats were killed, trunk blood and adrenals collected;
serum corticosterone concentration and CEH activity in the adrenal cytosol
measured, all as described in the methods section.
The results in Fig. 3.3a showed that acute prednisolone administration
had only limited effect on the CEH activity in rat adrenal. At all four
time points the prednisolone treated animals had lower CEH activities,
but the differences were only significant at two of these points (10.00 h
and 22.00 h, p<0.001). Furthermore, the pattern of diurnal variation
was different to the pattern observed in the previous experiments
(see Fig. 8.1 and Table 8.1). In this experiment the two highest
activities, which were not significantly different from each other in
either the control or prednisolone-treated animals, were at the end of
the light phase and the beginning of the dark phase. Although this
pattern would correlate with the known pattern of ACTH secretion as
well as, or better than, the pattern found previously, it was unclear
why there was an apparent shift in the peak activity.
The serum corticosterone concentrations do not resolve this problem
(Fig. 8.3b). The pattern observed with the control group was similar to
the pattern found in Section 8.2, but the pattern observed with the
prednisolone-treated group was similar to that obtained with CEH activity
in this experiment. However due to the large errors and low sample
numbers, none of the differences in the control group were statistically
significant and only two of the differences in the prednisolone-treated
group were statistically significant (10.00 h-22.00 h, p<0.01 and 10.00 h-
16.00 h, p<0.05). Furthermore, as with the CEH activity, the differences
in serum corticosterone concentration between the control group and
Fig. 8.3. Effect of prednisolone administration on diurnal
variation of rat adrenal cytosolic CEH activity and serum corticosterone
concentration. Rats were kept on a 12 h light-12 h dark cycle for
2 weeks. Half the rats were injected with prednisolone in propylene
glycol, and the control animals received only popylene glycol.
Details of the experiment are given in the text.
a, CEH activity I O, propylene glycol;
b, Serum corticosterone concentration J •, prednisolone.
For CEH activity the points are means - S.E.M. from 12 assays.
For corticosterone concentrations the points are the mean values
obtained from 3 rats - S.E.M.
mm, Dark phase.
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the prednisolone-treated group were only significant at two time points
(04.00 h and 22.00 h). However, at 04.00 h the serum corticosterone
concentration was higher in the prednisolone-treated group than in the
control group.
These results indicated that prednisolone treatment did have some
effect in lowering both CEH activity and serum corticosterone concentration,
apart from the exception noted above. However, at the doses used in
this experiment, the corticoid-induced suppression was not sufficient to
significantly alter the pattern or degree of diurnal variation observed
with CEH activity in rat adrenal cytosol.
8.3.2 Dexamethasone
The structure of dexamethasone is shown in Fig. 8.2. Similar to
prednisolone it has an extra double bond at position 1 and the 17a hydroxyl
group, but in addition it also contains a fluorine at position 9 and a
16a methyl group.
Rats were adapted to a 12 h light-12 h dark cycle as described in
the methods section. Half the animals received subcutaneous injections
of 500 yg dexamethasone in 200 yl saline at 72 h and 24 h before sacrifice.
The control group received 200 yl of saline alone. The animals were
killed, trunk blood and adrenals collected; serum corticosterone
concentration and CEH activity in the cytosol measured, all as described
in the methods section.
Fig. 8.4a shows that acute dexamethasone treatment substantially
reduced the CEH activity at all points in the 24 h cycle. All the
activities for the control group were significantly different to each
other as were all the points in the dexamethasone-treated group (p<0.001).
Furthermore, all the activities in the dexamethasone-treated group were
significantly lower than the corresponding activities in the control

































































Fig. 8.4. Effect of dexamethasone administration on the diurnal
variation of rat adrenal cytosolic CEH activity and serum corticosterone
concentration. Rats, adapted to a 12 h dark-12 h light cycle, received
subcutaneous injections of either dexamethasone in saline or saline alone.
Details of the experiment are given in the text. The results are
expressed as described in the legend to Fig. 8.3.
zzzzx , Dark phase.
a, CEH activity I O, saline;
b, serum corticosterone concentration j •, dexamethasone.
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of on average 31%. The pattern of diurnal variation was not altered
greatly, although the peak activity was shifted from the beginning of
the dark phase in the control group to later in the dark phase in the
dexamethasone-treated group. Considering the variation observed in
Section 8.2 in this respect, this probably does not constitute a major
difference.
The degree of variation between the highest and lowest activities
was 34% and 37% in the control and dexamethasone-treated groups,
respectively. However as the activity was higher in the control group
the variation in absolute activity was greater in the control group
(253 pmol oleic acid produced.min ^.mg protein "") compared to the
dexamethasone-treated group (183 pmol oleic acid produced.min ''".mg
protein . The results showed that dexamethasone treatment did affect
CEH activity in the rat adrenal.
The serum corticosterone concentration results showed almost total
suppression of corticosterone output in the dexamethasone-treated group
(Fig. 8.4b). The pattern of diurnal variation was the same as observed
in Section 8.2, although due to the small sample size and the large
errors, none of the concentrations in either the control group or in the
dexamethasone-treated group were statistically significantly different
from each other. However all the values obtained in the dexamethasone
group were much lower than the corresponding values in the control group,
although due to the spread of results in the control group at the two time
points during the light phase, the difference there was not statistically
significant. It was clear that dexamethasone had had an effect, as only
low levels of corticosterone were found in the treated animals. Even at
these low serum corticosterone concentrations, a slight diurnal
variation was observed.
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Taking the CEH activity and serum corticosterone concentration
results together, there appeared to be a contradiction. Although CEH
activity was significantly reduced, the enzyme was still reasonably active
at all time points and so the almost complete suppression of corticosterone
output cannot be explained simply in terms of CEH activity. This was
expected as ACTH affects the steroidogenic pathway at a number of points
other than CEH. For instance ACTH affects protein synthesis and
stimulates cholesterol side chain cleavage, probably via increased
transport or binding of cholesterol to the cytochrome P-450gcc rather
than an intrinsic effect on the enzyme activities (see Tait, Tait and Bell
(1980)). Therefore suppression of ACTH will also affect the steroidogenic
pathway at these points after the CEH step.
Furthermore the net flux of free cholesterol in adrenocortical
cells will be determined by the relative activities of CEH and acylcoenzyme
A:cholesterol acyl transferase (ACAT), the microsomal enzyme catalysing
the formation of cholesterol ester from free cholesterol and acylcoenzyme A
(see Fig. 1.1). It has been shown that stored cholesterol esters in
macrophage foam cells are constantly in a cycle of hydrolysis and
re-esterification (Brown, Ho and Goldstein (1980)). Net hydrolysis in
these cells was obtained by a reduction in the rate of ACAT-mediated
esterification and not an increase in hydrolysis. Very little information
was available on the regulation of microsomal ACAT activity in the
adrenal gland. However it was probable that the cholesterol esters in
adrenal cortex were in a dynamic equilibrium situation, undergoing a
continuous cycle of hydrolysis and re-esterification. Therefore net flux
of free cholesterol could be achieved by alteration of either CEH or
ACAT activity. Therefore when CEH activity was reduced in the corticoid-
induced ACTH-suppressed animals, the ACAT activity may now predominate
and so the net effect of the cholesterol substrate cycling would be
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towards esterification. Such a situation would lead to an even greater
effect on corticosteroid secretion (see Fig. 1.1).
Therefore the results obtained with dexamethasone treatment
supported the theory that adrenal cytosolic CEH activity was responding
in vivo to changes in secreted ACTH levels.
8.4 THE EFFECT OF ACUTE ACTH ADMINISTRATION ON THE DIURNAL VARIATION
OF CYTOSOLIC CEH ACTIVITY IN RAT ADRENAL
Section 8.2 showed that cytosolic CEH activity in the rat adrenal
varied diurnally in a pattern reflecting the known diurnal variation in
ACTH secretion in the rat (Ixart, Szafarczyk eit al_. (1977)). The use of
dexamethasone to suppress pituitary ACTH secretion gave a corresponding
decrease in CEH activity and corticosterone secretion and supported the
view that CEH varied in vivo in response to plasma ACTH levels
(Section 8.3.2). In this section the effect of acute ACTH administration
to rats before sacrifice was investigated, to further elucidate the
relationship between ACTH and CEH in vivo.
Rats were adapted to a 12 h light-12 h dark cycle as described in
the methods section. Half the animals received subcutaneous injections
of ACTH in 0.2 ml saline, 30 min before sacrifice. The control group
received 0.2 ml saline alone. The animals were killed, trunk blood and
adrenals collected; serum corticosterone concentration and CEH activity
in the cytosol measured, all as described in the methods section.
The results in Fig. 8 .5a show that ACTH administration in vivo
resulted in a significant increase in CEH activity at all points in the
light-dark cycle. The increase was about 30% at both points during the
dark phase and 13% and 68% at the early and late points in the light
phase,respectively. The diurnal variation observed in the control group
was not the pattern commonly obtained but was similar to a pattern





























































Fig. 8.5. Effect of acute ACTH administration on the diurnal variation
of rat adrenal cytosolic CEH activity and serum corticosterone
concentration. Rats, adapted to a 12 h dark-12 h light cycle,
received subcutaneous injections of either ACTH or saline, 30 min
before sacrifice. Details of the experiment are given in the text.
The results are expressed as described in the legend to Fig. 8.3.
P777] Dark phase.
a, CEH activity
. L 0 , saline; •, ACTH.
b, Serum corticosterone concentration j
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substantially reduced the variation observed and there was no significant
difference between the CEH activities measured at 04.00 h, 16.00 h and
22.00 h.
ACTH treatment increased the serum corticosterone concentration at
all points in the light-dark cycle, although the difference between ACTH
treatment and the control at 10.00 h was not statistically significant
(Fig. 8.5b). As observed with the CEH activities, the diurnal variation
observed in the control group was not the pattern commonly obtained but
again was similar to a pattern obtained once before (see experiment 4,
Table 8.1b). ACTH treatment almost totally abolished the pattern of
diurnal variation and there was no significant difference between the
serum corticosterone concentrations at any of the time points after ACTH
administration. These results indicated that the normal diurnal variation
in rat adrenal cytosolic CEH activity and serum corticosterone could be
abolished by acute ACTH administration. This supported the view that
rat adrenal cytosolic CEH activity varied in vivo in response to changes
in blood ACTH concentration.
8.5 SUMMARY
1. CEH activity in the rat adrenal cytosol was found to vary diurnally
in a pattern reflecting the known diurnal variation of ACTH secretion.
2. The serum corticosterone concentration closely paralleled the
variation in adrenal cytosolic CEH activity.
3. Prednisolone in propylene glycol was relatively ineffective, at the
doses used, in suppressing either the activity of CEH or the serum
corticosterone concentration.
4. Dexamethasone was effective in reducing serum corticosterone
concentration to low levels, and substantially lowering CEH activity.
5. The normal pattern of diurnal variation was still observed in the
corticoid suppressed animals.
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6. Acute ACTH administration almost totally abolished the normal
pattern of diurnal variation in both rat adrenal cytosolic CEH activity
and serum corticosterone concentration.
7. The results supported the view that cytosolic CEH activity in rat
adrenal varied in vivo in response to changes in ACTH concentration in
the blood.
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The substrates for CEH are long chain fatty acid esters of cholesterol .
In the adrenal cortex, cholesterol esters are stored in large lipid
droplets found in the cytoplasm (Garren, Gill £££^.(1971)). The lipid
droplets contain 70-80% of the total adrenal cholesterol and about 80-90%
of this cholesterol was found to be esterified to long chain unsaturated
fatty acids (Moses, Davis et_ al_. (1969) , Goodman (1965), Beckett and Boyd
(1975)). It was known that when animals were subjected to stressful
situations, or when ACTH was administered,there was a reduction in the
cholesterol ester content of the adrenal cortex (Sayers, Sayers et al.
(1944), Davis and Garren (1966)). It was found that ether anaesthesia
stress, which increases the ACTH concentration in the blood, caused an
increase in the activity of cytosolic CEH and depletion of lipid droplet
cholesterol esters (Trzeciak and Boyd (1973)). These experiments
established cholesterol esters in the lipid droplets as the substrate
for cytosolic CEH in vivo.
It had been shown that dietary factors which alter the fatty acid
composition in the lipid droplet cholesterol esters could have effects
on the activity of cytosolic CEH (Beckett and Boyd (1975), Vahouny,
Hodges and Treadwell (1979)). There have been further studies on the
lipid composition of the lipid droplets in ovarian tissue (Armstrong
and Flint (1973)) and rat adrenals (Mrotek, Mathew et_ al_. (1981)) under
different conditions, and on the use of rat adrenal lipid droplets as
substrate for the cholesterol side chain cleavage reaction by ACTH-
stimulated mitochondria (Farese, Prudente and Chuang (1980)). However,
adrenal lipid droplets contain about 2% by weight of protein, but little
work had been performed to investigate this protein component (Boyd and
Trzeciak (1973)).
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The adrenal lipid droplets have similar physical and chemical
properties to the well characterised plasma lipoproteins (reviewed
Scanu and Landsberger (1980), Chapman (1980), Levy (1981)). The
apoproteins of the lipoproteins have been shown to be more than
structural components and many have metabolic functions such as binding
to cellular receptors (apolipoproteins B and E), transfer of lipid
components (apolipoprotein D) and activation of lipid metabolising
enzymes such as lipoprotein lipase (apolipoprotein C-II) and lecithin:
cholesterol acyl transferase (apolipoprotein A-I) (see Owen and Mclntyre
(1982)). Considering the knowledge obtained from the study of the
apoprotein moiety of plasma lipoproteins it was surprising that there
had been no investigation of the protein component of adrenal lipid
droplets.
The aim of this work was to investigate the protein components of
isolated rat adrenal and bovine adrenocortical lipid droplets to obtain
information about their nature and properties. Their relationship to
cytosolic CEH was investigated and some preliminary experiments studying
the effect of bovine adrenocortical lipid droplets on bovine cytosolic
CEH activity were performed to determine if the apoproteins had any
metabolic function, other than a structural role.
9.2 INVESTIGATION OF THE PROTEINS ASSOCIATED WITH RAT ADRENAL AND
BOVINE ADRENOCORTICAL LIPID DROPLETS BY SDS/PAGE
Rat adrenal and bovine adrenocortical lipid droplets were isolated
and washed as described in the methods section. Two different methods
were used to delipidate the lipid droplets before investigation of the
proteins by SDS/PAGE. The first method was based upon the methods of
Scanu, Lewis and Bumpus (1958) devised for the delipidation of plasma
lipoproteins. The protein fraction obtained by this method was termed
apoACLD (apoadrenocortical lipid droplets). The second method was
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devised for the rapid delipidation and preparation of the lipid droplet
proteins specifically for SDS/PAGE.
9.2.1 Delipidation of lipid droplets by treatment with ethanol/ether
Lipid droplets (3 ml rat and 5 ml bovine) had 10 volumes of ice-cold
ethanol/diethyl ether (1:4, v/v) added to them and were left for 2 h at
0°C. The layers were separated by the addition of volume of distilled
water. The aqueous layer was re-extracted with ethanol/diethyl ether
(1:4, v/v) and the re-extracted aqueous layer was lyophilised. The freeze-
dried apoACLD fractions wer« dissolved in a small volume of 6 M urea/
1 mM EDTA and dialysed against 5 mM potassium phosphate buffer pH 7.4
overnight to remove the urea. Samples of the apoACLD solutions were
prepared and subjected to SDS/PAGE as described in the methods section.
Fig. 9.1 shows that little protein was present in the apoACLD
preparations. However a similar protein pattern was observed in rat and
bovine apoACLD. The major protein had Mr about 40 000 and there were
other proteins with Mr 65 000, 53 000 and 12 000. Although these
proteins had molecular weights similar to some of the standards used they
were not due to cross-contamination as bands corresponding to the other
molecular weight markers used (125 000, 92 000, 23 500) were not observed.
The Mr 65 000 and 53 000 proteins were more prominent in bovine apoACLD,
whereas the Mr 12 000 protein was more prominent in rat apoACLD.
These results suggested that 4 major proteins or protein subunits were
associated with adrenal lipid droplets and that the proteins were similar
in rat and bovine tissue.
9.2.2 Delipidation of lipid droplets by treatment with acetone
The method described in Section 9.2.1 was long and tedious.
Furthermore in future experiments (see Section 9.3) whole, non-delipidated
32 T 32 1
lipid droplets were labelled with P using y- P ATP. It would be









Fig. 9.1. SDS/PAGE of rat and bovine apoACLD.'delipidated by treatment
with ethanol:diethyl ether. Rat adrenal and bovine adrenocortical
lipid droplets were delipidated by ethanol:ether extraction as described
in the text. Samples of the apoACLD's (corresponding to approximately
2 ml lipid droplets) were prepared and subjected to SDS/PAGE on a 10%
gel and stained for protein as described in the methods section,
a, Rat apoACLD; b, Bovine apoACLD.
The arrows indicate the positions on the gel of molecular weight standards
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when handling material labelled with P. Therefore it was decided to
use a modification of the method used for the preparation of protein
samples for SDS/PAGE (see methods section) in these experiments.
The method adopted is described below.
Washed rat and bovine lipid droplets had ice-cold 50% (w/v) TCA
added to them up to a final concentration of 20% (w/v) TCA. The samples
were mixed and left for 10 min at 0°C, before centrifugation at 1000 x g
for 10 min. After centrifugation there was, occasionally, some
precipitated material but most of the lipid droplets were found in a
distinct, floating layer. The infranatant was carefully poured away
leaving the lipid droplet layer attached to the side of the tube.
The concentrated lipid droplets were delipidated by the addition of
5 ml ice-cold acetone. After mixing, the tubes were centrifuged at
1000 x g for 5 min and the acetone carefully removed by aspiration.
The protein pellet was washed with a further 2 ml ice-cold acetone,
and then dried by vacuum desiccation. The protein pellets were
dissolved in 50 pi 8 M urea/10% (w/v) SDS and 15 pi dissociation
buffer (see methods section), boiled for 5 min and subjected to SDS/PAGE
as described in the methods section.
Fig. 9.2 shows that this method of delipidation had a greatly
improved recovery over the first method. The results show that the
Mr 40 000 protein or subunit was the major protein component of adrenal
lipid droplets in both rat and bovine tissue. However there were
many other proteins associated with the lipid droplets. With bovine
lipid droplets further protein bands were observed at Mr >200 000,
140 000, 90 000, 75 000, 53 000, 47 000, 31 000, 28 000, 21 000, 20 000,
14 000 and 12 000. Most of these proteins were also observed with rat
lipid droplets, and no major differences between the two species were
apparent. Of the proteins found after delipidation by ethanol/ether
a b c
Fig. 9.2. SDS/PAGE of rat adrenal and bovine adrenocortical lipid
droplet proteins^delipidated with acetone. The lipid droplets were
delipidated with acetone as described in the text, and the delipidated
proteins subjected to SDS/PAGE on a 10% gel and stained for protein as
described in the methods section.
a, Delipidated rat lipid droplets (2 ml); b, Delipidated bovine lipid
droplets (3.5 ml); c, Delipidated bovine lipid droplets (1 ml).
The arrows indicate the positions on the gel of molecular weight standards.
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only the Mr 65 000 protein was now no longer apparent. With the
exception of the Mr 40 000 protein, none of the other proteins were
major proteins.
These results show that both bovine and rat lipid droplets have an
apoprotein with a major subunit of Mr 40 000. Several minor proteins
with a wide range of molecular weights can be observed, and the pattern
was essentially the same in both species. Delipidation of the lipid
droplets by ethanol/ether as described in Section 9.2.1 resulted in the
loss of most of the minor proteins, but the Mr 40 000 apoprotein remained
along with 3 other proteins. Where the major losses occur, during this
delipidation procedure, was not clear as losses will occur during the
extraction and also at the resolubilisation stage. Even in 6 M urea it
was not possible to resolubilise all the particulate material remaining
after lyophilisation. Therefore the proteins observed in Fig. 9.1 may
represent the proteins that were most readily solubilised after the
delipidation procedure.
A major objective in this study of lipid droplets was to determine
if CEH was one of the proteins detected on the substrate. The results
presented in Section 6 suggested that CEH activity was associated with
a protein of Mr 82 000-84 000. The results here show that no major
protein with that molecular weight was detected in the lipid droplets.
This could be due to the low concentration of CEH in adrenal cytosol.
Even in enzymically active preparations it was not possible to detect
the CEH enzyme protein in the 150-fold purified CEH^ preparation when
the gels were stained for protein.
9.3 32P-LABELLING OF RAT ADRENAL AND BOVINE ADRENOCORTICAL LIPID
DROPLET PROTEINS USING
32
■Y~ P J ATP
32 r 32 ]
Labelling of the CEH^ preparation with P using y- P J ATP
was used, with some success, to identify the CEH enzyme protein
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(see Section 6.3). This method was now used in an attempt to label the
proteins associated with the lipid droplets to determine if CEH was one
of the components of the protein fraction. In these experiments, both
apoACLD and whole non-delipidated lipid droplets were used.
9.3.1 ApoACLD
The apoACLD fractions from rat adrenal and bovine adrenocortical
lipid droplets were prepared as described in Section 9.2.1. The apoACLD
r 32 1
m 5 mM potassium phosphate buffer pH 7.4 were incubated with y- P ATP
2+ .
and Mg in the presence of the catalytic subunit of cAMP-dependent
protein kinase as described in the legend to Fig. 9.3. The phosphorylated
proteins were prepared and subjected to SDS/PAGE and autoradiography as
described in the methods section.
With rat apoACLD there were five phosphorylated proteins with
Mr 94 000, 65 000, 53 000, 40 000 and 34 000 but with bovine apoACLD
only the proteins with Mr 65 000, 53 000 and 40 000 were phosphorylated
(Fig. 9.3). In both cases the Mr 40 000 protein was the major phosphorylated
protein, and in general the phosphorylation pattern reflected the
pattern observed when the gels were stained for protein (Fig. 9.1).
However the Mr 94 000 and 34 000 proteins were not detected by protein
staining and the Mr 12 000 protein observed in Fig. 9.1 was not
phosphorylated. The fact that the Mr 65 000 and 53 000 proteins were
phosphorylated confirmed that these proteins were not due to cross-
contamination from the molecular weight standards. Fig. 9.3 also
shows that there was a substantial amount of material remaining on top
of the stacking and separating gels suggesting that solubilisation of
the material in the dissociation buffer was incomplete.
9.3.2. Whole lipid droplets
The process of delipidation with ethanol/ether, lyophilisation and
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32
Fig. 9.3. P-labelling of rat and bovine apoACLD. Rat (3 ml) and
bovj^e (5 ml) apoACLD were incubate^ for 30 min at 37 C with 0.1 mM£y- p] ATP (50 pCi, 1100 cpm.pmol ), 0.5 mM magnesium chloride and
the catalytic subunit of cAMP-dependent protein kinase (100 units).
The reaction was terminated by the addition of ice-cold 50% (w/v) TCA
and the precipitated proteins subjected to SDS/PAGE on a 10% gel and
autoradiography as described in the methods section. Autoradiograph
after a, 18 h exposure and b, 18 h exposure with presensitised film
and intensifying screen.
The arrows indicate the positions on the gel of molecular weight
standards. The gel stained for protein is shown in Fig. 9.1.
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possibly resulting in some unfolding of the tertiary structure. This
may have led to the exposure of possible phosphorylation sites not
normally accessible to cAMP-dependent protein kinase _in vivo.
Furthermore that method of delipidation led to great losses in the
minor components of the protein fraction (Figs. 9.1 and 9.2). For these
reasons it was decided to label whole, non-delipidated lipid droplets.
Rat adrenal and bovine adrenocortical lipid droplets were incubated
r 321 .with I y- P ATP as described in the legend to Fig. 9.3 and the
phosphorylated proteins subjected to SDS/PAGE and autoradiography as
described in the methods section. A major difference between rat and
bovine lipid droplets was discovered in this experiment. Whereas the
major apoprotein of Mr 40 000 was phosphorylated in rat lipid droplets
it was not phosphorylated in bovine lipid droplets (Fig. 9.4).
This suggests that in bovine lipid droplets the cAMP-dependent protein
kinase phosphorylation site(s) in the Mr 40 000 apoprotein were not
accessible to the catalytic subunit. It was possible that the protein
had a slightly different tertiary structure in whole lipid droplets,
or that the site(s) were blocked by another closely associated protein
or subunit, or by lipids. Another explanation may be that the protein
was already phosphorylated when the lipid droplets were isolated.
If the former explanation for the non-phosphorylation is correct,
the results in Fig. 9.3 show that when the proteins were delipidated
the phosphorylation site(s) were no longer hidden in the tertiary
structure or blocked, and the protein was phosphorylated.
Other phosphorylated proteins in the rat lipid droplets had
Mr 53 000 and 37 000 with a few minor phosphorylated proteins with
Mr 26 000, 15 000 and 14 000. In bovine lipid droplets the proteins
with Mr 53 000 and 37 000 were phosphorylated, although the Mr 37 000
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Fig. 9.4. P-labellmg of whole, non-delipidated rat and bovine
lipid droplets. Rat adrenal (2 ml) and bovine adrenocortical (3.5 ml)
r 32 1
lipid droplets were incubated with y- P ATP as described in the
legend to Fig. 9.3. The reaction was terminated by the addition of
ice-cold 50% (w/v) TCA and the proteins subjected to SDS/PAGE on a
10% gel (see Section 9.2.2) and autoradiography. Autoradiograph
after a, 18 h exposure and b, 18 h exposure with presensitised film
and intensifying screen.
The arrows indicate the positions on the gel of molecular weight
markers. The gel stained for protein is shown in Fig. 9.2.
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apoprotein (see Fig. 9.2). There were several other minor phosphorylated
proteins with molecular weights in the 100 000-60 000 and 20 000-12 000
range. In both cases there was some material that did not enter the gel.
No major protein with Mr 82 000-84 000 was phosphorylated in rat
lipid droplets, but there was some phosphorylation at this region in
bovine lipid droplets although it was a minor component. Therefore the
results suggest that CEH was not a major protein associated with lipid
droplets, when isolated as described in the methods section.
9.4 G-,3-3H JDFP-LABELLING OF BOVINE ADRENOCORTICAL LIPID DROPLET PROTEINS
had provided evidence for the identification of the CEH enzyme protein
(see Section 6.4). This method was now used to further investigate the
proteins associated with bovine adrenocortical lipid droplets. As in
32
the P-labelling studies, both apoACLD and whole non-delipidated lipid
droplets were studied.
9.4.1 ApoACLD
Bovine apoACLD were incubated with 30 qM |\,3-^hJ DFP as described
in the legend to Fig. 9.5. The labelled material was split into two
portions and subjected to SDS/PAGE as described in the methods section.
3
H-incorporation was determined by fluorography/autoradiography or by
liquid scintillation counting after elution of the protein from the
excised gel slices by NCS tissue solubiliser (see methods section).
On this occasion the Mr 40 000 apoprotein was hardly visible on
the gel after staining for protein and soaking in 1 M sodium salicylate
(Fig. 9.5a). The Mr 65 000 protein was the only major band with minor bands
3
at about Mr 53 000 and 20 000. No labelling of protein by H was
detected by fluorography (Fig. 9.5b).
3
Determination of the H incorporation after gel slicing and NCS








Fig. 9.5. [l,3-3H ] DFP-labelling of bovine apoACLD; Fluorography.r n[l,3-3Hj DFPBovine apoACLD (100 pg protein) were incubated with 30 uM
(6 Ci.mmol for 30 min at 37°G. The reaction was terminated by the
addition of an equal volume of ice-cold 25% (w/v) TCA. The precipitated
protein was subjected to SDS/PAGE on a 6-12% exponential gradient gel
and fluorography as described in the methods section,
a, Protein stain; b, Autoradiograph/Fluorograph.
The arrows indicate the position on the gel of molecular weight standards.
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incorporation into the Mr 65 000 protein and a low molecular weight
protein (Mr 13 000), but the peaks at Mr 47 000 and 40 000 consisted of
only one point and so were not significant (Fig. 9.6).
9.4.2 Whole lipid droplets
Agents such as DFP, label proteins at 'active-site' or 'essential'
serines where the reactivity of the serine residue is increased due to
its environment in the tertiary structure of the protein molecule
(Sigman and Mooser (1975)).
As noted in Section 9.3.2, the delipidation procedure may alter
the tertiary structure of the protein molecules. Whereas this may lead
to increased phosphorylation due to the exposure of more phosphorylation
sites, it was likely to reduce the amount of DFP labelling due to a
loss in reactivity of serine residues. Therefore the whole lipid
r 31
droplets were also incubated with 1,3- H DFP as described in the
legend to Fig. 9.7.
Fig. 9.7a shows that the Mr 40 000 protein was the major apoprotein
in this preparation with minor proteins of Mr 90 000, 68 000, 53 000/
47 000, and 20 000. However the autoradiograph obtained from this gel
T 3 1showed that none of the proteins were labelled by 1,3- H DFP, even
when these proteins were in a conformation much closer, presumably,
3
to their native state (Fig. 9.7b). The results obtained when H
incorporation was determined after gel slicing and NCS solubilisation
indicated that possibly one or two proteins with Mr about 21 000 and
labelling experiments was a protein with Mr 82 000-84 000 labelled.
Overall the results obtained in Sections 9.2, 9.3 and 9.4 showed
that both rat adrenal and bovine adrenocortical lipid droplets contained
a major apoprotein with a subunit Mr 40 000. Several minor proteins
were also detected and the pattern was similar in both species.
20 000 were labelled (Fig. 9.8).
125K 92K 66K 50K t3K 23 5K 12K fR0nt
SLICE No
Fig. 9.6. 3-"^hJ DFP-labelling of bovine apoACLD; Gel slices.
The experiment was performed as described in the legend to Fig. 9.5
3 . .....
except that H incorporation was determined by liquid scintillation
counting after elution of the protein from excised gel slices by
NCS tissue solubiliser (see methods section).









Fig. 9.7. ^1,3-^hJ DFP-labelling of whole bovine lipid droplets;
Fluorography. Bovine lipid droplets were incubated with 30 yM
JjL,3-^hJ DFP (6 Ci.mmol for 30 min at 37°C. The rest of the
experimental details are as described in the legend to Fig. 9.5.
3 .
H incorporation was determined by fluorography as described m
the methods section.
a, Protein stain; b, Autoradiograph/fluorograph.
The arrows indicate the position on the gel of molecular weight
standards.
125K 32K 66* 50* 63* 23* SK 12* OVE FRONT
i 1 ^ \ I I I)
SLICE No
Fig. 9.8. £l,3-^HJ DFP-labelling of whole bovine lipid droplets;
Gel slicing. The experiment was performed as described in the legend
3 .
to Fig. 9.7 except that H incorporation was determined by liquid
scintillation counting after elution of protein from excised gel
slices by NCS tissue solubiliser (see methods section).
The arrows indicate the position on the gel of molecular weight
standards.
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However, it was not known if the Mr 40 000 protein was identical in both
species, because this protein was phosphorylated in rat lipid droplets
but not in bovine lipid droplets, although it was phosphorylated in both
species after the delipidation treatment. No evidence was obtained to
suggest that CEH was a major component of the protein in either rat or
bovine adrenal lipid droplets.
9.5 PRELIMINARY EXPERIMENTS ON THE EFFECTS OF BOVINE ADRENOCORTICAL
LIPID DROPLETS ON BOVINE ADRENOCORTICAL CYTOSOLIC CEH ACTIVITY
It is well documented that some enzymes that act on hydrophobic, lipid
substrates require protein cofactors for full activity. Lipoprotein lipase
requires apolipoprotein C-II (Ganeson, Bradford et_ a]^. (1971)) , lecithin:
cholesterol acyl transferase (LCAT) requires apolipoprotein A-I (Fielding,
Shore and Fielding (1972)) and pancreatic lipase requires its colipase
(Borgstrom, Erlanson-Albertsson andWieloch (1979)) for maximal enzymic
activity. The substrates for these enzymes are triacylglycerols in
chylomicrons and VLDL, lecithin and cholesterol in HDL and triacylglycerols
complexed with bile salts and phospholipids, respectively. These
substrates are similar in nature to the cholesteryl ester-rich lipid
droplets that are the substrates for CEH in the adrenal cortex. It was
possible that a protein associated with the lipid droplets might serve
as a cofactor for CEH activity in the same way as apolipoprotein A-I in
HDL and apolipoprotein C-II in chylomicrons and VLDL stimulate LCAT and
lipoprotein lipase, respectively. Therefore, the effect of bovine
adrenocortical lipid droplets on cytosolic CEH activity was investigated.
9.5.1 Effect of bovine adrenocortical lipid droplets on the activity of
bovine adrenocortical cytosolic CEH
Bovine adrenocortical lipid droplets, prepared and washed as described
in the methods section, were added in increasing amounts to a constant
amount of bovine adrenocortical cytosol and the CEH activity measured as
described in the methods section.
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Bovine lipid droplets were found to contain CEH activity (Fig. 9.9).
On this occasion, with equal volumes of these particular preparations,
the CEH activity associated with the lipid droplets was about 44% of the
activity in the cytosol. The activity was expressed as cpm to allow
easy comparison of the two activities. The specific activity of the
enzyme in the cytosol was 650 pmol oleic acid produced.min ''".mg protein
whereas the specific activity in this lipid droplet preparation was
approximately 90 times this due to the low protein concentration of the
lipid droplet preparation (0.023 mg ml "") .
No stimulation of the CEH activity in the cytosol was observed upon
the addition of bovine lipid droplets (Fig. 9.9). The slope of the line
obtained with cytosol plus lipid droplets was not significantly different
from the slope of the line obtained with lipid droplets alone (p>0.1).
The results indicated that there was no protein in the lipid droplets
that could act as a cofactor for cytosolic CEH. However the degree of
interaction between the cytosolic CEH, the lipid droplets and the substrate
emulsion was unknown. The results also indicated that the cholesterol
esters in the lipid droplets did not interfere in the assay. The total
cholesterol concentration of this preparation of lipid droplets was
0.55 mg ml and so up to 12 yg of cholesterol ester derived from the
lipid droplets was added to the CEH assays in this experiment. As the
amount of labelled cholesterol ester in the substrate emulsion was
33 pg per assay, the lipid droplet cholesterol ester would represent a
dilution of up to -j. However no substrate inhibition was observed in
this experiment.
9.5.2 Effect of bovine adrenocortical lipid droplets on the modulation
of bovine adrenocortical cytosolic CEH
Although no evidence was obtained to suggest that lipid droplets
contain a protein cofactor for cytosolic CEH it was possible that the
Fig. 9.9. Effect of bovine adrenocortical lipid droplets on bovine
cytosolic CEH activity. Bovine adrenocortical lipid droplets
(560 yg cholesterol and 23 yg protein per ml in 10 mM potassium phosphate
buffer pH 7.4)were added in the amounts indicated to 20 yl bovine
tissue cytosol (4.7 mgml followed by addition of cholesterol
oleate substrate emulsion. CEH activity was determined as described
in the methods section.
O Bovine lipid droplets alone : Slope = 40.4 - 3.0 (Standardr r r error)
#, Cytosol plus bovine lipid droplets : Slope = 46.9 - 3.2 ^"g^ror)1"^
N.B. CEH activity was expressed as cpm above background to allow
comparison. Points are means - S.E.M. of triplicate assays. Slopes
were calculated by the method of least squares.
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putative cofactor may assist or affect the modulation of CEH activity.
This was investigated by preincubating bovine adrenocortical cytosol
oleate substrate emulsion was then added and CEH activity determined as
described in the methods section.
On this occasion the CEH activity associated with the lipid droplets
was much lower and represented less than 3% of the cytosolic CEH activity
(Fig. 9.10). In repeat experiments (see also Table 9.1) the CEH activity
associated with lipid droplets was always of this order. Incubation of
. . 2+
the lipid droplets with Mg resulted in almost complete deactivation of
the associated CEH activity. This suggested that there was phosphoprotein
phosphatase activity associated with the lipid droplets. However
2+
incubation of the lipid droplets with Mg /ATP/cAMP did not result in
activation of the associated CEH activity and so the lipid droplets did
not contain cAMP-dependent protein kinase. Furthermore, no significant
difference in the cytosolic CEH activity in either basal, deactivated or
activated states was found upon the addition of bovine lipid droplets to
the preincubations. Therefore, apart from the associated phosphoprotein
phosphatase activity, there was no evidence to suggest that the protein
fraction of lipid droplets could significantly effect the modulation of
cytosolic CEH activity.
9.5.3 The CEH activity associated with bovine adrenocortical lipid
It was clear from these preliminary experiments that there was CEH
activity associated with bovine adrenocortical lipid droplets. However
this activity was variable as more activity was associated with the
lipid droplet preparation used in Section 9.5.1 compared to the lipid
droplet preparation used in Section 9.5.2. Repeat experiments showed
2+ 2+
with Mg or Mg /ATP/cAMP in the presence or absence of bovine lipid
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Fig. 9.10. Effect of bovine adrenocortical lipid droplets on the
modulation of bovine adrenocortical cytosolic CEH activity.
Samples of cytosol (7.3 mgml ^), or lipid droplets (296 yg cholesterol.ml ,
or cytosol plus lipid droplets were preincubated with basal, deactivation
2+
(Mg ) or activation (cAMP) buffers as described in the methods section.
r 141Cholesterol 1- C oleate substrate emulsion was then added and CEH
activity measured as described in the methods section.
Results are means - S.E.M. of triplicate assays.
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that the lower activity was more frequently observed. The reason for
the higher activity obtained in Section 9.5.1 was unknown but it may be
due to incomplete washing.
Furthermore, some phosphoprotein phosphatase activity was associated
with the lipid droplets and the studies in Section 9.2 showed that there
were minor proteins associated with lipid droplets. These results
suggest that a carefully controlled and efficient washing scheme for the
lipid droplets must be used, in order to remove proteins that are not
integral but are merely associated with lipid droplets due to their
hydrophobic nature. An experiment was performed to investigate the
effect of sequential washing on the lipid droplets by monitoring total
cholesterol, protein (concentration and SDS/PAGE) and CEH activity.
Table 9.1 shows the effect of sequential washing of bovine lipid
droplets. The total cholesterol:protein ratio rose from 1.3 in the
unwashed state to 26.3 after 2 washes. This ratio was not appreciably
altered by further washing. The specific activity of CEH associated
with the lipid droplets also remained constant through washes 2-4,
suggesting a small amount of CEH enzyme protein was a permanent
consistuent of the lipid droplets. Fig. 9.11 shows that the protein
patterns on SDS/PAGE were almost identical after 2 and 4 washes, and
were similar to the previous results, although the problems of
inconsistent solubilisation and recovery of all the proteins were again
observed. However the results show that washing the lipid droplets
twice (as was the case in all experiments in this study) was effective
in removing loosely associated protein, and that fully washed bovine
adrenocortical lipid droplets consist of about 4% protein by weight.
9.6 SUMMARY
1. Rat adrenal and bovine adrenocortical lipid droplets were found to
contain a major apoprotein with a subunit of Mr 40 000.
Treatment
ProteinConcentration (mgml1)
TotalCh lesterol Concentration (mgml*)
Cholesterol Protein
CEHActivity
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Fig. 9.11. Effect of washing on the proteins associated with bovine
adrenocortical lipid droplets. Lipid droplets were prepared and
washed sequentially as described in the text. Samples from different
stages were subjected to SDS/PAGE on a 10% gel as described in
Section 9.2.2.
a, Unwashed lipid droplets (approximately 80 yg); b, Lipid droplets
washed twice (approximately 32 yg); c, Lipid droplets washed four
times (approximately 25 yg).
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2. This apoprotein was able to be phosphorylated in rat adrenal but
not bovine adrenocortical lipid droplets.
3. The delipidated apoprotein was able to be phosphorylated in both
cases.
4. Various minor proteins were found in both rat adrenal and bovine
adrenocortical lipid droplets, and some were able to be phosphorylated.
The protein and phosphorylation patterns observed were similar in rat
adrenal and bovine adrenocortical lipid droplets.
5. The major apoprotein with Mr 40 000 was not labelled by |\,3-^hJ DFP
but one or two minor proteins may be labelled by this reagent.
6. No evidence was obtained to suggest that CEH was a major component
of the protein fraction of rat adrenal or bovine adrenocortical lipid
droplets. However there was some CEH activity associated with bovine
adrenocortical lipid droplets.
7. Phosphoprotein phosphatase may also be associated with bovine
adrenocortical lipid droplets, but cAMP-dependent protein kinase was not
detected.
8. Sequential washing showed that bovine adrenocortical lipid droplets
contained 4% by weight of protein.
9. There was no evidence to suggest that any protein in bovine
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The primary aim in the study of adrenocortical cytosolic CEH was the
purification of the enzyme protein. In this study, detergent
solubilisation, hydrophobic chromatography and affinity chromatography
were investigated in this connection. A procedure for the partial
purification of the enzyme from bovine adrenocortical cytosol, using
detergent solubilisation was developed and the identification of the enzyme
r 32 i r 3 ]
protein was attempted using I y- Pi ATP and I 1,3— Hi DFP to label the
enzyme.
Initial studies with detergents had shown that cholate effectively
solubilised the CEH activity in ammonium sulphate precipitates prepared
from bovine adrenocortical cytosol. The solubilised enzyme eluted on
Sepharose CL-4B chromatography in one peak at 1.8 x Vq indicating
particles of uniform and relatively low molecular weight. The cholate
solubilised enzyme, so obtained, showed about an 8-fold purification
over the tissue cytosol. However, prolonged exposure of the enzyme to
cholate at 4°C resulted in significant losses of enzyme activity.
This prevented further purification of the enzyme in buffers containing
cholate even when the cholate concentration was as low as 0.02%.
Furthermore, ion-exchange chromatography was attempted, however cholate,
being an ionic detergent, interfered with the protein-adsorbant interactions.
It was probable that in the cholate solutions, the enzyme was present in
rather homogeneous protein-detergent complexes of similar charge, and
that these bind to and then elute en masse from the columns of opposite
charge. It is unlikely that cation exchangers would be more successful
in the purification of the diolate solubilised enzyme, as similar
problems would arise. Although cholate was found to be the most effective
detergent in the solubilisation of CEH, other non-ionic detergents,
such as nonylglucoside and Nonidet P42 gave encouraging results.
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It may be possible to avoid the problems of cholate-induced deactivation
and interference in ion-exchange techniques by exchanging the cholate
for a non-ionic detergent after the Sepharose CL-4B step. The hydroxyl-
apatite step just prior to the ion-exchange steps would be suitable
position for such a procedure. However, it is probable that non-
ionic detergents will also inhibit the CEH activity (see Berglund, Khoo
et_ a_l. (1980) , Fredrikson, Stalfors et al. (1981a) ) .
It was thought that hydrophobic chromatography would be a useful
technique in the purification of a lipophilic protein such as CEH.
However, in this study where a range of ligands were investigated a
successful purification was not obtained under the conditions
investigated. It was found that the enzyme could be successfully bound
to the columns, but it was impossible to elute the bound enzyme using a
wide range of elution conditions. It was possible that the enzyme was
eluted but in an inactive state. As the identity of the enzyme protein
was not known at this time, this could not be investigated. Cholate
solubilised enzyme was used in these experiments and so it was possible
that cholate was interfering in the protein-adsorbant interactions.
Some parallel experiments were performed with cholate solubilised enzyme
after dialysis to remove the cholate and this gave identical results
(results not shown). However the enzyme activity was unstable after
removal of the detergent. These results suggested that hydrophobic
chromatography, under the conditions investigated, was of little value in
the purification of CEH from bovine adrenocortical cytosol. There have
been no other reports on the use of this technique in the purification
of adrenal cytosolic CEH or HSL from adipose tissue.
Conventional affinity chromatography techniques are difficult to
apply to an enzyme such as CEH, where a hydrophobic substrate is the only
biospecific ligand. The problems associated with synthesising a
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conventional affinity matrix using cholesterol esters of long chain fatty
acids have prevented the use of this technique. However a simple
affinity column using glass beads non-covalently coated with cholesterol
oleate was developed in this study. CEH was bound to this column at
pH 8.4 and could be eluted by reducing the pH and inclusion of cholate
in the buffer. The enzyme activity was labile and was unable to be
stabilised. No protein could be detected on SDS/PAGE of the concentrated,
purified enzyme. One explanation for these results was that the enzyme
was in low concentration in the tissue. This, combined with the low
capacity of the affinity column, resulted in extremely small amounts of
enzyme protein being purified.
In a recent study, where CEH from bovine adrenocortical cytosol was
purified 300-fold, in the peak fraction, from a hydroxylapatite column,
the CEH represented only 1-2% of the protein in the purified fraction
(Cook, Lee and Yeaman (1981)). ^hJ DFP incorporation experiments
suggested a 15 000-fold purification would be necessary to purify the
enzyme to homogeneity. These results confirmed that CEH was in low
concentration in this tissue. Based on these figures the maximum amount
of enzyme protein present in the purified fraction from the affinity
column would be about 3-4 yg assuming 100% recovery. The results shown
in Fig. 4.4 showed that the enzyme was only partly eluted by different
conditions, although no detailed study could be performed due to the
instability of the enzyme. Therefore it was probable that only 1-2 yg
enzyme protein was eluted from the affinity column and this could be
lost due to binding to the glass surface and so the activity was
quickly lost and no protein was detected on the gels. As it was
probable that no protein was loaded onto the gel it is unlikely that the
more sensitive silver stain would be of any benefit in these experiments.
The discovery that CEH is present in adrenal cortex in such low
concentration has made the need for an effective affinity chromatography
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step in the purification of the enzyme even greater. In general, only
an affinity technique can give the high purification factors necessary
for enzymes in low concentrations. The glass bead column showed that
non-covalently coating a suitable surface with cholesterol oleate could
be a useful technique, but the columns used here were of low capacity.
Attempts to increase the capacity of the column by using larger numbers
of smaller beads were met with technical problems, and a stable coating
was not achieved. Assuming these problems can be overcome, a large
column of small (1 mm) beads with a thin coating of cholesterol oleate
may have the capacity to enable the isolation of pure enzyme in an
active state. Beads of smaller dimensions may not be suitable for this
technique as the thickness of coating may approach the diameter of the
bead and this could lead to increased problems with beads associating
and affecting the flow rate.
During the course of this study, several reports appeared describing
the purification of HSL from chicken adipose tissue (Berglund, Khoo
et^ al_. (1980)) and rat adipose tissue (Khoo, Berglund et al. (1980) ,
Fredrikson, Stralfors et_ al.(1981a)). All these studies included
detergent solubilisation and one reported the use of an affinity technique.
Fredrikson, Stralfors et aJ. (1981a) reported a 2000-fold purification
of HSL from rat adipose tissue using solubilisation by a non-ionic
detergent, f°ll°wed by gradient sievorptive chromatography and
chromatography on a "triacylglycerol-containing gel". This method was
also employed in this study, to determine whether these techniques
could be applied to the purification of CEH from adrenal cortex.
The CEH was purified 150-fold from bovine adrenocortical cytosol
by a modification of this method up to the second gradient sievorptive
chromatography step (CEH^ preparation). However attempts at affinity
chromatography using cholesterol oleate-containing gel or cholesterol
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oleate-coated glass beads were unsuccessful in further purification of
r 321 r 31the enzyme. Labelling experiments with I y- P ATP and 11,3— H DFP
indicated that the CEH enzyme protein had Mr 82 000-84 000. This protein
was not observed on SDS/PAGE when the gel was stained for protein.
This was not surprising as the enzyme protein would only represent 1%
of the total protein in this preparation. The silver stain should be
able to detect the protein if about 50 yg total protein was loaded on
the gel, however it may be masked by the many other proteins in the
preparation.
The estimate for the molecular weight of CEH from bovine adrenal
was similar to the molecular weight of 84 000 estimated for HSL in rat
adipose tissue (Khoo, Berglund e_t a_l. (1980), Fredrikson, Stralfors
_e£ al_. (1981a)) . Furthermore CEH was able to be partially purified from
bovine adrenal cortex using similar methods to those used for the
r 31
purification of HSL from rat adipose tissue. 1,3- H DFP labelling
of the CEHq2 Preparation resulted in two main proteins labelled with
Mr 84 000 and approximately 50 000. This was similar to the pattern of
labelling found by Fredrikson, Stralfors et_ al. (1981a) when the HSLn„
r 3i ...
preparation was labelled with 1>3- H DFP. Both enzymes were inhibited
to a similar degree by DFP. Incubation of the HSL „ preparation with
r 321ly- P ATP resulted in only one protein with Mr 84 000 being labelled
(Fredrikson, Stalfors et_ aH. (1981a)). A similar result was also found
in this study with one CEH^ preparation, although in general several
other proteins were also labelled. These results suggested that the CEH
activity of adrenal cortex and the HSL activity of adipose tissue were
contained on the same enzyme protein.
In another series of studies the HSL from chicken and rat adipose
tissue was purified 325- and 300-fold, respectively, using solubilisation
with Triton X-100 followed by ion-exchange chromatography (Berglund,
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Khoo £t^ a_l. (1980) , Khoo, Berglund e_t al_. (1980) ) . Although these
r 321preparations contained several proteins,! y- PJ ATP-labelling studies
indicated Mr's of 42 000 and 84 000 for the chicken and rat enzymes
respectively. Some preliminary evidence suggested that if the chicken
enzyme was treated with SDS buffer for only a short time at room
temperature an Mr of approximately 85 000 was obtained on SDS/PAGE
(Khoo, Berglund £t_ al_.(1980)). Cook, Lee and Yeaman (1981) reported a
60-fold purification of CEH from bovine adrenal cortex using solubilisation
by Triton X-100 and ion-exchange chromatography. A major band with
Mr 41 000 was observed in this preparation. Incubation of this
r 31
preparation with 1,3- H DFP gave two labelled proteins with Mr 84 000
and 29 000. Further chromatography on hydroxylapatite showed that the
. . 3
enzyme activity cofractionated with the H-labelled protein with
Mr 84 000, and was resolved from the Mr 41 000 and 29 000 proteins.
Therefore, as before, comparable procedures had been used, with similar
results in the purification of HSL from adipose tissue and CEH from
adrenal cortex.
Recently, a direct comparative study has been carried out on the
HSL from rat adipose tissue, purified by s°lukiiisati°n an^
gradient sievorptive chromatography (HSL^ preparation) and the CEH
from bovine adrenal cortex, purified by Triton X-100 solubilisation and
ion-exchange chromatography (Cook, Yeaman et_ al_. (1982)) . Comparison of
substrate specificities, inhibition characteristics, phosphorylation
and activation of the two enzymes provided strong evidence that the two
activities were catalysed by proteins that were identical to, or very
similar to each other.
The CEHq2 preparation contained no phosphoprotein phosphatase
activity but did exhibit residual cAMP-dependent and -independent
protein kinase activities. A further purification step is required to
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remove the protein kinase activity before this preparation could be used
in studies of the postulated control mechanism. However the ^3^2
detergent inhibits CEH, and may have inhibitory effects on phosphoprotein
phosphatase and cAMP-dependent protein kinase. Preliminary studies
(Section 6) showed that detergent inhibition is likely to prove a problem
if the CEH^ preparation is used as the source of CEH activity for
these experiments. It may be possible to exchange the detergent
for a less inhibitory detergent on a hydroxylapatite column, although
the two other detergents used with the CEH/HSL enzyme, cholate and
Triton X-100, have also been found to deactivate the enzyme on long term
exposure (see Section 3.4 this thesis, Berglund, Khoo et al.(1980)).
Therefore, although detergent solubilisation has been useful, and indeed,
necessary for the purification and identification of the CEH enzyme
protein it may prove to be imcompatible with detailed enzymological
studies of the enzyme.
This thesis contains the first reported study of the effect of a
phosphoprotein phosphatase, purified from bovine adrenocortical cytosol,
on the activity of bovine adrenocortical cytosolic CEH. An Mr 35 000,
multifunctional phosphoprotein phosphatase was purified to a state
approaching homogeneity. This enzyme was active when assayed against
32 32
p-nitrophenyl phosphate, P-labelled phosphohistone and P-labelled
phosphoCEH preparation. Divalent cations were not required for the
2+
phosphoprotem phosphatase activity but Mg and a thiol such as
2-mercaptoethanol were required for the alkaline phosphatase activity.
However, this enzyme did not deactivate CEH in the absence of divalent
cations and the addition of low concentrations of Mn^+, Mg^+, Co^+ and
2"^* 2+ 2+
Ca did not affect this result. Higher concentration of Mn and Mg
stimulated endogenous phosphoprotein phosphatases in the CEH preparation
used (cholate solubilised enzyme) and made interpretation of results
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2+
difficult. Higher concentrations of Ca also tended to inhibit the
enzyme activity. It was not known if this was a direct effect on the
enzyme activity or if it was due to the stimulation of endogenous
phosphoprotein phosphatases. There is little known about the effect of
2+
Ca or calmodulin on the enzyme system.
These results suggested that the low molecular weight phosphoprotein
phosphatase or catalytic subunit of the high molecular weight phosphatases
was not able to deactivate CEH. It was possible that another subunit,
present in the physiological forms of the phosphoprotein phosphatase,
was required for the dephosphorylation and deactivation of CEH. High
molecular weight forms of phosphoprotein phosphatase have been purified
from adrenal cortex, but the activities were not measured against CEH
(Kalala, Goris and Merlevede (1973), Ullman and Perlman (1975)).
There have been studies into the subunit composition of high molecular
weight phosphoprotein phosphatases but little is known about the
functions of these subunits (Tamura and Tsuiki (1980), Tamura, Kikuchi
et_ al_. (1980)) . The role of the phosphoprotein phosphatase with a
catalytic subunit, F , with Mr 70 000 and an activator protein, F ,
C A.
with Mr 50 000 (Yang, Vandenheede e_t al_. (1980), Vandenheede, Yang
et_ al_. (1980)) in the regulation of CEH activity in adrenal cortex is
unknown and requires further investigation. For these studies a pure
preparation of CEH, or one free from endogenous phosphoprotein
phosphatase activity, such as the CEH^ preparation, would be required.
This preparation was not available at the time that the experiments
described here were performed.
A phosphoprotein phosphatase with Mr 28 000 on Sephadex G-75, was
purified from rat adipose tissue via an ethanol precipitation step
(Severson and Sloan (1980)). This enzyme was able to deactivate the HSL
of rat adipose tissue in a divalent cation-dependent reaction.
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No SDS/PAGE evidence of the purity of this enzyme was given, and the
relationship of this enzyme to the Mr 35 000 phosphoprotein phosphatase
was not known. However, it was possible that the Mr 28 000 phosphoproteiu
phosphatase preparation contained other protein subunits of the
physiological phosphoprotein phosphatase, as it was not purified to the
extent that the Mr 35 000 subunit was.
Apolipoprotein A-I was found to inactivate CEH in a dose dependent
manner. Prior activation of CEH appeared to increase the sensitivity of
the enzyme to the inhibition. There are several possible mechanisms
that could explain these results such as: apolipoprotein A-I interacts
with the active centre of CEH, and the interaction is enhanced by
phosphorylation possibly via conformational changes; apolipoprotein A-I
interacts with another site on the enzyme and phosphorylation results in a
conformational change which leads to a more exposed allosteric site;
apolipoprotein A-I specifically deactivates CEH by dephosphorylation,
either directly or via stimulation of a phosphoprotein phosphatase;
apolipoprotein A-I interacts with the substrate emulsion to form
complexes in which the cholesterol ester is not available to CEH;
apolipoprotein A-I sequesters the newly formed fatty acid and prevents
its release into the aqueous layer of the assay system.
Studies showed that the apolipoprotein A-I did not contain non¬
specific phosphoprotein phosphatase activity and did not stimulate
phosphoprotein phosphatases. However it was able to interact and
disrupt the cholesterol oleate substrate emulsion in the presence of
phospholipid. Therefore interaction with the substrate emulsion could
partly explain the results. Control tubes with apolipoprotein A-I and
r 14 i . . .
cholesterol 1- C oleate substrate emulsion gave similar background
readings (which indicate the amount of [x-»c] oleate in the emulsion)
as the substrate emulsion on its own, indicating that apolipoprotein A-I
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[ 1-Uc]0
[l-UC ] odid not sequester 1- C oleic acid. However this was not tested with
leic acid standards. It may be possible in the future to
further elucidate the mechanism of the apolipoprotein A-I inhibition
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using purified CEH preparations with I-labelled apolipoprotem A-I,
r 3 i r 32 iI 1,3- HI DFP or a radiolabelled substrate analogue and I y- PI ATP.
The interaction of apolipoprotein A-I with different, labelled forms of
the enzyme may determine the nature of the interaction if it is a direct
apolipoprotein A-I/CEH enzyme protein interaction.
The physiological significance of such an inhibition is not known.
It is possible to speculate that HDL degradation in adrenal cortex could
lead to the deactivation of CEH via the production of apolipoprotein A-I.
This would prevent depletion of cholesterol ester stores during a
prolonged ACTH stimulation when lipoprotein uptake is increased, and
allow the build up of cholesterol ester stores following a prolonged ACTH
stimulus (see Fig. 1.1). However there is no evidence to suggest that
HDL plays a major role in the provision of cholesterol to bovine adrenal
glands. Furthermore, although it has been found that apolipoprotein A-I
inhibits hepatic triglyceride lipase, the mechanisms and physiological
significance of this inhibition are unknown (Kubo, Matsuzawa et al. (1981)).
Cytosolic CEH activity in rat adrenal was found to exhibit a diurnal
variation in its activity in response to the circadian rhythm of the
pituitary-adrenal axis. This is in contrast to an earlier report by
Pederson and Brownie (1979) where no difference in CEH activity was
found when measured at the high and low points of the circadian cycle.
The authors also stated that with sampling at 4 h intervals, a circadian
rhythm in CEH activity was either absent or very modest, however no
data were shown. Recently, the diurnal rhythm in rat adrenal cytosolic
CEH was confirmed by Beins, Vining and Balasubramaniam (1982), who
measured the enzyme activity at 10 points in the 24 h period.
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In the study here, serum corticosterone was found to reflect the
variation in CEH activity. The variation of plasma corticosterone found
by Beins, Vining and Balasubramaniam (1982) was similar to the variation
observed here. The concentration increased from a minimum in the middle
of the light phase to a maximum in the early part of the dark phase,
before decreasing in the later part the dark phase back to the minimum.
However the variation in adrenal CEH found by Beins, Vining and
Balasubramaniam (1982) did not fully correlate with the plasma
corticosterone or the known pattern of ACTH secretion. The CEH activity
increased from a low point in the middle of the light phase to a high
point at the onset of the dark phase, then decreased through the dark
phase to another low point before increasing to a further high level at
the onset of the light phase. This high level at the onset of the light
phase does not reflect the known ACTH secretion (Ixart, Szafarczyk et_ al.
(1977)) and was not reflected in the plasma corticosterone concentration.
Recently, a further study has described a diurnal rhythm for cytosolic
CEH in rat adrenals when the enzyme activity was measured at 6 points in
a 12 h light-12 h dark cycle (Civen, Leeb and Morin (1982)). However
the CEH activity was found to be lower during the dark phase than
throughout the light phase. This variation does not correlate with the
known ACTH and corticosterone rhythms, and is not compatible with the
results presented here or by Beins, Vining and Balasubramaniam (1982).
In the study here, the concentration of circulating ACTH was
perturbed by prior administration of either corticoid or ACTH iri vivo,
and the effect on adrenal CEH activity and serum corticosterone
concentration was monitored. Acute ACTH administration increased the
CEH activity and the serum corticosterone concentration at all points
in the light-dark cycle. Furthermore the diurnal variations observed
in the control group were almost totally abolished by the ACTH treatment.
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These results supported the view that rat adrenal cytosolic CEH activity
was under in vivo regulation by circulating ACTH. Furthermore, the
CEH activity at all time points was increased to a similar level by the
large dose of ACTH, suggesting an upper limit to the enzyme activity.
Dexamethasone treatment to suppress the pituitary secretion of ACTH
resulted in significant decreases in both CEH activity and serum
corticosterone at all time points. However the pattern of diurnal
variation in CEH activity and serum corticosterone was still observed
and unchanged. Recently it has been shown that dexamethasone blocked
the ACTH response but not the a-MSH response in rat pituitary corticotrophs
stimulated by synthetic CRF (Proulx-Ferland, Labrie et al.(1982)).
This suggests that only ACTH secretion is suppressed by dexamethasone,
and that the secretion of other peptides, derived from the POMC
molecule , is not affected. Therefore a reduction in adrenal cytosolic
CEH was observed here, probably, in response to a reduction in ACTH alone.
Taken together the results indicated that adrenal CEH activity was under
in vivo regulation in response to the levels of circulating ACTH, and
that the variation in enzyme activity observed was not due to some
inherent property of the adrenal cortex.
A simple method was devised for obtaining the lipid droplet
fractions from rat adrenal and bovine adrenocortical cytosol. It was
found that after two washes the total cholesterol:protein (mg:mg)
ratio was about 26:1 indicating that bovine adrenocortical lipid
droplets contained about 4% by weight protein. Further washing did not
alter this ratio, suggesting that two washes were sufficient to remove
loosely associated protein. The similarity or relationship of the lipid
droplets, so obtained, to the physiological situation in vivo was unknown.
A major apoprotein with a subunit Mr approximately 40 000 was found in
both rat and bovine lipid droplets. Several other proteins were observed
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including ones with Mr 90 000, 75 000, 65 000, 53 000, 20 000 and 12 000.
However, problems were encountered due to the low solubility of the
delipidated proteins in aqueous media. This resulted in some inconsistency
in the amount and relative proportions of the different apoproteins
observed in different experiments. The specific treatments devised for
the delipidation of plasma lipoproteins may provide more consistent
results, but the method used here led to unacceptable losses of the
already small amounts of protein in these preparations. The acetone
treatment substantially improved the yields of protein but did not
overcome the inconsistency introduced by incomplete resolubilisation
of the delipidated protein.
Labelling the protein fractions in whole lipid droplets with
phosphorylation of the Mr 40 000 apoprotein in the rat, but not bovine
tissue. After delipidation the Mr 40 000 subunit was phosphorylated in
both cases. Although, the possible reasons for the lack of labelling
in whole bovine lipid droplets were discussed in molecular terms,
the physiological significance of this finding was unknown. Several
other protein subunits were also phosphorylated, with a similar pattern
in rat and bovine tissue, but the physiological role of these
phosphorylations and whether they occur in_ vivo was not known.
In preliminary experiments no cAMP-dependent protein kinase activity
was detected in the bovine lipid droplets, although phosphoprotein
phosphatase activity was observed in these preparations.
Some CEH activity was found to be associated with bovine lipid
droplets. The specific activity after two washes was approximately 8 nmol
oleic acid produced.min ^.mg protein \ and subsequent washing did not
alter this figure. This suggested that the CEH enzyme protein was a
permanent constituent of the protein fraction of bovine adrenocortical
cAMP-dependent protein kinase resulted in the
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lipid droplets. The specific activity was approximately 10 times that
of the enzyme in the cytosol, due to the low protein concentration of the
lipid droplets. However, a subunit with Mr 82 000-84 000 was not
r 321detected m the lipid droplet protein fractions by I y- PI ATP or
r 31 . . . .1,3- Hi DFP labelling. This did not constitute a major contradiction
as the enzyme in cytosol would require a 15 000-fold purification for
homogeneity, and so even in lipid droplets where the enzyme was 10-fold
purer the enzyme protein would only constitute 0.075% of the total
protein. In most of the labelling experiments this would be about 0.1-
0.01.pg CEH enzyme protein. However the amount of protein used in the
r 321
y- P ATP-labelling of whole bovine lipid droplets was higher and
possibly some phosphorylation in the Mr 82 000-84 000 region was
detected. Preliminary experiments indicated that whole lipid droplets
did not significantly alter the activity of CEH in the cytosol,
suggesting a protein cofactor for the enzyme activity was not present
in the droplets.
10.2 OVERALL SUMMARY
1. Detergent solubilisation was essential for the purification and
identification of the CEH enzyme protein. However problems with detergent
inhibition in purified preparations may obstruct detailed enzymological
studies.
2. The CEH enzyme protein is in low concentration in adrenocortical
cytosol. An affinity technique is essential for the further purification
of the enzyme.
3. Labelling studies suggested that CEH activity in bovine adrenocortical
cytosol was associated with a protein with a subunit of Mr 82 000-84 000.
This enzyme protein is probably identical to, or similar to, the HSL
enzyme protein found in rat adipose tissue.
4. Apolipoprotein A-I inhibited bovine adrenocortical cytosolic CEH
activity, but the mechanism and physiological significance of the inhibition
was unclear.
179.
5. A low molecular weight (Mr 35 000) phosphoprotein phosphatase, of
the multifunctional phosphoprotein phosphatase type, purified from
bovine adrenocortical cytosol, did not deactivate bovine adrenocortical
cytosolic CEH.
6. CEH in rat adrenal cytosol exhibits a diurnal variation in its
activity in response to the circadian rhythm of the pituitary-adrenal
axis.
7. Bovine adrenocortical lipid droplets contain approximately 4% protein
by weight. A major apoprotein with a subunit Mr 40 000 was found,
which could be phosphorylated in rat but not bovine lipid droplets.
8. CEH was found to be a minor constituent of the lipid droplet
protein fraction.
10.3 FUTURE STUDIES
The CEH enzyme protein from bovine adrenocortical cytosol should be
further purified using detergent solubilisation and an affinity
chromatography technique to confirm the identity of the enzyme protein.
New detergents should be investigated to reduce the effects of detergent
inhibition on the purified preparations. The in vivo regulation of
the enzyme should be further studied in isolated cell systems.
Incubation of bovine adrenocortical cell suspensions or cultures with
32 ...
under different hormonal and other physiological stimuli could
allow the correlation of cytosolic CEH activity with the phosphorylation
state of the enzyme in vivo. Due to the low concentration of CEH and
the probable large number of phosphorylated proteins, it may be necessary
to partially purify the enzyme for these studies.
A physiological, high molecular weight, phosphoprotein phosphatase
should be purified from bovine adrenocortical cytosol, and its effect
on the dephosphorylation and deactivation of purified cytosolic CEH
in vitro, should be studied. The role of the non-catalytic subunits
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of the physiological phosphoprotein phosphatase should be investigated.
The role of the phosphorylatable phosphoprotein phosphatase inhibitor -1
in the regulation of cytosolic CEH could be studied in_ vitro and in vivo,
in the experiments described above.
The protein fraction of bovine adrenocortical lipid droplets should
be further studied to elucidate the role(s), if any, of the apoproteins.
The primary task is the development of a reliable delipidation and
resolubilisation procedure for the consistent and quantitative recovery
of the apoproteins for SDS/PAGE. However it may not be possible to
obtain all the apoproteins in aqueous solution, to determine the effect
of the apoproteins on the CEH enzyme activity, due to their
hydrophobic nature.
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